
<html lang="en"     class="pb-page"  data-request-id="eecea8e4-3985-45bc-aa35-3f053154d994"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-22;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01290;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition" /></meta><meta name="dc.Creator" content="Hui  Cai" /></meta><meta name="dc.Creator" content="Rou-Shu  Zhang" /></meta><meta name="dc.Creator" content="Jared  Orwenyo" /></meta><meta name="dc.Creator" content="John  Giddens" /></meta><meta name="dc.Creator" content="Qiang  Yang" /></meta><meta name="dc.Creator" content="Celia C.  LaBranche" /></meta><meta name="dc.Creator" content="David C.  Montefiori" /></meta><meta name="dc.Creator" content="Lai-Xi  Wang" /></meta><meta name="dc.Description" content="The N332 high-mannose glycan on the HIV-1 gp120 V3-loop is the target of many bNAbs. About 17% HIV isolates carry the N332 to N334 mutation, but the antibody recognition of the N334 N-glycan and it..." /></meta><meta name="Description" content="The N332 high-mannose glycan on the HIV-1 gp120 V3-loop is the target of many bNAbs. About 17% HIV isolates carry the N332 to N334 mutation, but the antibody recognition of the N334 N-glycan and it..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 1, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01290" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01290" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01290" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01290" /></link>
        
    
    

<title>Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01290" /></meta><meta property="og:title" content="Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0007.jpeg" /></meta><meta property="og:description" content="The N332 high-mannose glycan on the HIV-1 gp120 V3-loop is the target of many bNAbs. About 17% HIV isolates carry the N332 to N334 mutation, but the antibody recognition of the N334 N-glycan and its immunogenicity are not well characterized. Here we report the chemoenzymatic synthesis, antigenicity, and immunogenicity of the V3 N334 glycopeptides from HIV-1 A244 gp120, a key component in the partially successful Thai clinical trials. We found that synthetic V3 glycopeptide carrying a N334 high-mannose glycan could be recognized by bNAb PGT128 and PGT126 but not by 10-1074. Rabbit immunization with the synthetic three-component A244 glycopeptide immunogen elicited substantial glycan-dependent antibodies with broad reactivity to various HIV-1 gp120/gp140 carrying N332 or N334 glycosylation sites. These results indicated that the N334 site is vulnerable and the A244 V3 glycopeptide represents a valuable immunogen for further HIV-1 vaccine studies." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01290"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01290">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01290&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01290&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01290&amp;href=/doi/10.1021/acs.jmedchem.8b01290" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10116-10125</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01281" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01299" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 <i>N</i>-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Hui Cai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hui Cai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Cai">Hui Cai</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5394-8167" title="Orcid link">http://orcid.org/0000-0002-5394-8167</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rou-Shu Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rou-Shu Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rou-Shu++Zhang">Rou-Shu Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jared Orwenyo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jared Orwenyo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jared++Orwenyo">Jared Orwenyo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Giddens</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Giddens</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Giddens">John Giddens</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qiang Yang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qiang Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qiang++Yang">Qiang Yang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Celia C. LaBranche</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Celia C. LaBranche</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Surgery, Duke University Medical Center, Durham, North Carolina 27705, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Celia+C.++LaBranche">Celia C. LaBranche</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David C. Montefiori</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David C. Montefiori</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Surgery, Duke University Medical Center, Durham, North Carolina 27705, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++Montefiori">David C. Montefiori</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Lai-Xi Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lai-Xi Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#297e48474e1c1811695c444d074c4d5c"><span class="__cf_email__" data-cfemail="dd8abcb3bae8ece59da8b0b9f3b8b9a8">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lai-Xi++Wang">Lai-Xi Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4293-5819" title="Orcid link">http://orcid.org/0000-0003-4293-5819</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01290&amp;href=/doi/10.1021%2Facs.jmedchem.8b01290" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10116–10125</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 1, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 August 2018</li><li><span class="item_label"><b>Published</b> online</span>1 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 21 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01290" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01290</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10116%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHui%2BCai%252C%2BRou-Shu%2BZhang%252C%2BJared%2BOrwenyo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D22%26contentID%3Dacs.jmedchem.8b01290%26title%3DSynthetic%2BHIV%2BV3%2BGlycopeptide%2BImmunogen%2BCarrying%2Ba%2BN334%2BN-Glycan%2BInduces%2BGlycan-Dependent%2BAntibodies%2Bwith%2BPromiscuous%2BSite%2BRecognition%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10125%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01290"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">900</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01290" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Rou-Shu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Jared&quot;,&quot;last_name&quot;:&quot;Orwenyo&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Giddens&quot;},{&quot;first_name&quot;:&quot;Qiang&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;C. LaBranche&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. Montefiori&quot;},{&quot;first_name&quot;:&quot;Lai-Xi&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;10116-10125&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01290&quot;},&quot;abstract&quot;:&quot;The N332 high-mannose glycan on the HIV-1 gp120 V3-loop is the target of many bNAbs. About 17% HIV isolates carry the N332 to N334 mutation, but the antibody recognition of the N334 N-glycan and its immunogenicity are not well characterized. Here we report the chemoenzymatic synthesis, antigenicity, and immunogenicity of the V3 N334 glycopeptides from HIV-1 A244 gp120, a key component in the partially successful Thai clinical trials. We found that synthetic V3 glycopeptide carrying a N334 high-mannose glycan could be recognized by bNAb PGT128 and PGT126 but not by 10-1074. Rabbit immunization with the synthetic three-component A244 glycopeptide immunogen elicited substantial glycan-dependent antibodies with broad reactivity to various HIV-1 gp120/gp140 carrying N332 or N334 glycosylation sites. These results indicated that the N334 site is vulnerable and the A244 V3 glycopeptide represents a valuable immunogen for further HIV-1 vaccine studies.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01290&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01290" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01290&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01290" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01290&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01290" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01290&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01290&amp;href=/doi/10.1021/acs.jmedchem.8b01290" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01290" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01290" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01290%26sid%3Dliteratum%253Aachs%26pmid%3D30384610%26genre%3Darticle%26aulast%3DCai%26date%3D2018%26atitle%3DSynthetic%2BHIV%2BV3%2BGlycopeptide%2BImmunogen%2BCarrying%2Ba%2BN334%2BN-Glycan%2BInduces%2BGlycan-Dependent%2BAntibodies%2Bwith%2BPromiscuous%2BSite%2BRecognition%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D22%26spage%3D10116%26epage%3D10125%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291909" title="Immunology">Immunology</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=290879" title="Chemical biology">Chemical biology</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/jmcmar.2018.61.issue-22/20181121/jmcmar.2018.61.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The N332 high-mannose glycan on the HIV-1 gp120 V3-loop is the target of many bNAbs. About 17% HIV isolates carry the N332 to N334 mutation, but the antibody recognition of the N334 <i>N</i>-glycan and its immunogenicity are not well characterized. Here we report the chemoenzymatic synthesis, antigenicity, and immunogenicity of the V3 N334 glycopeptides from HIV-1 A244 gp120, a key component in the partially successful Thai clinical trials. We found that synthetic V3 glycopeptide carrying a N334 high-mannose glycan could be recognized by bNAb PGT128 and PGT126 but not by 10-1074. Rabbit immunization with the synthetic three-component A244 glycopeptide immunogen elicited substantial glycan-dependent antibodies with broad reactivity to various HIV-1 gp120/gp140 carrying N332 or N334 glycosylation sites. These results indicated that the N334 site is vulnerable and the A244 V3 glycopeptide represents a valuable immunogen for further HIV-1 vaccine studies.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Recently, broadly neutralizing antibodies (bNAbs) that target the high-mannose patch on HIV-1 have been discovered and show outstanding neutralization breadth and potency.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> For example, antibody PGT128 could neutralize over 70% of globally circulating viruses,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> while PGT121 has been shown to protect against high-dose vaginal simian human immunodeficiency virus (SHIV) challenge with passive immunization in macaques<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and to suppress virus replication in chronically infected macaques.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Also, 10-1074 was able to suppress viral load when used together with other bNAbs in animal models.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a> Previous studies have shown that bNAbs that target the V3-glycan bind the intrinsic high-mannose patch centered on the N332 high-mannose <i>N</i>-glycan.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9−12)</a> Indeed, we and others have demonstrated that the synthetic JR-FL V3 glycopeptide carrying a N332 high-mannose glycan could mimic the conserved epitope of several bNAbs and elicit glycan-dependent antibody responses by animal immunizations,<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13−16)</a> suggesting the N332 high-mannose glycan can be recognized by the immune system as non-self component and synthetic V3 glycopeptide carrying a N332 high-mannose glycan could mimic the epitope of V3-glycan class of bNAbs.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The V3 domain of HIV-1 typically contains three potential N-glycosylation sites with the N295 and N332 sites at the base and the N301 site within the loop.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The highly conserved <i>N</i>-glycan at N332 is the center of the intrinsic high-mannose patch. However, there are about 17% isolates carrying the N332 to N334 mutation.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The switch of the N-glycosylation from N332 to the N334 site was usually achieved by a double mutation, first at the 334 residue to introduce an Asn and then at the 336 residue to introduce a Ser or Thr residue, which generates a new NXS/T consensus sequence for N-glycosylation at the N334 site.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In fact, many HIV isolates that switch the N332 glycosylation to the N334 N-glycosylation are highly resistant to some of the high-mannose patch targeting bNAbs.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Therefore, it is interesting to examine how those bNAbs recognize the specific <i>N</i>-glycans in the V3 region with a shift of the N-glycosylation site from N332 to N334. In this study, we focused on the A244 strain V3 with a N334 glycosylation site. Interestingly, the corresponding gp120 envelope glycoprotein from the A244 strain was previously chosen as an important component of the vaccine used in the Thai clinical trials that showed a 31.5% reduction in the risk of acquiring infection.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> We sought to systematically study the antigenicity and immunogenicity of the HIV-1 A244 V3 glycopeptides with high-mannose or complex-type <i>N</i>-glycan attached at the N334, N301, and N295 sites. We efficiently synthesized the V3 glycopeptides derived from 244 strain using a chemoenzymatic method. Antibody binding studies indicated that the synthetic V3 glycopeptide with a high-mannose glycan at the N334, N301, or N295 was recognized by PGT128 and PGT126 but not by the N322 glycan-specific antibody 10-1074. Interestingly, 10-1074 was still unable to bind to our A244 V3 glycopeptide even after shifting the glycosylation site from N334 to N332. Preliminary rabbit immunization with a synthetic three-component immunogen containing the A244 glycopeptide elicited glycan-dependent antibodies that were cross-reactive to different HIV-1 gp120/gp140 glycoproteins and different synthetic high-mannose V3 glycopeptides with promiscuity of glycosylation sites.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70782" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70782" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemoenzymatic Synthesis of HIV-1 A244 V3 Glycopeptides</h3><div class="NLM_p">Similar to our previous studies on HIV-1 JR-FL glycopeptides,<a onclick="showRef(event, 'ref13 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref21">(13,21)</a> we selected the HIV-1 A244 mini-V3 domain (33-mer) corresponding to the residues 292–339, while the 305–320 tip residues were replaced by a dipeptide Pro-Gly (PG) insert as the basic peptide sequence.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The chemoenzymatic synthesis of the target A244 glycopeptides used a strategy similar to our previously reported synthesis of JR-FL V3 glycopeptides<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Briefly, cyclic precursor peptides (<b>1</b>) carrying an <i>N</i>-acetylglucosamine (GlcNAc) moiety at the N334 site were synthesized by solid phase peptide synthesis (SPPS) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). To achieve site-specific immobilization on streptavidin surface for binding analysis, a biotin tag was placed at the N-terminus. A Man<sub>9</sub>GlcNAc glycan was then transferred from the corresponding glycan oxazoline (<b>2</b>) using glycosynthase EndoA-N171A<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> to afford the desired glycopeptide (<b>3</b>) with a natural glycosidic bond in excellent yield (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Similarly, a sialylated complex-type glycan was transferred from the sialoglycan oxazoline (<b>4</b>) using EndoM-N175Q<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> as the catalyst to afford glycopeptide (<b>5</b>). Glycopeptides (<b>6</b>, <b>7</b>, <b>8</b>, and <b>9</b>) carrying a high-mannose and a complex type glycan at N301 and N295 sites, respectively, together with the aglycone V3 peptide (<b>10</b>) were also synthesized using the same strategy.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemoenzymatic synthesis of HIV-1 A244 V3 glycopeptides: (a) synthesis of A244 V3 glycopeptides carrying a high-mannose or a complex-type <i>N</i>-glycan at the N334 site; (b) structures of additional synthetic A244 V3 peptides and glycopeptides carrying a high-mannose or a complex-type <i>N</i>-glycan at the N301 and N295 sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Binding of A244 V3 Glycopeptides to bNAbs</h3><div class="NLM_p">The synthetic biotin tagged V3 glycopeptides were captured on NeutrAvidin immobilized CM5 chips with an identical response unit for binding evaluation of bNAbs PGT128, PGT126, PGT121, and 10-1074. We found that bNAb PGT128 could bind to all the V3 glycopeptides (<b>3</b>, <b>6</b>, and <b>8</b>) carrying a high-mannose glycan at the N334, N301, or N295 site with moderate affinity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), but no binding was observed to V3 glycopeptides bearing sialylated complex-type glycan (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Supporting Information, Figure S1</a>.) Thus, shifting the high-mannose <i>N</i>-glycan from N332 to the N334 site did not abolish the binding of antibody PGT128. Similarly, we found that PGT126 could bind all the V3 glycopeptides carrying a high-mannose glycan but not the glycopeptides carrying the complex-type <i>N</i>-glycan. These results verified that the recognition of PGT128 and PGT126 to high-mannose glycan is promiscuous in the context of the V3 peptide, consistent with a previous mutational study.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Interestingly, 10-1074 did not bind to any A244 V3 glycopeptides (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), while in a previous study we found that 10-1074 exhibited strong binding to JR-FL V3 glycopeptides carrying a high-mannose glycan at the N332 site.<a onclick="showRef(event, 'ref13 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref21">(13,21)</a> Switching the high-mannose glycan from N332 to N334 completely abolished binding of 10-1074. Similarly, PGT121 was unable to bind to the A244 glycopeptides bearing a high-mannose <i>N</i>-glycan but could bind to the glycopeptide (<b>7</b>) with a sialylated complex-type <i>N</i>-glycan placed at the N301 site (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Figure S1</a>). The binding specificity of PGT121 was consistent with our previous binding results with the JR-FL V3 glycopeptide.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Lastly, all the bNAbs we tested demonstrated no binding to the aglycone V3 peptide (<b>10</b>) under our SPR conditions (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Figure S1</a>), confirming that the peptide alone is not sufficient to achieve high affinity for these antibodies.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR sensorgrams of binding to A244 V3 high-mannose glycopeptides (<b>3</b>, <b>6</b>, and <b>8</b>) by bNAb PGT128, 10-1074, and PGT126.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Previous structural studies of PGT124, a homologous antibody of 10-1074, indicated that both the N332 high-mannose glycan and the GDIR motif at the base of V3 loop were critical for the binding to envelope glycoprotein gp120.<a onclick="showRef(event, 'ref9 ref24'); return false;" href="javascript:void(0);" class="ref ref9 ref24">(9,24)</a> As the A244 V3 peptide sequence includes the GDIR motif, the major difference between HIV-1 JR-FL and A224 V3 domains is that the conserved N-glycosylation at N332 site was moved to N334. We also synthesized a mutated A244 V3 glycopeptide (<b>11</b>) with the N334 shifted back to N332 and performed its binding to PGT128, PGT126, and 10-1074. This mutated A244 V3 glycopeptide (<b>11</b>) contains a similar N332 high-mannose glycan and the GDIR motif as the JR-FL V3 glycopeptide (<b>12</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Supporting Information, Figure S2</a>). PGT128 and PGT126 were able to bind the glycopeptide (<b>11</b>) with similar affinity as the other A244 glycopeptides which carried a high-mannose <i>N</i>-glycan at N334. Interestingly, the N332 glycan-specific 10-1074 antibody did not show any affinity to glycopeptide (<b>11</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Supporting Information, Figure S2</a>). These results further verified the promiscuous recognition of PGT128 and PGT126 to high-mannose glycan. However, the fact that 10-1074 did not show binding to glycopeptide (<b>11)</b> suggested that other amino acid residues in the V3 loop might be also critical for high-affinity recognition by 10-1074.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Synthesis of A244 V3 Glycopeptide Immunogen</h3><div class="NLM_p">To evaluate the immunogenicity of the HIV-1 A244 V3 glycopeptide, we synthesized a self-adjuvanting three-component HIV immunogen which included the A244 V3 glycopeptide with a high-mannose glycan at the N334 site, the P30 T-helper epitope FNNFTVSFWLRVPKVSASHLE,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and the Toll-like receptor 2 (TLR2) ligand lipopeptide Pam<sub>3</sub>CSK<sub>4</sub> <a onclick="showRef(event, 'ref14 ref26'); return false;" href="javascript:void(0);" class="ref ref14 ref26">(14,26)</a> to activate the immune cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Briefly, the lipopeptide (<b>13</b>), which contains the Pam<sub>3</sub>CSK<sub>4</sub> component, the T-helper peptide epitope, and an azide moiety, was prepared following the previously described procedure.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The A244 V3 glycopeptide (<b>14</b>) with an alkyne moiety placed at the N-terminus was synthesized by the chemoenzymatic method that involved the EndoM-N175A catalyzed transfer of a high-mannose <i>N</i>-glycan to the corresponding GlcNAc-peptide acceptor.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Finally, the desired glycopeptide immunogen (<b>15</b>) was afforded in excellent yield by copper(I)-catalyzed alkyne–azide [3 + 2] cycloaddition reaction (click chemistry) between the lipopeptide (<b>13</b>) and the glycopeptide (<b>14</b>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The identity and homogeneity of (<b>15</b>) were confirmed by analytical HPLC and LC–MS analysis.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesis of three-component HIV immunogen containing the A244 V3 N334 high-mannose glycopeptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Rabbit Immunization</h3><div class="NLM_p last">The three-component HIV-1 V3 glycopeptide immunogen (<b>15</b>) thus synthesized was formulated into liposomes following the previously reported procedures.<a onclick="showRef(event, 'ref14 ref27'); return false;" href="javascript:void(0);" class="ref ref14 ref27">(14,27)</a> The liposomes were then administered to rabbits (<i>n</i> = 3) at low-dosing of 50 μg of synthetic immunogen per immunization, delivered by subcutaneous and intramuscular injections. As the Pam<sub>3</sub>CSK<sub>4</sub> could serve as an adjuvant, no external adjuvants were added. After priming, a total of three boosters were given at intervals of 21 days. Bleeding was done 7 days after the last injection, and the obtained antisera from the three immunized rabbits were combined and used for binding analysis.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> ELISA Binding to gp120/gp140</h3><div class="NLM_p">We first evaluated the recognition of the antisera to an array of HIV-1 gp120 or gp140. The antisera showed significant binding to all the gp120/gp140s tested in our ELISA assays, including A244 gp120, JR-FL gp140, CN54 gp120, and MCON gp120, although the antisera binding to the JR-FL gp140 was relatively weak (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). This promiscuous binding to gp120/gp140 was similar to antibody PGT128 but different from 10-1074. PGT128 recognized all the tested gp120/gp140, but 10-1074 could only bind to the gp120/gp140 with a N332 glycosylation site (JR-FL, CN54, and MCON) but not a N334 site (A244). The broad recognition to gp120/gp140 by the antisera suggested that the N334 high-mannose <i>N</i>-glycan as part of the antigenic structure was also immunogenic and could direct specific immune responses. The antisera induced by previous synthesized V3 glycopeptide (JR-FL strain) immunogen carrying a N332 high-mannose glycan also showed broad recognition to the gp120/gp140.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, the recognition was significantly weaker than that by the A244 V3 glycopeptide immunogen (<b>15</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Table S1</a>). The end point titer to the JR-FL gp140 of the antisera induced by the JR-FL and A244 glycopeptide immunogen was the same. However, for the binding to the A244 gp120, CN54 gp120, and MCON gp120, the end point titer of the antisera elicited by the A244 V3 glycopeptide immunogen (<b>15</b>) was respectively 4-, 2-, and 4-fold greater than that by the JR-FL V3 glycopeptide immunogen (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Table S1</a>). Thus, the synthetic A244 glycopeptide immunogen (<b>15</b>) induced stronger antibody response than the JR-FL glycopeptide, suggesting the V3 glycopeptide bearing a N334 high-mannose glycan is more immunogenic than the V3 glycopeptide bearing a N332 high-mannose glycan.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the binding of the antisera and selected bNAbs to an array of HIV-1 gp120/gp140 envelope glycoproteins: (a) antisera from the A244 glycopeptide immunogen; (b) antibody PGT128; (c) antibody 10-1074. The HIV-1 A244 gp120 carries an <i>N</i>-glycan at the N334 site, while HIV-1 JR-FL gp140, CN54 gp120, and MCON gp120 have an <i>N</i>-glycan at the N332 site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> ELISA Binding to Synthetic A244 Glycopeptide</h3><div class="NLM_p">To further evaluate the antibody responses induced by the A244 glycopeptide immunogen, we measured the binding of rabbit antisera to the A244 V3 glycopeptides using ELISA. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a, the antisera exhibited strong binding to the N334 glycopeptide, while the affinity of the antisera to the N334 complex-type glycopeptide (<b>5</b>) and the aglycone V3 peptide (<b>10</b>) was weaker than that of the high-mannose glycopeptide (<b>3</b>). The antisera also exhibited strong recognition to the A244 glycopeptides (<b>6</b> and <b>8</b>) with a high-mannose <i>N</i>-glycan at the N301 and N295 site, respectively. Interestingly, the affinity of the antisera binding to the three high-mannose glycopeptides (<b>3</b>, <b>6</b>, and <b>8</b>) was about the same regardless of the conserved site of the high-mannose <i>N</i>-glycan along the V3 domain (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b,c), whereas the binding of the antisera to the complex type A244 glycopeptides (<b>5</b>, <b>7</b>, and <b>9</b>) was weaker than those of the corresponding high-mannose V3 glycopeptides (<b>3</b>, <b>6</b>, and <b>8</b>). These results suggest that antibodies raised by the three-component A244 glycopeptide immunogen bearing a high-mannose <i>N</i>-glycan at the N334 site may be glycan-dependent with binding specificity.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ELISA analysis of the binding of the antisera and antibody PGT128 to synthetic A244 V3 glycopeptides: (a–c) ELISA binding of the rabbit antisera to A244 V3 glycopeptides; (d–f) ELISA binding of the pretreated (V3 peptide-depressed) rabbit sera to A244 V3 glycopeptides; (g–i) ELISA binding of PGT128 to A244 V3 glycopeptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Previous studies using animal immunizations have shown that gp120 V3 peptides are immunogenic and can elicit antibody responses that target the peptide epitopes.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> These peptide-specific antibodies may interfere the binding of glycopeptide-specific antibodies to glycopeptides. To remove these peptide binding antibodies from the rabbit sera, we pretreated the sera with the aglycone peptide (<b>10</b>)-bound beads and performed ELISA binding using these pretreated sera, as demonstrated in our recent study.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>d, the pretreated sera exhibited very weak binding to the aglycone peptide (<b>10</b>), indicating that most of the peptide specific antibodies were efficiently removed. Interestingly, the pretreated sera showed significantly decreased binding to the N334 complex-type glycopeptide (<b>5</b>) when compared to the nontreated sera (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>d). However, the pretreated sera still showed high-affinity binding to the N334 high-mannose glycopeptide (<b>3</b>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>d), although the titer was slightly lower than that of the nontreated sera (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). These results suggest that substantial glycopeptide binding antibodies are still left in the sera. We next performed ELISA analysis to the N301 and N295 V3 glycopeptides with the pretreated sera. Consistent with the N334 V3 glycopeptides, the binding of the pretreated sera to the complex-type V3 glycopeptides (<b>7</b> and <b>9</b>) was much weaker than that of the corresponding high-mannose V3 glycopeptides (<b>6</b> and <b>8</b>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>e,f). More interestingly, the binding profiles to the N301 and N295 high-mannose glycopeptides (<b>6</b> and <b>8</b>) by the pretreated sera were identical with the N334 high-mannose glycopeptide (<b>3</b>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>e,f). In comparison, antibody PGT128 also recognized all the V3 high-mannose glycopeptides in ELISA binding with similar binding profiles (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>g–i), showing glycosylation site-promiscuity. Taken together, our results indicate that the synthetic V3 N334 high-mannose glycopeptide immunogen could induce substantial glycopeptide specific antibodies within a short-term immunization, and these antibodies show promiscuous recognition to HIV-1 gp120/gp140 envelope glycoproteins and synthetic V3 glycopeptides with apparent specificity to the high-mannose <i>N</i>-glycan. The broad recognition by the antisera raised by the A244 V3 glycopeptide immunogen was similar to PGT128 but differed from 10-1074, where PGT128 also recognized all the gp120/gp140 but 10-1074 recognized only the gp120/gp140 carrying a N332 glycan.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Preliminary Mapping of the Epitope of the Glycopeptide-Dependent Antibodies in the Antisera</h3><div class="NLM_p">The high-mannose glycopeptide-specific nature of the antibodies raised by the A244 glycopeptide immunogen prompted us to map the epitopes of the antibodies. In order to compare the binding with the mini-V3 (33-mer) glycopeptide (<b>3</b>), we also synthesized a full-length (43-mer) A244 V3 glycopeptide (<b>16</b>), a short (20-mer) A244 V3 glycopeptide (<b>17</b>), and a biotinylated high-mannose type <i>N</i>-glycan (<b>18</b>) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a). Surprisingly, the pretreated sera exhibited equal binding to the full-length, mini, and short V3 high-mannose glycopeptides (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a), indicating the recognition was mainly dependent by the high-mannose glycan. Some of the bNAbs including PGT128 have been shown to recognize free <i>N</i>-glycans,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> particularly in glycan arrays,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> but the binding affinity was much lower than that of the V3 glycopeptides.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> To verify whether the elicited antibodies targeted the free <i>N</i>-glycan, we performed the ELISA binding to the free high-mannose glycan (<b>18</b>). The pretreated sera showed only very weak recognition to the high-mannose glycan (<b>18</b>) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a) and also to the aglycone peptide (<b>10</b>) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>d). In addition, we also examined the binding of the pretreated antisera with several V1V2 glycopeptides carrying a high-mannose <i>N</i>-glycan but having a peptide sequence that is unrelated to the V3 peptide. Similar to the free high-mannose type <i>N</i>-glycan binding study, no apparent binding of the rabbit antisera to the V1V2 glycopeptides was observed (data not shown). Taken together, these peptide binding results suggest that the antibodies elicited by the synthetic A244 glycopeptide immunogen specifically target the epitopes formed by the high-mannose glycan and the peptide epitope. Weak binding of the pretreated sera to the free high-mannose glycan was desired as this could avoid eliciting substantial anti-glycan self-reactive antibodies, which is one of the challenges in immunogen design for targeting the high-mannose patch.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Next, we performed ELISA analysis to the N332 V3 glycopeptides with the pretreated sera. The sera antibodies bind to the A244 mutated N332 V3 glycopeptide (<b>11</b>), JR-FL V3 N332 glycopeptide (<b>12</b>), and CN54 V3 N332 glycopeptide (<b>19</b>), showing similar binding profiles as the A244 N334 glycopeptide (<b>3</b>) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b). We also analyzed the cross binding of the A244 glycopeptides with the pretreated antisera elicited by the JR-FL N332 V3 glycopeptide immunogen that was previously described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> We found that the pretreated sera showed similar binding profiles to the JR-FL V3 N332 glycopeptide (<b>12</b>) and A244 N334 glycopeptide (<b>3</b>), while the binding to the A244 N334 complex-type glycopeptide (<b>5</b>) was decreased (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Figure S3</a>). These results suggest that the A244 V3 glycopeptide has the potential to elicit high-mannose glycopeptide specific antibody responses with promiscuity of glycosylation sites, which is similar to PGT128 and PGT126, and the synthetic V3 glycopeptide with a N334 high-mannose glycan may be a potential antigen for HIV vaccine design.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. ELISA analysis of the binding of the antisera with additional HIV-1 V3 glycopeptides and free high-mannose <i>N</i>-glycans: (a) ELISA binding of the pretreated sera to A244 N334 high-mannose glycopeptide with different length of the peptide backbone; (b) ELISA binding of the pretreated sera to different V3 N332 high-mannose glycopeptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Viral Neutralization</h3><div class="NLM_p last">To examine if the anti-sera elicited by the this A244 V3 glycopeptide possessed any virus neutralizing activity, we next performed a TZM-bl cell-based neutralization assay against tier 1 and tier 2 HIV-1 viruses.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> The preliminary experiment showed that the obtained antisera from the short-term immunization in rabbits did not neutralize the tier 1 and tier 2 HIV-1 viruses (data not shown), which is similar to recent immunization studies with the HIV-1 JR-FL N332 high-mannose glycopeptide immunogen in rabbits<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and with a synthetic mini-V3 glycopeptide mixed with an adjuvant in rhesus macaque.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In general, HIV-1 bNAbs typically have some unusual traits, such as the long heavy-chain third complementarity-determining regions, the high levels of somatic mutations, and the high frequency of insertions and deletions.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> After extensive virus Env diversification, most bNAb evolution during HIV-1infection has been observed.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Currently, there is only one report demonstrating that immunization with a well-ordered Env trimer in cow could elicit broad viral neutralizing activities that target the CD4 binding site.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In another related study, repetitive vaccination with a special HIV-1 Env trimer carrying high-mannose glycans over a 4-year period resulted in induction of some V3-glycan specific antibodies,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> but the antibodies raised could only neutralize the pseudoviruses bearing a high density of high-mannose <i>N</i>-glycans.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As a defense to help the virus evade the immune system, the host cell synthesized <i>N</i>-glycans coated on HIV-1 Env are usually weakly immunogenic. Nevertheless, the glycosylation defense is still vulnerable, as many glycan-directed bNAbs such as PGT128 and 10-1074 have been isolated from infected individuals, and these antibodies can recognize and penetrate the glycan shield of HIV-1. Many of these antibodies target the high-mannose patch centered around the glycan at N332 on V3 loop and demonstrate protection against mucosal SHIV challenge in animal models, thus proving promising template for vaccine design. These bNAbs demonstrate varying degrees of dependency on the N332 glycan site, and a shift of the N332 glycan to the N334 position could result in escape from serum neutralizing antibodies. We and others have demonstrated that V3 glycopeptide bearing a high-mannose glycan at the N332 site could mimic the epitope of some bNAbs and showed the potential to elicit glycan-dependent antibodies responses. However, the immunogenicity of V3 glycopeptide with a N334 high-mannose glycan and its recognition by the PGT bNAbs are not clear. In this study, we sought to systematically investigate the immunogenicity of V3 N334 high-mannose glycopeptide by antibody binding and preliminary rabbit immunization. The 33-mer V3 glycopeptides derived from the A244 strain were efficiently synthesized by chemoenzymatic methods. SPR binding revealed that PGT128 and PGT126 could recognize all the high-mannose glycopeptides, showing promiscuity of glycosylation site, which is similar to the recognition to JR-FL V3 glycopeptides. However, the binding was completely abolished for 10-1074 when the N332 high-mannose glycan was shifted to N334 site. Surprisingly, 10-1074 did not bind to the A244 high-mannose glycopeptide with the N334 being shifted back to N332, suggesting that the precise peptide sequence was also important. These binding results indicated that the N334 high-mannose glycopeptide could mimic the conserved epitope of PGT128 and PGT121 but not 10-1074.</div><div class="NLM_p last">To evaluate the immunogenicity of the A244 V3 glycopeptide, we conjugated the V3 glycopeptide carrying a high-mannose glycan at N334 to a universal T cell epitope and a TLR2 agonist aiming to enhance the immune responses. Preliminary immunization studies in rabbits indicated that the synthetic glycopeptide immunogen elicited antibody responses with broad recognition to the gp120/gp140 carrying N332 or N334 glycan. We found that the antisera induced by the A244 V3 glycopeptide immunogen showed stronger binding to the gp120/gp140 than that by the JR-FL V3 glycopeptide immunogen. This broad recognition was similar to PGT128 but different from 10-1074, where PGT128 also recognized all the gp120/gp140 but 10-1074 only recognized the gp120/gp140 carrying a conserved N332 glycan. Further glycopeptide binding studies revealed that the synthetic A244 V3 glycopeptide immunogen induced substantial glycopeptide specific antibodies. The pretreated antisera exhibited strong binding to all the A244 V3 high-mannose glycopeptides and the V3 high-mannose glycopeptides from other strains, with similar binding profiles. However, the binding of the pretreated antisera to the complex-type glycopeptides was significantly decreased, showing binding preference to the high-mannose glycopeptides. The strong binding to the high-mannose V3 glycopeptides with promiscuity of glycosylation site and weak binding to the complex-type glycopeptides were very similar to the PGT128 and PGT126, although the two bNAbs show no binding to the complex-type glycopeptides. The antisera raised by the A244 glycopeptide immunogen in a preliminary immunization study in rabbits did not show neutralizing activity against tier 1 and tier 2 HIV-1 viruses, probably due to the lack of somatic mutation of the antibodies in a short-term immunization. Nevertheless, the ability of the A244 glycopeptide immunogen to raise substantial glycopeptide-specific antibodies that are cross-reactive to different HIV-1 gp120/gp140 envelope glycoproteins bearing <i>N</i>-glycans at either the N332 or N334 glycosylation site suggests that the A244 V3 glycopeptide may serve as a valuable component for future HIV-1 vaccine design.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78156" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78156" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The antigenicity and immunogenicity of the V3 N334 glycopeptides from the HIV-1 A244 strain that carries a conserved N334 <i>N</i>-glycan were systematically evaluated through chemoenzymatic synthesis, antibody binding analysis, and rabbit immunization studies. The experimental results indicate that the synthetic A244 V3 glycopeptide immunogen with a high-mannose <i>N</i>-glycan at the N334 site could elicit substantial glycopeptide specific antibodies which are similar to PGT128 and PGT126 in terms of their promiscuous recognition of HIV-1 gp120/gp140 envelope glycoproteins as well as synthetic V3 glycopeptides. These results suggest that the N334 glycan in the context of the V3 domain is vulnerable and immunogenic. To further evaluate the immunogenicity of A244 glycopeptide immunogen to raise neutralizing antibody responses, future experiments should be directed to immunization studies in non-human primate models using the A244 glycopeptide as a key vaccine component together with other HIV-1 vaccine candidates.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Purity Assessment</h3><div class="NLM_p last">All synthetic peptides and glycopeptides possessed a purity of at least 95%, which was assessed by reverse phase HPLC and mass spectrometric analysis (see the <a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">Supporting Information</a> for details).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedures</h3><div class="NLM_p last">A Waters 626 HPLC system equipped with a dual absorbance UV detector was used for analytical HPLC. The synthetic V3 peptides and glycopeptides were injected into a C18 column (YMC-Triart C18, 4.6 mm × 250 mm, 5 μm) and were run at a flow rate of 1 mL/min using a linear gradient (15–45% MeCN containing 0.1% TFA over 30 min). The peptides containing Pam<sub>3</sub>CK<sub>4</sub> were injected into a CN column (YMC-Pack CN, 4.6 mm × 250 mm, 5 μm) and were run by a linear gradient (20–70% MeCN containing 0.1% TFA over 50 min). All ESI-MS spectra were measured on a Micromass ZQ-4000 single-quadrupole mass spectrometer. Preparative reverse-phase HPLC for V3 peptides and glycopeptides was carried out on a Waters 600 HPLC system equipped with a C18 column (Waters XBridge, Prep Shield RP 10 mm × 250 mm, 5 μm) at a flow rate of 4 mL/min. A CN column (YMC-Pack CN, 10 mm × 250 mm, 5 μm) was used for the preparative HPLC purification of the lipopeptides.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Peptide Synthesis</h3><div class="NLM_p">The glycopeptides (<b>12</b>, <b>18</b>, and <b>19</b>) were synthesized in our previous studies.<a onclick="showRef(event, 'ref13 ref21'); return false;" href="javascript:void(0);" class="ref ref13 ref21">(13,21)</a>A CEM Liberty Blue microwave-assisted peptide synthesizer was used for peptide synthesis. Following the Fmoc chemistry strategy, PAL-PEG-PS resin (0.18 mmol/g) was used on a 0.1 mmol scale. 6 equiv of Fmoc-protected amino acids, 6 equiv of TBTU, and 12 equiv of DIPEA in DMF were used for couplings, which were carried out at 45 °C for 20 min. For the longer full-length V3 peptides, the coupling cycle was repeated. The building block Fmoc-(Ac<sub>3</sub>GlcNAc)-Asn-OH was placed at the desired glycosylation sites. Fmoc deprotection was done using 20% piperidine in DMF containing 0.1 M HOBt. After completion of the synthesis, the obtained resin was washed with dichloromethane (DCM) (3×) and then reacted with the biotinylated linker NHS-LC-biotin in the presence of an excess of DIPEA. After washing the resin with DMF (3×) and DCM (3×), cleavage was carried out by adding cocktail R (TFA/thioanisole/ethanedithiol/anisole = 90/5/3/2) to the resin. After 2 h, the resin was filtered and the collected solution was added to cold diethyl ether for peptide precipitation. The obtained crude peptide was dissolved in acetic acid and then lyophilized. A 20% aqueous DMSO solution was used for the cyclization of the peptides, and a 5% aqueous hydrazine solution was used for the de-O-acetylation of the acetylated GlcNAc moiety. After lyophilization, the obtained crude peptides were purified by preparative RP-HPLC.</div><div class="NLM_p last">GlcNAc-peptide (<b>1</b>). ESI-MS: calcd, M = 4260.7448; found (<i>m</i>/<i>z</i>) 1066.0159 [M + 4H]<sup>4+</sup>, 1421.0188 [M + 3H]<sup>3+</sup>. RP-HPLC retention time <i>t</i><sub>R</sub> = 28.8 min.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemoenzymatic Synthesis of A244 V3 Glycopeptide Carrying a High-Mannose Glycan</h3><div class="NLM_p last">Glycopeptide <b>1</b> (1.45 mg, 0.34 μmol) was mixed with Man<sub>9</sub>-oxazoline <b>2</b> (2.83 mg, 1.7 μmol) and Endo-A<sup>N171A</sup> (40 μg) in phosphate buffer (100 mM, pH 7, 100 μL), and the mixture was incubated at 30 °C. The enzymatic reaction was monitored by analytical RP-HPLC. Upon completion, the reaction was quenched by adding 0.1% aq TFA. The crude product was then purified by RP-HPLC to give glycopeptide <b>3</b> (1.75 mg, 87%). ESI MS: calcd, M = 5923.20; found (<i>m</i>/<i>z</i>) 1185.52 [M + 5H]<sup>5+</sup>, 1481.65 [M + 4H]<sup>4+</sup>, 1975.20 [M + 3H]<sup>3+</sup>. RP-HPLC retention time <i>t</i><sub>R</sub> = 26.5 min.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemoenzymatic Synthesis of A244 V3 Glycopeptide Carrying a Complex-Type Glycan</h3><div class="NLM_p last">Glycopeptide <b>1</b> (1.15 mg, 0.27 μmol), sialylated complex-type oxazoline <b>4</b> (2.7 mg, 1.35 μmol), and Endo-M<sup>N175Q</sup> (40 μg) were mixed in phosphate buffer (100 mM, pH 7, 100 μL) and then incubated at 30 °C. The enzymatic reaction was monitored by analytical RP-HPLC. Upon completion, the reaction was quenched by adding 0.1% aq TFA. The crude product was then purified by RP-HPLC to yield the glycopeptide <b>5</b> (1.37 mg, 81%). ESI MS: calcd M = 6263.53; found (<i>m</i>/<i>z</i>) 1253.55 [M + 5H]<sup>5+</sup>, 1566.68 [M + 4H]<sup>4+</sup>, 2088.65 [M + 3H]<sup>3+</sup>. RP-HPLC retention time <i>t</i><sub>R</sub> = 25.9 min.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Synthesis of A244 Glycopeptide Immunogen</h3><div class="NLM_p last">The synthesis of lipopeptide (<b>13</b>) containing the Pam<sub>3</sub>CSK<sub>4</sub> and P30 T cell epitope was described in our previous study.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Glycopeptide (<b>14</b>) carrying an alkyne linker was synthesized using SPPS and chemoenzymatic method, as described in a previous study for the similar JR-FL glycopeptide.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Finally, lipopeptide (<b>13</b>) (1.5 mg, 0.35 μmol), A244 alkyne glycopeptide <b>14</b> (2.5 mg, 0.43 μmol), and CuOAc (4 μg, 0.03 μmol) were dissolved in 100 μL of DMF and then incubated at 40 °C for 18 h. The reaction mixture was diluted by adding 1 mL of water and then lyophilized. After HPLC purification on a CN column, the desired immunogen <b>15</b> (2.8 mg, 78%) was obtained.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Surface Plasmon Resonance (SPR) Measurement</h3><div class="NLM_p last">SPR was run on a BIAcore T200 system (GE Healthcare) at 25 °C to evaluate the interactions between the synthetic glycopeptides and the antibodies PGT121, PGT128, and 10-1074. The synthesized glycopeptides and free glycans carrying a biotin tag were immobilized on neutravidin-coated CM5 sensor chips (GE Healthcare) in HBS-P buffer (10 mM HEPES, 150 mM NaCl, P20 surfactant 0.05% v/v, pH 7.4) until 200 response unit (RU) was reached. PGT121, PGT128, and 10-1074 were injected individually over the chip at 2-fold increasing concentration in HBS-P buffer at a flow rate of 40 μL/min for 180 s. Then HBS-P buffer was injected at a flow rate of 40 μL/min for 1210 s to allow for dissociation. Chip regeneration was done by injection of 3 M MgCl<sub>2</sub> (50 μL/min for 3 min), followed by injection of HBS-P buffer (50 μL/min for 5 min). SPR data were processed by the BIAcore T200 evaluation software. To obtain the apparent kinetic parameters, appropriate blank references were subtracted and the sensorgrams were fitted globally using a 1:1 Langmuir binding model.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Rabbits Immunization</h3><div class="NLM_p">New Zealand White rabbits (8 weeks old, female) were fused to evaluate the immunogenicity of the synthetic A244 glycopeptide immunogen. Immunizations were carried out by Spring Valley Laboratories, Inc., licensed by the United States Department of Agriculture (APHIS registration number 51-R-051) and has been accredited fully and continuously by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALACi). All animal experiments were performed according to the NIH Guide for the Care and Use of Laboratory Animal.</div><div class="NLM_p last">The synthetic three-component A244 glycopeptide immunogen <b>15</b> was incorporated into liposome following a reported procedure.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> New Zealand White rabbits (<i>n</i> = 3) were immunized by intramuscular and subcutaneous injections of the liposome containing 50 μg of <b>15</b>. After priming, three booster injections were given at interval of 21 days. Then bleeding was done 7 days after last immunization. The rabbit sera from each group were pooled together and used for ELISA analysis.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> ELISA Binding to gp120/gp140</h3><div class="NLM_p last">Gp120/gp140 (2 μg/mL in PBS) was coated on the 96-well ELISA microtiter plates by incubating at 4 °C overnight. After washing the plates with PBS/0.05% Tween-20, the plates were blocked by incubating with 2% sodium caseinate (w/v) in PBS at room temperature for 1 h. After washing three times, the plates were titrated against rabbit antisera diluted in PBS containing 1% sodium caseinate and incubated at 37 °C for 1 h. After washing three times, horseradish peroxidase (HRP)-conjugated goat anti-human IgG (H + L) antibody or horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (H + L) antibody (1:3000 diluted in PBDS) was added to the plates (100 μL/well). The plates were then incubated for 1 h at 37 °C. After washing three times, a substrate solution of 3,3′,5,5′-tetramethylbenidine (TMB) was added. After 5 min for color development, a solution of 1 M H<sub>3</sub>PO<sub>4</sub> was added to quench the reaction, and the readout was recorded at a wavelength of 450 nm.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Treatment of Polyclonal Antisera with Unglycosylated Peptide Beads</h3><div class="NLM_p last">Streptavidin magnetic beads (1 mg, New England BioLabs) were first incubated with the synthetic A244 V3 peptide <b>10</b> (0.5 mg/mL, 500 μL) at 37 °C for 30 min. After washing the beads three times with PBS buffer, 1 mL of antisera elicited by glycopeptide immunogen <b>15</b> was added and incubated for 30 min at 37 °C to subtract the peptide specific antibodies. The supernatant was then separated by applying magnet and used for ELISA analysis.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> ELISA Binding to Synthetic V3 Glycopeptides</h3><div class="NLM_p last">To perform peptide ELISA, NeutrAvidin diluted in PBS (5 μg/mL) was added (100 μL/well) to the 96-well ELISA microtiter plates and incubated at 4 °C overnight. After washing with PBS/0.05% Tween-20, the plates were blocked with 2% sodium caseinate (w/v) dissolved in PBS at room temperature for 1 h. After washing three times, biotinylated A244 glycopeptides dissolved in 1% casein PBS (2 μg/mL) were added to the wells (100 μL/well) and incubated at 37 °C for 1 h.. After washing three times, the plates were titrated against rabbit antisera diluted in 1% sodium caseinate and were incubated at 37 °C for 1 h. The plates were washed three times, and then a solution (100 μL/well) of 1:3000 diluted horseradish peroxidase (HRP)-conjugated goat anti-human IgG (H + L) antibody or horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (H + L) antibody in 1% PBS was added to the wells, and the wells were incubated for 1 h at 37 °C. After washing three times, the TMB substrate solution was added. After 5 min for color development, a solution of 1 M H<sub>3</sub>PO<sub>4</sub> was added to quench the reaction, and the readout was recorded at a wavelength of 450 nm.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01290" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01290" class="ext-link">10.1021/acs.jmedchem.8b01290</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SPR sensor grams of the binding of PGT128, PGT126, 10-1074, and PGT121 to synthetic A244 V3 glycopeptides (Figure S1); SPR analysis of the binding of bNAbs to mutated A244 high-mannose glycopeptide (<b>11</b>) and JR-FL N332 high-mannose glycopeptide (<b>12</b>) (Figure S2); ELISA analysis of the binding of the antisera induced by JR-FL N332 V3 glycopeptide to the JR-FL V3 glycopeptide and A244 V3 glycopeptides (Figure S3); comparison of end point titers of the antisera induced by the JR-FL and A244 V3 glycopeptide immunogens to HIV-1 gp120/gp140s (Table S1); HPLC and mass spectrometry profiles of synthetic glycopeptides (<b>1</b>, <b>3</b>, <b>5</b>–<b>11</b>, and <b>14</b>–<b>17</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf">jm8b01290_si_001.pdf (2.04 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_002.csv">jm8b01290_si_002.csv (19.45 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01290" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lai-Xi Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry
and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4293-5819" title="Orcid link">http://orcid.org/0000-0003-4293-5819</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f0a7919e97c5c1c8b0859d94de959485"><span class="__cf_email__" data-cfemail="c394a2ada4f6f2fb83b6aea7eda6a7b6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Cai</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry
and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5394-8167" title="Orcid link">http://orcid.org/0000-0002-5394-8167</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rou-Shu Zhang</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry
and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jared Orwenyo</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry
and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Giddens</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry
and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qiang Yang</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry
and Biochemistry, University of Maryland, College Park, Maryland 20742, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia C. LaBranche</span> - <span class="hlFld-Affiliation affiliation">Department of Surgery, Duke University
Medical Center, Durham, North Carolina 27705, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. Montefiori</span> - <span class="hlFld-Affiliation affiliation">Department of Surgery, Duke University
Medical Center, Durham, North Carolina 27705, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Antibody 10-1074 was kindly provided by Prof. Pamela Bjorkman. The PGT126, PGT128, and HIV-1 gp120s and gp140s were provided by the NIH AIDS reagent program. This work was supported by the National Institutes of Health (Grant R01 AI113896).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">SHIV</td><td class="NLM_def"><p class="first last">simian human immunodeficiency virus</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11072" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11072" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pejchal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khayat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depetris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katpally, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marozsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloveste, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogohara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanlan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1126/science.1213256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscience.1213256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=21998254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2mu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=1097-1103&author=R.+Pejchalauthor=K.+J.+Dooresauthor=L.+M.+Walkerauthor=R.+Khayatauthor=P.+S.+Huangauthor=S.+K.+Wangauthor=R.+L.+Stanfieldauthor=J.+P.+Julienauthor=A.+Ramosauthor=M.+Crispinauthor=R.+Depetrisauthor=U.+Katpallyauthor=A.+Marozsanauthor=A.+Cupoauthor=S.+Malovesteauthor=Y.+Liuauthor=R.+McBrideauthor=Y.+Itoauthor=R.+W.+Sandersauthor=C.+Ogoharaauthor=J.+C.+Paulsonauthor=T.+Feiziauthor=C.+N.+Scanlanauthor=C.+H.+Wongauthor=J.+P.+Mooreauthor=W.+C.+Olsonauthor=A.+B.+Wardauthor=P.+Poignardauthor=W.+R.+Schiefauthor=D.+R.+Burtonauthor=I.+A.+Wilson&title=A+potent+and+broad+neutralizing+antibody+recognizes+and+penetrates+the+HIV+glycan+shield&doi=10.1126%2Fscience.1213256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield</span></div><div class="casAuthors">Pejchal, Robert; Doores, Katie J.; Walker, Laura M.; Khayat, Reza; Huang, Po-Ssu; Wang, Sheng-Kai; Stanfield, Robyn L.; Julien, Jean-Philippe; Ramos, Alejandra; Crispin, Max; Depetris, Rafael; Katpally, Umesh; Marozsan, Andre; Cupo, Albert; Maloveste, Sebastien; Liu, Yan; McBride, Ryan; Ito, Yukishige; Sanders, Rogier W.; Ogohara, Cassandra; Paulson, James C.; Feizi, Ten; Scanlan, Christopher N.; Wong, Chi-Huey; Moore, John P.; Olson, William C.; Ward, Andrew B.; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Wilson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6059</span>),
    <span class="NLM_cas:pages">1097-1103</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield.  However, several of the recently identified PGT broadly neutralizing antibodies appear to interact directly with the HIV glycan coat.  Crystal structures of antigen-binding fragments (Fabs) PGT 127 and 128 with Man9 at 1.65 and 1.29 angstrom resoln., resp., and glycan binding data delineate a specific high mannose-binding site.  Fab PGT 128 complexed with a fully glycosylated gp120 outer domain at 3.25 angstroms reveals that the antibody penetrates the glycan shield and recognizes two conserved glycans as well as a short β-strand segment of the gp120 V3 loop, accounting for its high binding affinity and broad specificify.  Furthermore, our data suggest that the high neutralization potency of PGT 127 and 128 IgGs may be mediated by crosslinking Env trimers on the viral surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbe0WYPsyGi7Vg90H21EOLACvtfcHk0lj6PuqS0aqDxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2mu7jK&md5=9320a11936c8da451d3bc7c494ba6c4c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1213256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1213256%26sid%3Dliteratum%253Aachs%26aulast%3DPejchal%26aufirst%3DR.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DWalker%26aufirst%3DL.%2BM.%26aulast%3DKhayat%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26aulast%3DWang%26aufirst%3DS.%2BK.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DCrispin%26aufirst%3DM.%26aulast%3DDepetris%26aufirst%3DR.%26aulast%3DKatpally%26aufirst%3DU.%26aulast%3DMarozsan%26aufirst%3DA.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DMaloveste%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DOgohara%26aufirst%3DC.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DScanlan%26aufirst%3DC.%2BN.%26aulast%3DWong%26aufirst%3DC.%2BH.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DOlson%26aufirst%3DW.%2BC.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DA%2520potent%2520and%2520broad%2520neutralizing%2520antibody%2520recognizes%2520and%2520penetrates%2520the%2520HIV%2520glycan%2520shield%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D1097%26epage%3D1103%26doi%3D10.1126%2Fscience.1213256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkowska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pejchal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Hui, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitcham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phogat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simek, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koff, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span> <span> </span><span class="NLM_article-title">Broad neutralization coverage of HIV by multiple highly potent antibodies</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>477</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1038/nature10373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature10373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=21849977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2011&pages=466-470&author=L.+M.+Walkerauthor=M.+Huberauthor=K.+J.+Dooresauthor=E.+Falkowskaauthor=R.+Pejchalauthor=J.+P.+Julienauthor=S.+K.+Wangauthor=A.+Ramosauthor=P.+Y.+Chan-Huiauthor=M.+Moyleauthor=J.+L.+Mitchamauthor=P.+W.+Hammondauthor=O.+A.+Olsenauthor=P.+Phungauthor=S.+Flingauthor=C.+H.+Wongauthor=S.+Phogatauthor=T.+Wrinauthor=M.+D.+Simekauthor=W.+C.+Koffauthor=I.+A.+Wilsonauthor=D.+R.+Burtonauthor=P.+Poignard&title=Broad+neutralization+coverage+of+HIV+by+multiple+highly+potent+antibodies&doi=10.1038%2Fnature10373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Broad neutralization coverage of HIV by multiple highly potent antibodies</span></div><div class="casAuthors">Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Pejchal, Robert; Julien, Jean-Philippe; Wang, Sheng-Kai; Ramos, Alejandra; Chan-Hui, Po-Ying; Moyle, Matthew; Mitcham, Jennifer L.; Hammond, Phillip W.; Olsen, Ole A.; Phung, Pham; Fling, Steven; Wong, Chi-Huey; Phogat, Sanjay; Wrin, Terri; Simek, Melissa D.; Koff, Wayne C.; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">477</span>
        (<span class="NLM_cas:issue">7365</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses.  Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades.  Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies.  The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design.  Anal. of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favorable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes.  Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concns. is a highly pos. indicator for the eventual design of an effective antibody-based HIV vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDU82fw15s7Vg90H21EOLACvtfcHk0lgk5PAzJVm2Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers7nM&md5=8e1e3b8a562bce684067f701efe9e9eb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature10373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10373%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DL.%2BM.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DFalkowska%26aufirst%3DE.%26aulast%3DPejchal%26aufirst%3DR.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DS.%2BK.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DChan-Hui%26aufirst%3DP.%2BY.%26aulast%3DMoyle%26aufirst%3DM.%26aulast%3DMitcham%26aufirst%3DJ.%2BL.%26aulast%3DHammond%26aufirst%3DP.%2BW.%26aulast%3DOlsen%26aufirst%3DO.%2BA.%26aulast%3DPhung%26aufirst%3DP.%26aulast%3DFling%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DC.%2BH.%26aulast%3DPhogat%26aufirst%3DS.%26aulast%3DWrin%26aufirst%3DT.%26aulast%3DSimek%26aufirst%3DM.%2BD.%26aulast%3DKoff%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DPoignard%26aufirst%3DP.%26atitle%3DBroad%2520neutralization%2520coverage%2520of%2520HIV%2520by%2520multiple%2520highly%2520potent%2520antibodies%26jtitle%3DNature%26date%3D2011%26volume%3D477%26spage%3D466%26epage%3D470%26doi%3D10.1038%2Fnature10373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moldt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakasz, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Hui, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swiderek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisgrau, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piaskowski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">18921</span>– <span class="NLM_lpage">18925</span>, <span class="refDoi"> DOI: 10.1073/pnas.1214785109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1073%2Fpnas.1214785109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18921-18925&author=B.+Moldtauthor=E.+G.+Rakaszauthor=N.+Schultzauthor=P.+Y.+Chan-Huiauthor=K.+Swiderekauthor=K.+L.+Weisgrauauthor=S.+M.+Piaskowskiauthor=Z.+Bergmanauthor=D.+I.+Watkinsauthor=P.+Poignardauthor=D.+R.+Burton&title=Highly+potent+HIV-specific+antibody+neutralization+in+vitro+translates+into+effective+protection+against+mucosal+SHIV+challenge+in+vivo&doi=10.1073%2Fpnas.1214785109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1214785109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1214785109%26sid%3Dliteratum%253Aachs%26aulast%3DMoldt%26aufirst%3DB.%26aulast%3DRakasz%26aufirst%3DE.%2BG.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DChan-Hui%26aufirst%3DP.%2BY.%26aulast%3DSwiderek%26aufirst%3DK.%26aulast%3DWeisgrau%26aufirst%3DK.%2BL.%26aulast%3DPiaskowski%26aufirst%3DS.%2BM.%26aulast%3DBergman%26aufirst%3DZ.%26aulast%3DWatkins%26aufirst%3DD.%2BI.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DHighly%2520potent%2520HIV-specific%2520antibody%2520neutralization%2520in%2520vitro%2520translates%2520into%2520effective%2520protection%2520against%2520mucosal%2520SHIV%2520challenge%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D18921%26epage%3D18925%26doi%3D10.1073%2Fpnas.1214785109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barouch, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moldt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkolola, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borducchi, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackmore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanisetty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1038/nature12744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature12744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=24172905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSnsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=224-228&author=D.+H.+Barouchauthor=J.+B.+Whitneyauthor=B.+Moldtauthor=F.+Kleinauthor=T.+Y.+Oliveiraauthor=J.+Liuauthor=K.+E.+Stephensonauthor=H.+W.+Changauthor=K.+Shekharauthor=S.+Guptaauthor=J.+P.+Nkololaauthor=M.+S.+Seamanauthor=K.+M.+Smithauthor=E.+N.+Borducchiauthor=C.+Cabralauthor=J.+Y.+Smithauthor=S.+Blackmoreauthor=S.+Sanisettyauthor=J.+R.+Perryauthor=M.+Beckauthor=M.+G.+Lewisauthor=W.+Rinaldiauthor=A.+K.+Chakrabortyauthor=P.+Poignardauthor=M.+C.+Nussenzweigauthor=D.+R.+Burton&title=Therapeutic+efficacy+of+potent+neutralizing+HIV-1-specific+monoclonal+antibodies+in+SHIV-infected+rhesus+monkeys&doi=10.1038%2Fnature12744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys</span></div><div class="casAuthors">Barouch, Dan H.; Whitney, James B.; Moldt, Brian; Klein, Florian; Oliveira, Thiago Y.; Liu, Jinyan; Stephenson, Kathryn E.; Chang, Hui-Wen; Shekhar, Karthik; Gupta, Sanjana; Nkolola, Joseph P.; Seaman, Michael S.; Smith, Kaitlin M.; Borducchi, Erica N.; Cabral, Crystal; Smith, Jeffrey Y.; Blackmore, Stephen; Sanisetty, Srisowmya; Perry, James R.; Beck, Matthew; Lewis, Mark G.; Rinaldi, William; Chakraborty, Arup K.; Poignard, Pascal; Nussenzweig, Michel C.; Burton, Dennis R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7475</span>),
    <span class="NLM_cas:pages">224-228</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with extraordinary potency and breadth have recently been described.  In humanized mice, combinations of monoclonal antibodies have been shown to suppress viremia, but the therapeutic potential of these monoclonal antibodies has not yet been evaluated in primates with an intact immune system.  Here we show that administration of a cocktail of HIV-1-specific monoclonal antibodies, as well as the single glycan-dependent monoclonal antibody PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic simian-human immunodeficiency virus SHIV-SF162P3.  A single monoclonal antibody infusion afforded up to a 3.1 log decline of plasma viral RNA in 7 days and also reduced proviral DNA in peripheral blood, gastrointestinal mucosa and lymph nodes without the development of viral resistance.  Moreover, after monoclonal antibody administration, host Gag-specific T-lymphocyte responses showed improved functionality.  Virus rebounded in most animals after a median of 56 days when serum monoclonal antibody titers had declined to undetectable levels, although, notably, a subset of animals maintained long-term virol. control in the absence of further monoclonal antibody infusions.  These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys as well as an impact on host immune responses.  Our findings strongly encourage the investigation of monoclonal antibody therapy for HIV-1 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFJNqWV26uV7Vg90H21EOLACvtfcHk0lgk5PAzJVm2Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSnsbzE&md5=c05e1d0bebf3686841bb0a4897032d48</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature12744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12744%26sid%3Dliteratum%253Aachs%26aulast%3DBarouch%26aufirst%3DD.%2BH.%26aulast%3DWhitney%26aufirst%3DJ.%2BB.%26aulast%3DMoldt%26aufirst%3DB.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DT.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DStephenson%26aufirst%3DK.%2BE.%26aulast%3DChang%26aufirst%3DH.%2BW.%26aulast%3DShekhar%26aufirst%3DK.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DNkolola%26aufirst%3DJ.%2BP.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DBorducchi%26aufirst%3DE.%2BN.%26aulast%3DCabral%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DJ.%2BY.%26aulast%3DBlackmore%26aufirst%3DS.%26aulast%3DSanisetty%26aufirst%3DS.%26aulast%3DPerry%26aufirst%3DJ.%2BR.%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%2BG.%26aulast%3DRinaldi%26aufirst%3DW.%26aulast%3DChakraborty%26aufirst%3DA.%2BK.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520efficacy%2520of%2520potent%2520neutralizing%2520HIV-1-specific%2520monoclonal%2520antibodies%2520in%2520SHIV-infected%2520rhesus%2520monkeys%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D224%26epage%3D228%26doi%3D10.1038%2Fnature12744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halper-Stromberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheid, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bournazos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spatz, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diskin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billerbeck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labitt, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaebler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcovecchio, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Incesu, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieniasz, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravetch, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span> <span> </span><span class="NLM_article-title">HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1038/nature11604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature11604" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=118-122&author=F.+Kleinauthor=A.+Halper-Strombergauthor=J.+A.+Horwitzauthor=H.+Gruellauthor=J.+F.+Scheidauthor=S.+Bournazosauthor=H.+Mouquetauthor=L.+A.+Spatzauthor=R.+Diskinauthor=A.+Abadirauthor=T.+Zangauthor=M.+Dornerauthor=E.+Billerbeckauthor=R.+N.+Labittauthor=C.+Gaeblerauthor=P.+M.+Marcovecchioauthor=R.+B.+Incesuauthor=T.+R.+Eisenreichauthor=P.+D.+Bieniaszauthor=M.+S.+Seamanauthor=P.+J.+Bjorkmanauthor=J.+V.+Ravetchauthor=A.+Plossauthor=M.+C.+Nussenzweig&title=HIV+therapy+by+a+combination+of+broadly+neutralizing+antibodies+in+humanized+mice&doi=10.1038%2Fnature11604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature11604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11604%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DHalper-Stromberg%26aufirst%3DA.%26aulast%3DHorwitz%26aufirst%3DJ.%2BA.%26aulast%3DGruell%26aufirst%3DH.%26aulast%3DScheid%26aufirst%3DJ.%2BF.%26aulast%3DBournazos%26aufirst%3DS.%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DSpatz%26aufirst%3DL.%2BA.%26aulast%3DDiskin%26aufirst%3DR.%26aulast%3DAbadir%26aufirst%3DA.%26aulast%3DZang%26aufirst%3DT.%26aulast%3DDorner%26aufirst%3DM.%26aulast%3DBillerbeck%26aufirst%3DE.%26aulast%3DLabitt%26aufirst%3DR.%2BN.%26aulast%3DGaebler%26aufirst%3DC.%26aulast%3DMarcovecchio%26aufirst%3DP.%2BM.%26aulast%3DIncesu%26aufirst%3DR.%2BB.%26aulast%3DEisenreich%26aufirst%3DT.%2BR.%26aulast%3DBieniasz%26aufirst%3DP.%2BD.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26aulast%3DPloss%26aufirst%3DA.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26atitle%3DHIV%2520therapy%2520by%2520a%2520combination%2520of%2520broadly%2520neutralizing%2520antibodies%2520in%2520humanized%2520mice%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D118%26epage%3D122%26doi%3D10.1038%2Fnature11604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shingai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donau, O. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plishka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckler-White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piatak, M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrov, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. A.</span></span> <span> </span><span class="NLM_article-title">Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1038/nature12746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature12746" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=277-280&author=M.+Shingaiauthor=Y.+Nishimuraauthor=F.+Kleinauthor=H.+Mouquetauthor=O.+K.+Donauauthor=R.+Plishkaauthor=A.+Buckler-Whiteauthor=M.+Seamanauthor=M.+Piatakauthor=J.+D.+Lifsonauthor=D.+S.+Dimitrovauthor=M.+C.+Nussenzweigauthor=M.+A.+Martin&title=Antibody-mediated+immunotherapy+of+macaques+chronically+infected+with+SHIV+suppresses+viraemia&doi=10.1038%2Fnature12746"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature12746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12746%26sid%3Dliteratum%253Aachs%26aulast%3DShingai%26aufirst%3DM.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DDonau%26aufirst%3DO.%2BK.%26aulast%3DPlishka%26aufirst%3DR.%26aulast%3DBuckler-White%26aufirst%3DA.%26aulast%3DSeaman%26aufirst%3DM.%26aulast%3DPiatak%26aufirst%3DM.%26aulast%3DLifson%26aufirst%3DJ.%2BD.%26aulast%3DDimitrov%26aufirst%3DD.%2BS.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26atitle%3DAntibody-mediated%2520immunotherapy%2520of%2520macaques%2520chronically%2520infected%2520with%2520SHIV%2520suppresses%2520viraemia%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D277%26epage%3D280%26doi%3D10.1038%2Fnature12746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazumyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golijanin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckler-White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadjadpour, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankoff, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. A.</span></span> <span> </span><span class="NLM_article-title">A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>533</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1038/nature17677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature17677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27120156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=105-109&author=R.+Gautamauthor=Y.+Nishimuraauthor=A.+Peguauthor=M.+C.+Nasonauthor=F.+Kleinauthor=A.+Gazumyanauthor=J.+Golijaninauthor=A.+Buckler-Whiteauthor=R.+Sadjadpourauthor=K.+Wangauthor=Z.+Mankoffauthor=S.+D.+Schmidtauthor=J.+D.+Lifsonauthor=J.+R.+Mascolaauthor=M.+C.+Nussenzweigauthor=M.+A.+Martin&title=A+single+injection+of+anti-HIV-1+antibodies+protects+against+repeated+SHIV+challenges&doi=10.1038%2Fnature17677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges</span></div><div class="casAuthors">Gautam, Rajeev; Nishimura, Yoshiaki; Pegu, Amarendra; Nason, Martha C.; Klein, Florian; Gazumyan, Anna; Golijanin, Jovana; Buckler-White, Alicia; Sadjadpour, Reza; Wang, Keyun; Mankoff, Zachary; Schmidt, Stephen D.; Lifson, Jeffrey D.; Mascola, John R.; Nussenzweig, Michel C.; Martin, Malcolm A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7601</span>),
    <span class="NLM_cas:pages">105-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the success of potent anti-retroviral drugs in controlling human immunodeficiency virus type 1 (HIV-1) infection, little progress has been made in generating an effective HIV-1 vaccine.  Although passive transfer of anti-HIV-1 broadly neutralizing antibodies can protect mice or macaques against a single high-dose challenge with HIV or simian/human (SIV/HIV) chimeric viruses (SHIVs) resp., the long-term efficacy of a passive antibody transfer approach for HIV-1 has not been examd.  Here we show, on the basis of the relatively long-term protection conferred by hepatitis A immune globulin, the efficacy of a single injection (20 mg kg-1) of four anti-HIV-1-neutralizing monoclonal antibodies (VRC01, VRC01-LS, 3BNC117, and 10-1074 (refs 9, 10, 11, 12)) in blocking repeated weekly low-dose virus challenges of the clade B SHIVAD8.  Compared with control animals, which required two to six challenges (median = 3) for infection, a single broadly neutralizing antibody infusion prevented virus acquisition for up to 23 weekly challenges.  This effect depended on antibody potency and half-life.  The highest levels of plasma-neutralizing activity and, correspondingly, the longest protection were found in monkeys administered the more potent antibodies 3BNC117 and 10-1074 (median = 13 and 12.5 wk, resp.).  VRC01, which showed lower plasma-neutralizing activity, protected for a shorter time (median = 8 wk).  The introduction of a mutation that extends antibody half-life into the crystallizable fragment (Fc) domain of VRC01 increased median protection from 8 to 14.5 wk.  If administered to populations at high risk of HIV-1 transmission, such an immunoprophylaxis regimen could have a major impact on virus transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopfDc-leNrmrVg90H21EOLACvtfcHk0lir8HX3I8Rwww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVGntL8%253D&md5=d2b317db5192db8323f6b835aa6f3d4d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature17677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17677%26sid%3Dliteratum%253Aachs%26aulast%3DGautam%26aufirst%3DR.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DPegu%26aufirst%3DA.%26aulast%3DNason%26aufirst%3DM.%2BC.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DGazumyan%26aufirst%3DA.%26aulast%3DGolijanin%26aufirst%3DJ.%26aulast%3DBuckler-White%26aufirst%3DA.%26aulast%3DSadjadpour%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DMankoff%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DS.%2BD.%26aulast%3DLifson%26aufirst%3DJ.%2BD.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26atitle%3DA%2520single%2520injection%2520of%2520anti-HIV-1%2520antibodies%2520protects%2520against%2520repeated%2520SHIV%2520challenges%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D105%26epage%3D109%26doi%3D10.1038%2Fnature17677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caskey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoofs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagounis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreider, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Learn, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimeliovich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unson-O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiland, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummerle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer-Pack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignacio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zingman, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulick, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatkenheuer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlesinger, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine, F.</span></span> <span> </span><span class="NLM_article-title">Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/nm.4268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnm.4268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28092665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=185-191&author=M.+Caskeyauthor=T.+Schoofsauthor=H.+Gruellauthor=A.+Settlerauthor=T.+Karagounisauthor=E.+F.+Kreiderauthor=B.+Murrellauthor=N.+Pfeiferauthor=L.+Nogueiraauthor=T.+Y.+Oliveiraauthor=G.+H.+Learnauthor=Y.+Z.+Cohenauthor=C.+Lehmannauthor=D.+Gillorauthor=I.+Shimeliovichauthor=C.+Unson-O%E2%80%99Brienauthor=D.+Weilandauthor=A.+Roblesauthor=T.+Kummerleauthor=C.+Wyenauthor=R.+Levinauthor=M.+Witmer-Packauthor=K.+Erenauthor=C.+Ignacioauthor=S.+Kissauthor=A.+P.+Westauthor=H.+Mouquetauthor=B.+S.+Zingmanauthor=R.+M.+Gulickauthor=T.+Kelerauthor=P.+J.+Bjorkmanauthor=M.+S.+Seamanauthor=B.+H.+Hahnauthor=G.+Fatkenheuerauthor=S.+J.+Schlesingerauthor=M.+C.+Nussenzweigauthor=F.+Kleine&title=Antibody+10-1074+suppresses+viremia+in+HIV-1-infected+individuals&doi=10.1038%2Fnm.4268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</span></div><div class="casAuthors">Caskey, Marina; Schoofs, Till; Gruell, Henning; Settler, Allison; Karagounis, Theodora; Kreider, Edward F.; Murrell, Ben; Pfeifer, Nico; Nogueira, Lilian; Oliveira, Thiago Y.; Learn, Gerald H.; Cohen, Yehuda Z.; Lehmann, Clara; Gillor, Daniel; Shimeliovich, Irina; Unson-O'Brien, Cecilia; Weiland, Daniela; Robles, Alexander; Kummerle, Tim; Wyen, Christoph; Levin, Rebeka; Witmer-Pack, Maggi; Eren, Kemal; Ignacio, Caroline; Kiss, Szilard; West, Anthony P., Jr.; Mouquet, Hugo; Zingman, Barry S.; Gulick, Roy M.; Keler, Tibor; Bjorkman, Pamela J.; Seaman, Michael S.; Hahn, Beatrice H.; Fatkenheuer, Gerd; Schlesinger, Sarah J.; Nussenzweig, Michel C.; Klein, Florian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-191</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoclonal antibody 10-1074 targets the V3 glycan supersite on the HIV-1 envelope (Env) protein.  It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far.  Here we report on its safety and activity in 33 individuals who received a single i.v. infusion of the antibody. 10-1074 was well tolerated and had a half-life of 24.0 d in participants without HIV-1 infection and 12.8 d in individuals with HIV-1 infection.  Thirteen individuals with viremia received the highest dose of 30 mg/kg 10-1074.  Eleven of these participants were 10-1074-sensitive and showed a rapid decline in viremia by a mean of 1.52 log10 copies/mL.  Virol. anal. revealed the emergence of multiple independent 10-1074-resistant viruses in the first weeks after infusion.  Emerging escape variants were generally resistant to the related V3-specific antibody PGT121, but remained sensitive to antibodies targeting nonoverlapping epitopes, such as the anti-CD4-binding-site antibodies 3BNC117 and VRC01.  The results demonstrate the safety and activity of 10-1074 in humans and support the idea that antibodies targeting the V3 glycan supersite might be useful for the treatment and prevention of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohubBuHPyKerVg90H21EOLACvtfcHk0ljYAkjmX1o5vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCls78%253D&md5=c3ec584ad3426c930869f92ee2748e6b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm.4268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4268%26sid%3Dliteratum%253Aachs%26aulast%3DCaskey%26aufirst%3DM.%26aulast%3DSchoofs%26aufirst%3DT.%26aulast%3DGruell%26aufirst%3DH.%26aulast%3DSettler%26aufirst%3DA.%26aulast%3DKaragounis%26aufirst%3DT.%26aulast%3DKreider%26aufirst%3DE.%2BF.%26aulast%3DMurrell%26aufirst%3DB.%26aulast%3DPfeifer%26aufirst%3DN.%26aulast%3DNogueira%26aufirst%3DL.%26aulast%3DOliveira%26aufirst%3DT.%2BY.%26aulast%3DLearn%26aufirst%3DG.%2BH.%26aulast%3DCohen%26aufirst%3DY.%2BZ.%26aulast%3DLehmann%26aufirst%3DC.%26aulast%3DGillor%26aufirst%3DD.%26aulast%3DShimeliovich%26aufirst%3DI.%26aulast%3DUnson-O%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DWeiland%26aufirst%3DD.%26aulast%3DRobles%26aufirst%3DA.%26aulast%3DKummerle%26aufirst%3DT.%26aulast%3DWyen%26aufirst%3DC.%26aulast%3DLevin%26aufirst%3DR.%26aulast%3DWitmer-Pack%26aufirst%3DM.%26aulast%3DEren%26aufirst%3DK.%26aulast%3DIgnacio%26aufirst%3DC.%26aulast%3DKiss%26aufirst%3DS.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DZingman%26aufirst%3DB.%2BS.%26aulast%3DGulick%26aufirst%3DR.%2BM.%26aulast%3DKeler%26aufirst%3DT.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DHahn%26aufirst%3DB.%2BH.%26aulast%3DFatkenheuer%26aufirst%3DG.%26aulast%3DSchlesinger%26aufirst%3DS.%2BJ.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DKleine%26aufirst%3DF.%26atitle%3DAntibody%252010-1074%2520suppresses%2520viremia%2520in%2520HIV-1-infected%2520individuals%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D185%26epage%3D191%26doi%3D10.1038%2Fnm.4268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garces, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saye-Francisco, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">Structural evolution of glycan recognition by a family of potent HIV antibodies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.cell.2014.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=69-79&author=F.+Garcesauthor=D.+Sokauthor=L.+Kongauthor=R.+McBrideauthor=H.+J.+Kimauthor=K.+F.+Saye-Franciscoauthor=J.+P.+Julienauthor=Y.+Huaauthor=A.+Cupoauthor=J.+P.+Mooreauthor=J.+C.+Paulsonauthor=A.+B.+Wardauthor=D.+R.+Burtonauthor=I.+A.+Wilson&title=Structural+evolution+of+glycan+recognition+by+a+family+of+potent+HIV+antibodies&doi=10.1016%2Fj.cell.2014.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DGarces%26aufirst%3DF.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DSaye-Francisco%26aufirst%3DK.%2BF.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DStructural%2520evolution%2520of%2520glycan%2520recognition%2520by%2520a%2520family%2520of%2520potent%2520HIV%2520antibodies%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D69%26epage%3D79%26doi%3D10.1016%2Fj.cell.2014.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saye-Francisco, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulp, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickramasinghe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">236ra63</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3008104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscitranslmed.3008104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=24828077" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=236ra63&author=D.+Sokauthor=K.+J.+Dooresauthor=B.+Brineyauthor=K.+M.+Leauthor=K.+L.+Saye-Franciscoauthor=A.+Ramosauthor=D.+W.+Kulpauthor=J.+P.+Julienauthor=S.+Menisauthor=L.+Wickramasingheauthor=M.+S.+Seamanauthor=W.+R.+Schiefauthor=I.+A.+Wilsonauthor=P.+Poignardauthor=D.+R.+Burton&title=Promiscuous+glycan+site+recognition+by+antibodies+to+the+high-mannose+patch+of+gp120+broadens+neutralization+of+HIV&doi=10.1126%2Fscitranslmed.3008104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008104%26sid%3Dliteratum%253Aachs%26aulast%3DSok%26aufirst%3DD.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DBriney%26aufirst%3DB.%26aulast%3DLe%26aufirst%3DK.%2BM.%26aulast%3DSaye-Francisco%26aufirst%3DK.%2BL.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DKulp%26aufirst%3DD.%2BW.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DMenis%26aufirst%3DS.%26aulast%3DWickramasinghe%26aufirst%3DL.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DPromiscuous%2520glycan%2520site%2520recognition%2520by%2520antibodies%2520to%2520the%2520high-mannose%2520patch%2520of%2520gp120%2520broadens%2520neutralization%2520of%2520HIV%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D236ra63%26doi%3D10.1126%2Fscitranslmed.3008104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheid, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halper-Stromberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanapragasam, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuitemaker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span> <span> </span><span class="NLM_article-title">Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">E3268</span>– <span class="NLM_lpage">3277</span>, <span class="refDoi"> DOI: 10.1073/pnas.1217207109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1073%2Fpnas.1217207109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=23115339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvValsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E3268-3277&author=H.+Mouquetauthor=L.+Scharfauthor=Z.+Eulerauthor=Y.+Liuauthor=C.+Edenauthor=J.+F.+Scheidauthor=A.+Halper-Strombergauthor=P.+N.+Gnanapragasamauthor=D.+I.+Spencerauthor=M.+S.+Seamanauthor=H.+Schuitemakerauthor=T.+Feiziauthor=M.+C.+Nussenzweigauthor=P.+J.+Bjorkman&title=Complex-type+N-glycan+recognition+by+potent+broadly+neutralizing+HIV+antibodies&doi=10.1073%2Fpnas.1217207109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies</span></div><div class="casAuthors">Mouquet, Hugo; Scharf, Louise; Euler, Zelda; Liu, Yan; Eden, Caroline; Scheid, Johannes F.; Halper-Stromberg, Ariel; Gnanapragasam, Priyanthi N. P.; Spencer, Daniel I. R.; Seaman, Michael S.; Schuitemaker, Hanneke; Feizi, Ten; Nussenzweig, Michel C.; Bjorkman, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">E3268-E3277, SE3268/1-SE3268/55</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Broadly neutralizing HIV antibodies (bNAbs) can recognize carbohydrate-dependent epitopes on gp120.  In contrast to previously characterized glycan-dependent bNAbs that recognize high-mannose N-glycans, PGT121 binds complex-type N-glycans in glycan microarrays.  We isolated the B-cell clone encoding PGT121, which segregates into PGT121-like and 10-1074-like groups distinguished by sequence, binding affinity, carbohydrate recognition, and neutralizing activity.  Group 10-1074 exhibits remarkable potency and breadth but no detectable binding to protein-free glycans.  Crystal structures of unliganded PGT121, 10-1074, and their likely germ-line precursor reveal that differential carbohydrate recognition maps to a cleft between complementarity detg. region (CDR)H2 and CDRH3.  This cleft was occupied by a complex-type N-glycan in a "liganded" PGT121 structure.  Swapping glycan contact residues between PGT121 and 10-1074 confirmed their importance for neutralization.  Although PGT121 binds complex-type N-glycans, PGT121 recognized high-mannose-only HIV envelopes in isolation and on virions.  As HIV envelopes exhibit varying proportions of high-mannose- and complex-type N-glycans, these results suggest promiscuous carbohydrate interactions, an advantageous adaptation ensuring neutralization of all viruses within a given strain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAQMgrEu6up7Vg90H21EOLACvtfcHk0ljYAkjmX1o5vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvValsrvM&md5=ab234bbc5bad15a72dc23d23d602a6c7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217207109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217207109%26sid%3Dliteratum%253Aachs%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DScharf%26aufirst%3DL.%26aulast%3DEuler%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEden%26aufirst%3DC.%26aulast%3DScheid%26aufirst%3DJ.%2BF.%26aulast%3DHalper-Stromberg%26aufirst%3DA.%26aulast%3DGnanapragasam%26aufirst%3DP.%2BN.%26aulast%3DSpencer%26aufirst%3DD.%2BI.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DSchuitemaker%26aufirst%3DH.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26atitle%3DComplex-type%2520N-glycan%2520recognition%2520by%2520potent%2520broadly%2520neutralizing%2520HIV%2520antibodies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE3268%26epage%3D3277%26doi%3D10.1073%2Fpnas.1217207109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gristick, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyubimov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartweger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span> <span> </span><span class="NLM_article-title">Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1251</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03632-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fs41467-018-03632-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=29593217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A280%3ADC%252BC1MnmsFSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1251&author=C.+O.+Barnesauthor=H.+B.+Gristickauthor=N.+T.+Freundauthor=A.+Escolanoauthor=A.+Y.+Lyubimovauthor=H.+Hartwegerauthor=A.+P.+Westauthor=A.+E.+Cohenauthor=M.+C.+Nussenzweigauthor=P.+J.+Bjorkman&title=Structural+characterization+of+a+highly-potent+V3-glycan+broadly+neutralizing+antibody+bound+to+natively-glycosylated+HIV-1+envelope&doi=10.1038%2Fs41467-018-03632-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope</span></div><div class="casAuthors">Barnes Christopher O; Gristick Harry B; West Anthony P Jr; Bjorkman Pamela J; Freund Natalia T; Escolano Amelia; Hartweger Harald; Nussenzweig Michel C; Freund Natalia T; Lyubimov Artem Y; Cohen Aina E; Nussenzweig Michel C</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1251</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccine design efforts.  Developing bNAbs with increased efficacy requires understanding how antibodies interact with the native oligomannose and complex-type N-glycan shield that hides most protein epitopes on HIV-1 envelope (Env).  Here we present crystal structures, including a 3.8-ÅA X-ray free electron laser dataset, of natively glycosylated Env trimers complexed with BG18, the most potent V3/N332gp120 glycan-targeting bNAb reported to date.  Our structures show conserved contacts mediated by common D gene-encoded residues with the N332gp120 glycan and the gp120 GDIR peptide motif, but a distinct Env-binding orientation relative to PGT121/10-1074 bNAbs.  BG18's binding orientation provides additional contacts with N392gp120 and N386gp120 glycans near the V3-loop base and engages protein components of the V1-loop.  The BG18-natively-glycosylated Env structures facilitate understanding of bNAb-glycan interactions critical for using V3/N332gp120 bNAbs therapeutically and targeting their epitope for immunogen design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUOmuADByiLoUSrryheKE6fW6udTcc2eZo__CFrVAnJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnmsFSlsA%253D%253D&md5=fa256c8aaf8426492c8e6765d417fbfe</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03632-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03632-y%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DC.%2BO.%26aulast%3DGristick%26aufirst%3DH.%2BB.%26aulast%3DFreund%26aufirst%3DN.%2BT.%26aulast%3DEscolano%26aufirst%3DA.%26aulast%3DLyubimov%26aufirst%3DA.%2BY.%26aulast%3DHartweger%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26atitle%3DStructural%2520characterization%2520of%2520a%2520highly-potent%2520V3-glycan%2520broadly%2520neutralizing%2520antibody%2520bound%2520to%2520natively-glycosylated%2520HIV-1%2520envelope%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1251%26doi%3D10.1038%2Fs41467-018-03632-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toonstra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Systematic synthesis and binding study of HIV V3 glycopeptides reveal the fine epitopes of several broadly neutralizing antibodies</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1566</span>– <span class="NLM_lpage">1575</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00319</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1566-1575&author=J.+Orwenyoauthor=H.+Caiauthor=J.+Giddensauthor=M.+N.+Aminauthor=C.+Toonstraauthor=L.+X.+Wang&title=Systematic+synthesis+and+binding+study+of+HIV+V3+glycopeptides+reveal+the+fine+epitopes+of+several+broadly+neutralizing+antibodies&doi=10.1021%2Facschembio.7b00319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic synthesis and binding study of HIV V3 glycopeptides reveal the fine epitopes of several broadly neutralizing antibodies</span></div><div class="casAuthors">Orwenyo, Jared; Cai, Hui; Giddens, John; Amin, Mohammed N.; Toonstra, Christian; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1566-1575</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A class of new glycan-reactive broadly neutralizing antibodies represented by PGT121, 10-1074, and PGT128 has recently been discovered that targets specific N-glycans and the peptide region around the V3 domain.  However, the glycan specificity and fine epitopes of these bNAbs remain to be further defined.  We report here a systematic chemoenzymic synthesis of homogeneous V3 glycopeptides derived from the HIV-1 JR-FL strain carrying defined N-glycans at N332, N301, and N295 sites.  Antibody binding studies revealed that both the nature and site of glycosylation in the context of the V3 domain were crit. for high-affinity binding.  It was found that antibody PGT128 exhibited specificity for high-mannose N-glycan with glycosylation site promiscuity, PGT121 showed binding specificity for glycopeptide carrying a sialylated N-glycan at N301 site, and 10-1074 was specific for glycopeptide carrying a high-mannose N-glycan at N332 site.  The synthesis and binding studies permit a detailed assessment of the glycan specificity and the requirement of peptide in the context of antibody-antigen recognition.  The identified glycopeptides can be used as potential templates for HIV vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEO2wxUHa1-7Vg90H21EOLACvtfcHk0liM4LlX3DJIWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLo%253D&md5=39749d23caab82b374b2b8a95342c7b5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00319%26sid%3Dliteratum%253Aachs%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DGiddens%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DM.%2BN.%26aulast%3DToonstra%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DSystematic%2520synthesis%2520and%2520binding%2520study%2520of%2520HIV%2520V3%2520glycopeptides%2520reveal%2520the%2520fine%2520epitopes%2520of%2520several%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D1566%26epage%3D1575%26doi%3D10.1021%2Facschembio.7b00319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Synthetic three-component HIV-1 V3 glycopeptide immunogens induce glycan-dependent antibody responses</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1513</span>– <span class="NLM_lpage">1522</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.chembiol.2017.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=29107699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1513-1522&author=H.+Caiauthor=J.+Orwenyoauthor=J.+P.+Giddensauthor=Q.+Yangauthor=R.+Zhangauthor=C.+C.+LaBrancheauthor=D.+C.+Montefioriauthor=L.+X.+Wang&title=Synthetic+three-component+HIV-1+V3+glycopeptide+immunogens+induce+glycan-dependent+antibody+responses&doi=10.1016%2Fj.chembiol.2017.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses</span></div><div class="casAuthors">Cai, Hui; Orwenyo, Jared; Giddens, John P.; Yang, Qiang; Zhang, Roushu; La Branche, Celia C.; Montefiori, David C.; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1513-1522.e4</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Eliciting broadly neutralizing antibody (bNAb) responses against HIV-1 is a major goal for a prophylactic HIV-1 vaccine.  One approach is to design immunogens based on known broadly neutralizing epitopes.  Here we report the design and synthesis of an HIV-1 glycopeptide immunogen derived from the V3 domain.  We performed glycopeptide epitope mapping to det. the minimal glycopeptide sequence as the epitope of V3-glycan-specific bNAbs PGT128 and 10-1074.  We further constructed a self-adjuvant three-component immunogen that consists of a 33-mer V3 glycopeptide epitope, a universal T helper epitope P30, and a lipopeptide (Pam3CSK4) that serves as a ligand of Toll-like receptor 2.  Rabbit immunization revealed that the synthetic self-adjuvant glycopeptide could elicit substantial glycan-dependent antibodies that exhibited broader recognition of HIV-1 gp120s than the non-glycosylated V3 peptide.  These results suggest that the self-adjuvant synthetic glycopeptides can serve as an important component to elicit glycan-specific antibodies in HIV vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJGZKJM6oJ4rVg90H21EOLACvtfcHk0lif69rt3Nbppg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehsL%252FE&md5=c5a1544360c7608d5831ddeb89d51087</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DGiddens%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLaBranche%26aufirst%3DC.%2BC.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DSynthetic%2520three-component%2520HIV-1%2520V3%2520glycopeptide%2520immunogens%2520induce%2520glycan-dependent%2520antibody%2520responses%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1513%26epage%3D1522%26doi%3D10.1016%2Fj.chembiol.2017.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussedat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vohra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerhoff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cale, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkowicz, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radakovich, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anasti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armand, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pancera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiev, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Holle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdool-Karim, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Tejada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaai7521</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aai7521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscitranslmed.aai7521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28298421" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=S.+M.+Alamauthor=B.+Aussedatauthor=Y.+Vohraauthor=R.+R.+Meyerhoffauthor=E.+M.+Caleauthor=W.+E.+Walkowiczauthor=N.+A.+Radakovichauthor=K.+Anastiauthor=L.+Armandauthor=R.+Parksauthor=L.+Sutherlandauthor=R.+Scearceauthor=M.+G.+Joyceauthor=M.+Panceraauthor=A.+Druzauthor=I.+S.+Georgievauthor=T.+Von+Holleauthor=A.+Eatonauthor=C.+Foxauthor=S.+G.+Reedauthor=M.+Louderauthor=R.+T.+Bailerauthor=L.+Morrisauthor=S.+S.+Abdool-Karimauthor=M.+Cohenauthor=H.+X.+Liaoauthor=D.+C.+Montefioriauthor=P.+K.+Parkauthor=A.+Fernandez-Tejadaauthor=K.+Wieheauthor=S.+Santraauthor=T.+B.+Keplerauthor=K.+O.+Saundersauthor=J.+Sodroskiauthor=P.+D.+Kwongauthor=J.+R.+Mascolaauthor=M.+Bonsignoriauthor=M.+A.+Moodyauthor=S.+Danishefskyauthor=B.+F.+Haynes&title=Mimicry+of+an+HIV+broadly+neutralizing+antibody+epitope+with+a+synthetic+glycopeptide&doi=10.1126%2Fscitranslmed.aai7521"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aai7521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aai7521%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DAussedat%26aufirst%3DB.%26aulast%3DVohra%26aufirst%3DY.%26aulast%3DMeyerhoff%26aufirst%3DR.%2BR.%26aulast%3DCale%26aufirst%3DE.%2BM.%26aulast%3DWalkowicz%26aufirst%3DW.%2BE.%26aulast%3DRadakovich%26aufirst%3DN.%2BA.%26aulast%3DAnasti%26aufirst%3DK.%26aulast%3DArmand%26aufirst%3DL.%26aulast%3DParks%26aufirst%3DR.%26aulast%3DSutherland%26aufirst%3DL.%26aulast%3DScearce%26aufirst%3DR.%26aulast%3DJoyce%26aufirst%3DM.%2BG.%26aulast%3DPancera%26aufirst%3DM.%26aulast%3DDruz%26aufirst%3DA.%26aulast%3DGeorgiev%26aufirst%3DI.%2BS.%26aulast%3DVon%2BHolle%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DC.%26aulast%3DReed%26aufirst%3DS.%2BG.%26aulast%3DLouder%26aufirst%3DM.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DMorris%26aufirst%3DL.%26aulast%3DAbdool-Karim%26aufirst%3DS.%2BS.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DPark%26aufirst%3DP.%2BK.%26aulast%3DFernandez-Tejada%26aufirst%3DA.%26aulast%3DWiehe%26aufirst%3DK.%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DKepler%26aufirst%3DT.%2BB.%26aulast%3DSaunders%26aufirst%3DK.%2BO.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DMoody%26aufirst%3DM.%2BA.%26aulast%3DDanishefsky%26aufirst%3DS.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DMimicry%2520of%2520an%2520HIV%2520broadly%2520neutralizing%2520antibody%2520epitope%2520with%2520a%2520synthetic%2520glycopeptide%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aai7521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Multivalent antigen presentation enhances the immunogenicity of a synthetic three-component HIV-1 V3 glycopeptide vaccine</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.8b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.8b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVyms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=582-589&author=H.+Caiauthor=R.+Zhangauthor=J.+Orwenyoauthor=J.+Giddensauthor=Q.+Yangauthor=C.+C.+LaBrancheauthor=D.+C.+Montefioriauthor=L.+X.+Wang&title=Multivalent+antigen+presentation+enhances+the+immunogenicity+of+a+synthetic+three-component+HIV-1+V3+glycopeptide+vaccine&doi=10.1021%2Facscentsci.8b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine</span></div><div class="casAuthors">Cai, Hui; Zhang, Roushu; Orwenyo, Jared; Giddens, John; Yang, Qiang; LaBranche, Celia C.; Montefiori, David C.; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">582-589</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV-1 envelope glycoproteins gp120 and gp41 are presented on the virus surface as a trimer of heterodimer and are the targets of broadly neutralizing antibodies (bNAbs).  We describe here the synthesis and preliminary immunol. evaluation of a three-component trivalent HIV-1 V3 glycopeptide immunogen aiming to raise glycopeptide epitope-specific antibodies.  Click chem. confers efficient synthesis of the lipopeptide-glycopeptide conjugate that carries three copies of HIV-1 JR-FL gp120 V3 glycopeptide with a high-mannose glycan at the N332 glycosylation site.  We found that the multi-valent presentation substantially enhanced the immunogenicity of the V3 glycopeptide.  The antisera induced by the three-component multi-valent glycopeptide immunogen exhibited stronger binding to heterologous HIV-1 gp120s and the trimeric gp140s than that from the monovalent glycopeptide immunogen.  The antisera generated from this preliminary rabbit immunization did not show virus neutralization activity, probably due to the lack of somatic maturation.  The ability to elicit substantial glycopeptide epitope-specific antibodies by the three-component trivalent glycopeptide immunogen suggests that it could serve as a valuable vaccine component in combination with other vaccine candidates for further immunization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9RP_0rT13bVg90H21EOLACvtfcHk0lif69rt3Nbppg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVyms70%253D&md5=c35d7c340270a14337c7d0afd63b7c5f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.8b00060%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DGiddens%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLaBranche%26aufirst%3DC.%2BC.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DMultivalent%2520antigen%2520presentation%2520enhances%2520the%2520immunogenicity%2520of%2520a%2520synthetic%2520three-component%2520HIV-1%2520V3%2520glycopeptide%2520vaccine%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2018%26volume%3D4%26spage%3D582%26epage%3D589%26doi%3D10.1021%2Facscentsci.8b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marozsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khayat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deller, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnsmb.2594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=23708606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=796-803&author=L.+Kongauthor=J.+H.+Leeauthor=K.+J.+Dooresauthor=C.+D.+Murinauthor=J.+P.+Julienauthor=R.+McBrideauthor=Y.+Liuauthor=A.+Marozsanauthor=A.+Cupoauthor=P.+J.+Klasseauthor=S.+Hoffenbergauthor=M.+Caulfieldauthor=C.+R.+Kingauthor=Y.+Huaauthor=K.+M.+Leauthor=R.+Khayatauthor=M.+C.+Dellerauthor=T.+Claytonauthor=H.+Tienauthor=T.+Feiziauthor=R.+W.+Sandersauthor=J.+C.+Paulsonauthor=J.+P.+Mooreauthor=R.+L.+Stanfieldauthor=D.+R.+Burtonauthor=A.+B.+Wardauthor=I.+A.+Wilson&title=Supersite+of+immune+vulnerability+on+the+glycosylated+face+of+HIV-1+envelope+glycoprotein+gp120&doi=10.1038%2Fnsmb.2594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120</span></div><div class="casAuthors">Kong, Leopold; Lee, Jeong Hyun; Doores, Katie J.; Murin, Charles D.; Julien, Jean-Philippe; McBride, Ryan; Liu, Yan; Marozsan, Andre; Cupo, Albert; Klasse, Per-Johan; Hoffenberg, Simon; Caulfield, Michael; King, C. Richter; Hua, Yuanzi; Le, Khoa M.; Khayat, Reza; Deller, Marc C.; Clayton, Thomas; Tien, Henry; Feizi, Ten; Sanders, Rogier W.; Paulson, James C.; Moore, John P.; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">796-803</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A substantial proportion of the broadly neutralizing antibodies (bnAbs) identified in certain HIV-infected donors recognize glycan-dependent epitopes on HIV-1 gp120.  Here we elucidate how the bnAb PGT 135 binds its Asn332 glycan-dependent epitope from its 3.1-Å crystal structure with gp120, CD4 and Fab 17b.  PGT 135 interacts with glycans at Asn332, Asn392 and Asn386, using long CDR loops H1 and H3 to penetrate the glycan shield and access the gp120 protein surface.  EM reveals that PGT 135 can accommodate the conformational and chem. diversity of gp120 glycans by altering its angle of engagement.  Combined structural studies of PGT 135, PGT 128 and 2G12 show that this Asn332-dependent antigenic region is highly accessible and much more extensive than initially appreciated, which allows for multiple binding modes and varied angles of approach; thereby it represents a supersite of vulnerability for antibody neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXb1rDhP3sPrVg90H21EOLACvtfcHk0lhgOmtn7vXsmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cqu7o%253D&md5=a9dba6767a1e724af9601ee88b1dc990</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2594%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DMurin%26aufirst%3DC.%2BD.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMarozsan%26aufirst%3DA.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DHoffenberg%26aufirst%3DS.%26aulast%3DCaulfield%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DC.%2BR.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DLe%26aufirst%3DK.%2BM.%26aulast%3DKhayat%26aufirst%3DR.%26aulast%3DDeller%26aufirst%3DM.%2BC.%26aulast%3DClayton%26aufirst%3DT.%26aulast%3DTien%26aufirst%3DH.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DSupersite%2520of%2520immune%2520vulnerability%2520on%2520the%2520glycosylated%2520face%2520of%2520HIV-1%2520envelope%2520glycoprotein%2520gp120%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D796%26epage%3D803%26doi%3D10.1038%2Fnsmb.2594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majeed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montabana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrov, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span> <span> </span><span class="NLM_article-title">Structure of a V3-containing HIV-1 gp120 core</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1126/science.1118398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscience.1118398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=1025-1028&author=C.+C.+Huangauthor=M.+Tangauthor=M.+Y.+Zhangauthor=S.+Majeedauthor=E.+Montabanaauthor=R.+L.+Stanfieldauthor=D.+S.+Dimitrovauthor=B.+Korberauthor=J.+Sodroskiauthor=I.+A.+Wilsonauthor=R.+Wyattauthor=P.+D.+Kwong&title=Structure+of+a+V3-containing+HIV-1+gp120+core&doi=10.1126%2Fscience.1118398"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1118398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1118398%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DMajeed%26aufirst%3DS.%26aulast%3DMontabana%26aufirst%3DE.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DDimitrov%26aufirst%3DD.%2BS.%26aulast%3DKorber%26aufirst%3DB.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWyatt%26aufirst%3DR.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520of%2520a%2520V3-containing%2520HIV-1%2520gp120%2520core%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D1025%26epage%3D1028%26doi%3D10.1126%2Fscience.1118398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rerks-Ngarm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitisuttithum, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitayaphan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaewkungwal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premsri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namwat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benenson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurunathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stablein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birx, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunsuttiwat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamboonruang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thongcharoen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunasol, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span> <span> </span><span class="NLM_article-title">Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">2209</span>– <span class="NLM_lpage">2220</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0908492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1056%2FNEJMoa0908492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=19843557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=2209-2220&author=S.+Rerks-Ngarmauthor=P.+Pitisuttithumauthor=S.+Nitayaphanauthor=J.+Kaewkungwalauthor=J.+Chiuauthor=R.+Parisauthor=N.+Premsriauthor=C.+Namwatauthor=M.+de+Souzaauthor=E.+Adamsauthor=M.+Benensonauthor=S.+Gurunathanauthor=J.+Tartagliaauthor=J.+G.+McNeilauthor=D.+P.+Francisauthor=D.+Stableinauthor=D.+L.+Birxauthor=S.+Chunsuttiwatauthor=C.+Khamboonruangauthor=P.+Thongcharoenauthor=M.+L.+Robbauthor=N.+L.+Michaelauthor=P.+Kunasolauthor=J.+H.+Kim&title=Vaccination+with+ALVAC+and+AIDSVAX+to+prevent+HIV-1+infection+in+Thailand&doi=10.1056%2FNEJMoa0908492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand</span></div><div class="casAuthors">Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Nitayaphan, Sorachai; Kaewkungwal, Jaranit; Chiu, Joseph; Paris, Robert; Premsri, Nakorn; Namwat, Chawetsan; De Souza, Mark; Adams, Elizabeth; Benenson, Michael; Gurunathan, Sanjay; Tartaglia, Jim; Mcneil, John G.; Francis, Donald P.; Stablein, Donald; Birx, Deborah L.; Chunsuttiwat, Supamit; Khamboonruang, Chirasak; Thongcharoen, Prasert; Robb, Merlin L.; Michael, Nelson L.; Kunasol, Prayura; Kim, Jerome H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2209-2220</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is crit. to pandemic control.  In a community-based, randomized, multicenter, double-blind, placebo-controlled efficacy trial, the authors evaluated four priming injections of a recombinant canarypox vector vaccine (ALVAC-HIV [vCP1521]) plus two booster injections of a recombinant glycoprotein 120 subunit vaccine (AIDSVAX B/E).  The vaccine and placebo injections were administered to 16,402 healthy men and women between the ages of 18 and 30 years in Rayong and Chon Buri provinces in Thailand.  The volunteers, primarily at heterosexual risk for HIV infection, were monitored for the coprimary end points: HIV-1 infection and early HIV-1 viremia, at the end of the 6-mo vaccination series and every 6 mo thereafter for 3 years.  In the intention-to-treat anal. involving 16,402 subjects, there was a trend toward the prevention of HIV-1 infection among the vaccine recipients, with a vaccine efficacy of 26.4% (95% confidence interval [CI], -4.0 to 47.9).  In the perprotocol anal. involving 12,542 subjects, the vaccine efficacy was 26.2% (95% CI, -13.3 to 51.9).  In the modified intention-to-treat anal. involving 16,395 subjects (with the exclusion of 7 subjects who were found to have had HIV-1 infection at baseline), the vaccine efficacy was 31.2% (95% CI, 1.1 to 52.1).  Vaccination did not affect the degree of viremia or the CD4+ T-cell count in subjects in whom HIV-1 infection was subsequently diagnosed.  This ALVAC-HIV and AIDSVAX B/E vaccine regimen may reduce the risk of HIV infection in a community-based population with largely heterosexual risk.  Vaccination did not affect the viral load or CD4+ count in subjects with HIV infection.  Although the results show only a modest benefit, they offer insight for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyn4FIQSdHi7Vg90H21EOLACvtfcHk0lhgOmtn7vXsmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsb%252FO&md5=22aa3862aeaf5c28e7d595a369fbd134</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0908492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0908492%26sid%3Dliteratum%253Aachs%26aulast%3DRerks-Ngarm%26aufirst%3DS.%26aulast%3DPitisuttithum%26aufirst%3DP.%26aulast%3DNitayaphan%26aufirst%3DS.%26aulast%3DKaewkungwal%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DJ.%26aulast%3DParis%26aufirst%3DR.%26aulast%3DPremsri%26aufirst%3DN.%26aulast%3DNamwat%26aufirst%3DC.%26aulast%3Dde%2BSouza%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DE.%26aulast%3DBenenson%26aufirst%3DM.%26aulast%3DGurunathan%26aufirst%3DS.%26aulast%3DTartaglia%26aufirst%3DJ.%26aulast%3DMcNeil%26aufirst%3DJ.%2BG.%26aulast%3DFrancis%26aufirst%3DD.%2BP.%26aulast%3DStablein%26aufirst%3DD.%26aulast%3DBirx%26aufirst%3DD.%2BL.%26aulast%3DChunsuttiwat%26aufirst%3DS.%26aulast%3DKhamboonruang%26aufirst%3DC.%26aulast%3DThongcharoen%26aufirst%3DP.%26aulast%3DRobb%26aufirst%3DM.%2BL.%26aulast%3DMichael%26aufirst%3DN.%2BL.%26aulast%3DKunasol%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26atitle%3DVaccination%2520with%2520ALVAC%2520and%2520AIDSVAX%2520to%2520prevent%2520HIV-1%2520infection%2520in%2520Thailand%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D2209%26epage%3D2220%26doi%3D10.1056%2FNEJMoa0908492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rerks-Ngarm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Excler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, N. L.</span></span> <span> </span><span class="NLM_article-title">HIV vaccines: lessons learned and the way forward</span>. <i>Curr. Opin. HIV AIDS</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1097/COH.0b013e32833d17ac</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1097%2FCOH.0b013e32833d17ac" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=20978385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A280%3ADC%252BC3cbisFSgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=428-434&author=J.+H.+Kimauthor=S.+Rerks-Ngarmauthor=J.+L.+Exclerauthor=N.+L.+Michael&title=HIV+vaccines%3A+lessons+learned+and+the+way+forward&doi=10.1097%2FCOH.0b013e32833d17ac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">HIV vaccines: lessons learned and the way forward</span></div><div class="casAuthors">Kim Jerome H; Rerks-Ngarm Supachai; Excler Jean-Louis; Michael Nelson L</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in HIV and AIDS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  An effective HIV vaccine is a global health priority.  We describe lessons learned from four HIV vaccine trials that failed to demonstrate efficacy and one that showed modest protection as a pathway forward.  RECENT FINDINGS:  The Merck Ad5 phase IIb T-cell vaccine failed to show efficacy and might have increased the risk of HIV acquisition in men who have sex with men.  Although VaxGen gp120 alone was not efficacious in groups at high risk for HIV-1 infection, the RV144 ALVAC prime and gp120 boost regimen showed 31% efficacy in low-incidence heterosexuals.  All trials demonstrated the limitations of available laboratory and animal models to assess relevant vaccine-induced immune responses and predict clinical trial outcome.  Analysis of innate and adaptive responses induced in RV144 will guide future trial design.  SUMMARY:  Future HIV vaccine trials should define the RV144 immune responses relevant to protection, improve durability and level of protection, and assess efficacy in diverse risk groups.  New strategies examining heterologous vector prime-boost, universal inserts, replicating vectors, and novel protein or adjuvant immunogens should be explored to induce T-cell and antibody responses.  HIV vaccine development requires innovative ideas and a sustained long-term commitment of scientists, governments, and the community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTK-9zJcAGcnELvajU9pjPfW6udTcc2eaOnwhPK6y9Drntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbisFSgtg%253D%253D&md5=ff455e858b9acf48fd14744ac5afcfec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e32833d17ac&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e32833d17ac%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DRerks-Ngarm%26aufirst%3DS.%26aulast%3DExcler%26aufirst%3DJ.%2BL.%26aulast%3DMichael%26aufirst%3DN.%2BL.%26atitle%3DHIV%2520vaccines%253A%2520lessons%2520learned%2520and%2520the%2520way%2520forward%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2010%26volume%3D5%26spage%3D428%26epage%3D434%26doi%3D10.1097%2FCOH.0b013e32833d17ac" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toonstra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5453</span>– <span class="NLM_lpage">5456</span>, <span class="refDoi"> DOI: 10.1039/C7CC02059G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1039%2FC7CC02059G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28466900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslWrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=5453-5456&author=H.+Caiauthor=J.+Orwenyoauthor=J.+Guenagaauthor=J.+Giddensauthor=C.+Toonstraauthor=R.+T.+Wyattauthor=L.+X.+Wang&title=Synthetic+multivalent+V3+glycopeptides+display+enhanced+recognition+by+glycan-dependent+HIV-1+broadly+neutralizing+antibodies&doi=10.1039%2FC7CC02059G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies</span></div><div class="casAuthors">Cai, Hui; Orwenyo, Jared; Guenaga, Javier; Giddens, John; Toonstra, Christian; Wyatt, Richard T.; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5453-5456</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We describe here the synthesis of novel multivalent HIV V3 domain glycopeptides and their binding to broadly neutralizing antibodies PGT128 and 10-1074.  Our binding data reveal a distinct mode of antigen recognition by the two antibodies and further suggest that multivalent glycopeptides could mimic the neutralizing epitopes more efficiently than the monomeric glycopeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquUL0g4ELWL7Vg90H21EOLACvtfcHk0ligYQXOwQxQGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslWrt78%253D&md5=a03830b43cb5b099e89fa134f244984d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC7CC02059G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC02059G%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DGuenaga%26aufirst%3DJ.%26aulast%3DGiddens%26aufirst%3DJ.%26aulast%3DToonstra%26aufirst%3DC.%26aulast%3DWyatt%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DSynthetic%2520multivalent%2520V3%2520glycopeptides%2520display%2520enhanced%2520recognition%2520by%2520glycan-dependent%2520HIV-1%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2017%26volume%3D53%26spage%3D5453%26epage%3D5456%26doi%3D10.1039%2FC7CC02059G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umekawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2214</span>– <span class="NLM_lpage">2223</span>, <span class="refDoi"> DOI: 10.1021/ja8074677</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja8074677" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ogtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=2214-2223&author=W.+Huangauthor=C.+Liauthor=B.+Liauthor=M.+Umekawaauthor=K.+Yamamotoauthor=X.+Zhangauthor=L.+X.+Wang&title=Glycosynthases+enable+a+highly+efficient+chemoenzymatic+synthesis+of+N-glycoproteins+carrying+intact+natural+N-glycans&doi=10.1021%2Fja8074677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosynthases Enable a Highly Efficient Chemoenzymatic Synthesis of N-Glycoproteins Carrying Intact Natural N-Glycans</span></div><div class="casAuthors">Huang, Wei; Li, Cishan; Li, Bing; Umekawa, Midori; Yamamoto, Kenji; Zhang, Xinyu; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2214-2223</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Homogeneous N-glycoproteins carrying defined natural N-glycans are essential for detailed structural and functional studies.  The transglycosylation activity of the endo-β-N-acetylglucosaminidases from Arthrobacter protophormiae (Endo-A) and Mucor hiemalis (Endo-M) holds great potential for glycoprotein synthesis, but the wild-type enzymes are not practical for making glycoproteins carrying native N-glycans because of their predominant activity for product hydrolysis.  In this article, we report studies of two endoglycosidase-based glycosynthases, EndoM-N175A and EndoA-N171A, and their usefulness in constructing homogeneous N-glycoproteins carrying natural N-glycans.  The oligosaccharide oxazoline corresponding to the biantennary complex-type N-glycan was synthesized and tested with the two glycosynthases.  The EndoM-N175A mutant was able to efficiently transfer the complex-type glycan oxazoline to a GlcNAc peptide and GlcNAc-contg. RNase to form the corresponding homogeneous glycopeptide/glycoprotein.  The EndoA-N171A mutant did not recognize the complex-type N-glycan oxazoline but could efficiently use the high-mannose-type glycan oxazoline for transglycosylation.  These mutants possess the transglycosylation activity but lack the hydrolytic activity toward the product.  Kinetic studies revealed that the dramatically enhanced synthetic efficiency of the EndoA-N171A mutant was due to the significantly reduced hydrolytic activity toward both the Man9GlcNAc oxazoline and the product as well as to its enhanced activity for transglycosylation.  Thus, the two mutants described here represent the first endoglycosidase-based glycosynthases enabling a highly efficient synthesis of homogeneous natural N-glycoproteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoasUdb3lI0ibVg90H21EOLACvtfcHk0ligYQXOwQxQGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ogtb8%253D&md5=9da9a7def29006536e5b0b68093ef0dc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja8074677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja8074677%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DUmekawa%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DGlycosynthases%2520enable%2520a%2520highly%2520efficient%2520chemoenzymatic%2520synthesis%2520of%2520N-glycoproteins%2520carrying%2520intact%2520natural%2520N-glycans%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D2214%26epage%3D2223%26doi%3D10.1021%2Fja8074677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umekawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Efficient glycosynthase mutant derived from Mucor hiemalis endo-beta-N-acetylglucosaminidase capable of transferring oligosaccharide from both sugar oxazoline and natural N-glycan</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.059832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1074%2Fjbc.M109.059832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=19880511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sqtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=511-521&author=M.+Umekawaauthor=C.+Liauthor=T.+Higashiyamaauthor=W.+Huangauthor=H.+Ashidaauthor=K.+Yamamotoauthor=L.+X.+Wang&title=Efficient+glycosynthase+mutant+derived+from+Mucor+hiemalis+endo-beta-N-acetylglucosaminidase+capable+of+transferring+oligosaccharide+from+both+sugar+oxazoline+and+natural+N-glycan&doi=10.1074%2Fjbc.M109.059832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient glycosynthase mutant derived from Mucor hiemalis endo-β-N-acetylglucosaminidase capable of transferring oligosaccharide from both sugar oxazoline and natural N-glycan</span></div><div class="casAuthors">Umekawa, Midori; Li, Cishan; Higashiyama, Takayuki; Huang, Wei; Ashida, Hisashi; Yamamoto, Kenji; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">511-521</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Endo-M, an endo-β-N-acetylglucosaminidase from Mucor hiemalis, is a family 85 glycoside hydrolase.  This enzyme is unique in that it can transfer en bloc the oligosaccharide of various types of N-glycans onto different acceptors, and thereby it enzymically generates diverse glycoconjugates.  In this study, we performed mutational and kinetic studies focusing on a key catalytic asparagine 175 of Endo-M.  We have shown that most of the Asn-175 mutants had significantly diminished hydrolysis activity but acted as glycosynthases capable of using synthetic sugar oxazoline for transglycosylation.  Our results confirm the crit. role of this asparagine residue in promoting the formation of an oxazolinium ion intermediate in the first step of the substrate-assisted catalysis.  Interestingly, the N175Q mutant was found to possess dramatically enhanced glycosynthase-like activity with sugar oxazoline in comparison with N175A and a transglycosidase-like activity with "natural" N-glycan as well.  These results also implicated the significance of amide side chain in the asparagine 175 of Endo-M for promoting oxazoline transglycosylation in the second step of the catalysis.  The highly efficient syntheses of glycopeptides/glycoproteins by N175Q combined with synthetic sugar oxazolines or natural N-glycan substrates were exemplified.  In addn., we also identified several previously unknown residues that seem to play a role in the catalysis of Endo-M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBD4ZIpq3WcrVg90H21EOLACvtfcHk0lgr4oLK0RsVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sqtr%252FL&md5=0b9c4027515318c2041a2df4501cfba0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.059832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.059832%26sid%3Dliteratum%253Aachs%26aulast%3DUmekawa%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DAshida%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DEfficient%2520glycosynthase%2520mutant%2520derived%2520from%2520Mucor%2520hiemalis%2520endo-beta-N-acetylglucosaminidase%2520capable%2520of%2520transferring%2520oligosaccharide%2520from%2520both%2520sugar%2520oxazoline%2520and%2520natural%2520N-glycan%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D511%26epage%3D521%26doi%3D10.1074%2Fjbc.M109.059832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gristick, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Boehmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schamber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazumyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golijanin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatkenheuer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span> <span> </span><span class="NLM_article-title">Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnsmb.3291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27617431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2rtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=906-915&author=H.+B.+Gristickauthor=L.+von+Boehmerauthor=A.+P.+Westauthor=M.+Schamberauthor=A.+Gazumyanauthor=J.+Golijaninauthor=M.+S.+Seamanauthor=G.+Fatkenheuerauthor=F.+Kleinauthor=M.+C.+Nussenzweigauthor=P.+J.+Bjorkman&title=Natively+glycosylated+HIV-1+Env+structure+reveals+new+mode+for+antibody+recognition+of+the+CD4-binding+site&doi=10.1038%2Fnsmb.3291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site</span></div><div class="casAuthors">Gristick, Harry B.; von Boehmer, Lotta; West Jr, Anthony P.; Schamber, Michael; Gazumyan, Anna; Golijanin, Jovana; Seaman, Michael S.; Fatkenheuer, Gerd; Klein, Florian; Nussenzweig, Michel C.; Bjorkman, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">906-915</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutralizing antibodies (bNAbs) recognize and/or accommodate N-glycans on the trimeric envelope glycoprotein (Env).  Variability in high-mannose and complex-type Env glycoforms leads to heterogeneity that usually precludes visualization of the native glycan shield.  We present 3.5-Å- and 3.9-Å-resoln. crystal structures of the HIV-1 Env trimer with fully processed and native glycosylation, revealing a glycan shield of high-mannose and complex-type N-glycans, which we used to define complete epitopes of two bNAbs.  Env trimer was complexed with 10-1074 (against the V3-loop) and IOMA, a new CD4-binding site (CD4bs) antibody.  Although IOMA derives from VH1-2*02, the germline gene of CD4bs-targeting VRC01-class bNAbs, its light chain lacks the short CDRL3 that defines VRC01-class bNAbs.  Thus IOMA resembles 8ANC131-class/VH1-46-derived CD4bs bNAbs, which have normal-length CDRL3s.  The existence of bNAbs that combine features of VRC01-class and 8ANC131-class antibodies has implications for immunization strategies targeting VRC01-like bNAbs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrACMDFZbOSGbVg90H21EOLACvtfcHk0lgr4oLK0RsVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2rtb3I&md5=03038d4919d4cb0b6952c336d5253b8e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3291%26sid%3Dliteratum%253Aachs%26aulast%3DGristick%26aufirst%3DH.%2BB.%26aulast%3Dvon%2BBoehmer%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DSchamber%26aufirst%3DM.%26aulast%3DGazumyan%26aufirst%3DA.%26aulast%3DGolijanin%26aufirst%3DJ.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DFatkenheuer%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26atitle%3DNatively%2520glycosylated%2520HIV-1%2520Env%2520structure%2520reveals%2520new%2520mode%2520for%2520antibody%2520recognition%2520of%2520the%2520CD4-binding%2520site%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D906%26epage%3D915%26doi%3D10.1038%2Fnsmb.3291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span> <span> </span><span class="NLM_article-title">Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6106</span>– <span class="NLM_lpage">6110</span>, <span class="refDoi"> DOI: 10.1002/anie.201300390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1002%2Fanie.201300390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=23616304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVeit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=6106-6110&author=H.+Caiauthor=M.+S.+Chenauthor=Z.+Y.+Sunauthor=Y.+F.+Zhaoauthor=H.+Kunzauthor=Y.+M.+Li&title=Self-adjuvanting+synthetic+antitumor+vaccines+from+MUC1+glycopeptides+conjugated+to+T-cell+epitopes+from+tetanus+toxoid&doi=10.1002%2Fanie.201300390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid</span></div><div class="casAuthors">Cai, Hui; Chen, Mei-Sha; Sun, Zhan-Yi; Zhao, Yu-Fen; Kunz, Horst; Li, Yan-Mei</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6106-6110</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The MUC1 tandem repeat glycopeptide sequence HGVTSAPDTRPAPGSTAPPA was coupled to three known universal T-helper cell epitope peptides P4 (TT1273-1284: GQIGN DPNRDIL), P2 (TT830-843: QYIKANSKFIGITE), and P30 (TT947-967: FNNFTVSFWLRVPKVSASHLE) derived from the tetanus toxoid.  Efficient two-component antitumor vaccines were obtained by conjugation of MUC1 tandem repeat glycopeptides with the tetanus toxoid P30 peptide.  The P30 T-cell epitope obviously is of superior efficiency compared to the P2 and P4 epitopes.  The sera induced by BSA-conjugated vaccines showed stronger binding to MCF-7 cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkEbHQij537LVg90H21EOLACvtfcHk0lgr4oLK0RsVcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVeit7g%253D&md5=c8c0d5c7d46a331cda57385d5dd101e9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fanie.201300390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201300390%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DZhao%26aufirst%3DY.%2BF.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%2BM.%26atitle%3DSelf-adjuvanting%2520synthetic%2520antitumor%2520vaccines%2520from%2520MUC1%2520glycopeptides%2520conjugated%2520to%2520T-cell%2520epitopes%2520from%2520tetanus%2520toxoid%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D6106%26epage%3D6110%26doi%3D10.1002%2Fanie.201300390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palitzsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorlemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stergiou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerlind, U.</span></span> <span> </span><span class="NLM_article-title">Microarray analysis of antibodies induced with synthetic antitumor vaccines: Specificity against diverse mucin core structures</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3884</span>, <span class="refDoi"> DOI: 10.1002/chem.201603921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1002%2Fchem.201603921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27957769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVaqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3875-3884&author=C.+Pettauthor=H.+Caiauthor=J.+Liuauthor=B.+Palitzschauthor=M.+Schorlemerauthor=S.+Hartmannauthor=N.+Stergiouauthor=M.+Luauthor=H.+Kunzauthor=E.+Schmittauthor=U.+Westerlind&title=Microarray+analysis+of+antibodies+induced+with+synthetic+antitumor+vaccines%3A+Specificity+against+diverse+mucin+core+structures&doi=10.1002%2Fchem.201603921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Microarray analysis of antibodies induced with synthetic antitumor vaccines: Specificity against diverse mucin core structures</span></div><div class="casAuthors">Pett, Christian; Cai, Hui; Liu, Jia; Palitzsch, Bjoern; Schorlemer, Manuel; Hartmann, Sebastian; Stergiou, Natascha; Lu, Mengji; Kunz, Horst; Schmitt, Edgar; Westerlind, Ulrika</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3875-3884</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Glycoprotein research is pivotal for vaccine development and biomarker discovery.  Many successful methodologies for reliably increasing the antigenicity toward tumor-assocd. glycopeptide structures have been reported.  Deeper insights into the quality and specificity of the raised polyclonal, humoral reactions are often not addressed, despite the fact that an immunol. memory, which produces antibodies with cross-reactivity to epitopes exposed on healthy cells, may cause autoimmune diseases.  In the current work, three MUC1 antitumor vaccine candidates conjugated with different immune stimulants are evaluated immunol.  For assessment of the influence of the immune stimulant on antibody recognition, a comprehensive library of mucin 1 glycopeptides (>100 entries) is synthesized and employed in antibody microarray profiling; these range from small tumor-assocd. glycans (TN, STN, and T-antigen structures) to heavily extended O-glycan core structures (type-1 and type-2 elongated core 1-3 tri-, tetra-, and hexasaccharides) glycosylated in variable d. at the five different sites of the MUC1 tandem repeat.  This is one of the most extensive glycopeptide libraries ever made through total synthesis.  On tumor cells, the core 2 β-1,6-N-acetylglucosaminyltransferase-1 (C2GlcNAcT-1) is down-regulated, resulting in lower amts. of the branched core 2 structures, which favor formation of linear core 1 or core 3 structures, and in particular, truncated tumor-assocd. antigen structures.  The core 2 structures are commonly found on healthy cells and the elucidation of antibody cross-reactivity to such epitopes may predict the tumor-selectivity and safety of synthetic vaccines.  With the extended mucin core structures in hand, antibody cross-reactivity toward the branched core 2 glycopeptide epitopes is explored.  It is obsd. that the induced antibodies recognize MUC1 peptides with very high glycosylation site specificity.  The nature of the antibody response is characteristically different for antibodies directed to glycosylation sites in either the immune-dominant PDTR or the GSTA domain.  All antibody sera show high reactivity to the tumor-assocd. saccharide structures on MUC1.  Extensive glycosylation with branched core 2 structures, typically found on healthy cells, abolishes antibody recognition of the antisera and suggests that all vaccine conjugates preferentially induce a tumor-specific humoral immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQUSP4J2-84rVg90H21EOLACvtfcHk0ljEiwZMR0JxrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVaqs7c%253D&md5=6af0f627abe8d7c19adef5f7c7cea23a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fchem.201603921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201603921%26sid%3Dliteratum%253Aachs%26aulast%3DPett%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPalitzsch%26aufirst%3DB.%26aulast%3DSchorlemer%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DStergiou%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DWesterlind%26aufirst%3DU.%26atitle%3DMicroarray%2520analysis%2520of%2520antibodies%2520induced%2520with%2520synthetic%2520antitumor%2520vaccines%253A%2520Specificity%2520against%2520diverse%2520mucin%2520core%2520structures%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D3875%26epage%3D3884%26doi%3D10.1002%2Fchem.201603921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaekwad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G. J.</span></span> <span> </span><span class="NLM_article-title">Robust immune responses elicited by a fully synthetic three-component vaccine</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2007.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnchembio.2007.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=17767155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=663-667&author=S.+Ingaleauthor=M.+A.+Wolfertauthor=J.+Gaekwadauthor=T.+Buskasauthor=G.+J.+Boons&title=Robust+immune+responses+elicited+by+a+fully+synthetic+three-component+vaccine&doi=10.1038%2Fnchembio.2007.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Robust immune responses elicited by a fully synthetic three-component vaccine</span></div><div class="casAuthors">Ingale, Sampat; Wolfert, Margreet A.; Gaekwad, Jidnyasa; Buskas, Therese; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The overexpression of saccharides such as globo-H, LewisY, and Tn antigen is a common feature of oncogenic transformed cells.  Endeavors to exploit this aberrant glycosylation for cancer vaccine development have been complicated by difficulties in eliciting high titers of IgG antibodies against classical conjugates of tumor-assocd. carbohydrates to carrier proteins.  The authors designed, chem. synthesized, and immunol. evaluated a no. of fully synthetic vaccine candidates to establish strategies to overcome the poor immunogenicity of tumor-assocd. carbohydrates and glycopeptides.  The have found that a 3-component vaccine composed of a TLR2 agonist, a promiscuous peptide T-helper epitope, and a tumor-assocd. glycopeptide can elicit in mice exceptionally high titers of IgG antibodies that can recognize cancer cells expressing the tumor-assocd. carbohydrate.  The superior properties of the vaccine candidate are attributed to the local prodn. of cytokines, upregulation of co-stimulatory proteins, enhanced uptake by macrophages and dendritic cells, and avoidance of epitope suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdz62dPelB7Vg90H21EOLACvtfcHk0ljEiwZMR0JxrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO&md5=43cb22b797d84c8b60bedca1a5aee7ea</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.25%26sid%3Dliteratum%253Aachs%26aulast%3DIngale%26aufirst%3DS.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DGaekwad%26aufirst%3DJ.%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DBoons%26aufirst%3DG.%2BJ.%26atitle%3DRobust%2520immune%2520responses%2520elicited%2520by%2520a%2520fully%2520synthetic%2520three-component%2520vaccine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D663%26epage%3D667%26doi%3D10.1038%2Fnchembio.2007.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gils, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derking, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketas, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozorowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moldt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Breemen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Ramirez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koff, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakasz, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overbaugh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span> <span> </span><span class="NLM_article-title">HIV-1 neutralizing antibodies induced by native-like envelope trimers</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">aac4223</span>, <span class="refDoi"> DOI: 10.1126/science.aac4223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscience.aac4223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=26089353" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2015&pages=aac4223&author=R.+W.+Sandersauthor=M.+J.+van+Gilsauthor=R.+Derkingauthor=D.+Sokauthor=T.+J.+Ketasauthor=J.+A.+Burgerauthor=G.+Ozorowskiauthor=A.+Cupoauthor=C.+Simonichauthor=L.+Gooauthor=H.+Arendtauthor=H.+J.+Kimauthor=J.+H.+Leeauthor=P.+Pugachauthor=M.+Williamsauthor=G.+Debnathauthor=B.+Moldtauthor=M.+J.+van+Breemenauthor=G.+Isikauthor=M.+Medina-Ramirezauthor=J.+W.+Backauthor=W.+C.+Koffauthor=J.+P.+Julienauthor=E.+G.+Rakaszauthor=M.+S.+Seamanauthor=M.+Guttmanauthor=K.+K.+Leeauthor=P.+J.+Klasseauthor=C.+LaBrancheauthor=W.+R.+Schiefauthor=I.+A.+Wilsonauthor=J.+Overbaughauthor=D.+R.+Burtonauthor=A.+B.+Wardauthor=D.+C.+Montefioriauthor=H.+Deanauthor=J.+P.+Moore&title=HIV-1+neutralizing+antibodies+induced+by+native-like+envelope+trimers&doi=10.1126%2Fscience.aac4223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac4223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac4223%26sid%3Dliteratum%253Aachs%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3Dvan%2BGils%26aufirst%3DM.%2BJ.%26aulast%3DDerking%26aufirst%3DR.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DOzorowski%26aufirst%3DG.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DSimonich%26aufirst%3DC.%26aulast%3DGoo%26aufirst%3DL.%26aulast%3DArendt%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPugach%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DDebnath%26aufirst%3DG.%26aulast%3DMoldt%26aufirst%3DB.%26aulast%3Dvan%2BBreemen%26aufirst%3DM.%2BJ.%26aulast%3DIsik%26aufirst%3DG.%26aulast%3DMedina-Ramirez%26aufirst%3DM.%26aulast%3DBack%26aufirst%3DJ.%2BW.%26aulast%3DKoff%26aufirst%3DW.%2BC.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DRakasz%26aufirst%3DE.%2BG.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BK.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLaBranche%26aufirst%3DC.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DOverbaugh%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DDean%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26atitle%3DHIV-1%2520neutralizing%2520antibodies%2520induced%2520by%2520native-like%2520envelope%2520trimers%26jtitle%3DScience%26date%3D2015%26volume%3D349%26spage%3Daac4223%26doi%3D10.1126%2Fscience.aac4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Taeye, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozorowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Pena, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Kerkhof, T. L. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasmeen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crampton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontjer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeStefano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koff, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuitemaker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggink, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkhout, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crotty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span> <span> </span><span class="NLM_article-title">Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">1702</span>– <span class="NLM_lpage">1715</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.cell.2015.11.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2015&pages=1702-1715&author=S.+W.+de+Taeyeauthor=G.+Ozorowskiauthor=A.+T.+de+la+Penaauthor=M.+Guttmanauthor=J.+P.+Julienauthor=T.+L.+G.+M.+van+den%0AKerkhofauthor=J.+A.+Burgerauthor=L.+K.+Pritchardauthor=P.+Pugachauthor=A.+Yasmeenauthor=J.+Cramptonauthor=J.+Huauthor=I.+Bontjerauthor=J.+L.+Torresauthor=H.+Arendtauthor=J.+DeStefanoauthor=W.+C.+Koffauthor=H.+Schuitemakerauthor=D.+Egginkauthor=B.+Berkhoutauthor=H.+Deanauthor=C.+LaBrancheauthor=S.+Crottyauthor=M.+Crispinauthor=D.+C.+Montefioriauthor=P.+J.+Klasseauthor=K.+K.+Leeauthor=J.+P.+Mooreauthor=I.+A.+Wilsonauthor=A.+B.+Wardauthor=R.+W.+Sanders&title=Immunogenicity+of+stabilized+HIV-1+envelope+trimers+with+reduced+exposure+of+non-neutralizing+epitopes&doi=10.1016%2Fj.cell.2015.11.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.11.056%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BTaeye%26aufirst%3DS.%2BW.%26aulast%3DOzorowski%26aufirst%3DG.%26aulast%3Dde%2Bla%2BPena%26aufirst%3DA.%2BT.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2Bden%2BKerkhof%26aufirst%3DT.%2BL.%2BG.%2BM.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DPritchard%26aufirst%3DL.%2BK.%26aulast%3DPugach%26aufirst%3DP.%26aulast%3DYasmeen%26aufirst%3DA.%26aulast%3DCrampton%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DBontjer%26aufirst%3DI.%26aulast%3DTorres%26aufirst%3DJ.%2BL.%26aulast%3DArendt%26aufirst%3DH.%26aulast%3DDeStefano%26aufirst%3DJ.%26aulast%3DKoff%26aufirst%3DW.%2BC.%26aulast%3DSchuitemaker%26aufirst%3DH.%26aulast%3DEggink%26aufirst%3DD.%26aulast%3DBerkhout%26aufirst%3DB.%26aulast%3DDean%26aufirst%3DH.%26aulast%3DLaBranche%26aufirst%3DC.%26aulast%3DCrotty%26aufirst%3DS.%26aulast%3DCrispin%26aufirst%3DM.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BK.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26atitle%3DImmunogenicity%2520of%2520stabilized%2520HIV-1%2520envelope%2520trimers%2520with%2520reduced%2520exposure%2520of%2520non-neutralizing%2520epitopes%26jtitle%3DCell%26date%3D2015%26volume%3D163%26spage%3D1702%26epage%3D1715%26doi%3D10.1016%2Fj.cell.2015.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span> <span> </span><span class="NLM_article-title">Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1038/nchem.2463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnchem.2463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27001729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFGrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=338-346&author=S.+S.+Shivatareauthor=S.+H.+Changauthor=T.+I.+Tsaiauthor=S.+Y.+Tsengauthor=V.+S.+Shivatareauthor=Y.+S.+Linauthor=Y.+Y.+Chengauthor=C.+T.+Renauthor=C.+C.+Leeauthor=S.+Pawarauthor=C.+S.+Tsaiauthor=H.+W.+Shihauthor=Y.+F.+Zengauthor=C.+H.+Liangauthor=P.+D.+Kwongauthor=D.+R.+Burtonauthor=C.+Y.+Wuauthor=C.+H.+Wong&title=Modular+synthesis+of+N-glycans+and+arrays+for+the+hetero-ligand+binding+analysis+of+HIV+antibodies&doi=10.1038%2Fnchem.2463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies</span></div><div class="casAuthors">Shivatare, Sachin S.; Chang, Shih-Huang; Tsai, Tsung-I.; Tseng, Susan Yu; Shivatare, Vidya S.; Lin, Yih-Shyan; Cheng, Yang-Yu; Ren, Chien-Tai; Lee, Chang-Chun David; Pawar, Sujeet; Tsai, Charng-Sheng; Shih, Hao-Wei; Zeng, Yi-Fang; Liang, Chi-Hui; Kwong, Peter D.; Burton, Dennis R.; Wu, Chung-Yi; Wong, Chi-Huey</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new class of broadly neutralizing antibodies (bNAbs) from HIV donors has been reported to target the glycans on gp120-a glycoprotein found on the surface of the virus envelope-thus renewing hope of developing carbohydrate-based HIV vaccines.  However, the version of gp120 used in previous studies was not from human T cells and so the glycosylation pattern could be somewhat different to that found in the native system.  Moreover, some antibodies recognized two different glycans simultaneously and this cannot be detected with the commonly used glycan microarrays on glass slides.  Here, we have developed a glycan microarray on an aluminum-oxide-coated glass slide contg. a diverse set of glycans, including homo- and mixed N-glycans (high-mannose, hybrid and complex types) that were prepd. by modular chemo-enzymic methods to detect the presence of hetero-glycan binding behaviors.  This new approach allows rapid screening and identification of optimal glycans recognized by neutralizing antibodies, and could speed up the development of HIV-1 vaccines targeting cell surface glycans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ8px3BeQ4bLVg90H21EOLACvtfcHk0ljNvyIiY9TywQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFGrtbo%253D&md5=b7603c4a18633b2ce8ded2e67e9e0812</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2463%26sid%3Dliteratum%253Aachs%26aulast%3DShivatare%26aufirst%3DS.%2BS.%26aulast%3DChang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DT.%2BI.%26aulast%3DTseng%26aufirst%3DS.%2BY.%26aulast%3DShivatare%26aufirst%3DV.%2BS.%26aulast%3DLin%26aufirst%3DY.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BY.%26aulast%3DRen%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DPawar%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DC.%2BS.%26aulast%3DShih%26aufirst%3DH.%2BW.%26aulast%3DZeng%26aufirst%3DY.%2BF.%26aulast%3DLiang%26aufirst%3DC.%2BH.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DModular%2520synthesis%2520of%2520N-glycans%2520and%2520arrays%2520for%2520the%2520hetero-ligand%2520binding%2520analysis%2520of%2520HIV%2520antibodies%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D338%26epage%3D346%26doi%3D10.1038%2Fnchem.2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidachary, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span> <span> </span><span class="NLM_article-title">Unprecedented role of hybrid N-glycans as ligands for HIV-1 broadly neutralizing antibodies</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">5202</span>– <span class="NLM_lpage">5210</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b00896</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b00896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVKrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=5202-5210&author=V.+S.+Shivatareauthor=S.+S.+Shivatareauthor=C.+D.+Leeauthor=C.+H.+Liangauthor=K.+S.+Liaoauthor=Y.+Y.+Chengauthor=G.+Saidacharyauthor=C.+Y.+Wuauthor=N.+H.+Linauthor=P.+D.+Kwongauthor=D.+R.+Burtonauthor=C.+H.+Wong&title=Unprecedented+role+of+hybrid+N-glycans+as+ligands+for+HIV-1+broadly+neutralizing+antibodies&doi=10.1021%2Fjacs.8b00896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Role of Hybrid N-Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies</span></div><div class="casAuthors">Shivatare, Vidya S.; Shivatare, Sachin S.; Lee, Chang-Chun David; Liang, Chi-Hui; Liao, Kuo-Shiang; Cheng, Yang-Yu; Saidachary, Gannerla; Wu, Chung-Yi; Lin, Nan-Horng; Kwong, Peter D.; Burton, Dennis R.; Wong, Chi-Huey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5202-5210</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of an HIV vaccine has been hampered by the extraordinary mutability and genetic diversity of the virus, particularly the substantial sequence diversity of gp120 and gp 41 envelope glycoproteins existing in more than 2000 HIV variants.  The highly diverse glycans on HIV spikes are commonly considered as immunol. silent self-antigens; however, the discovery of highly potent broadly neutralizing antibodies (bNAbs) from HIV patients targeting the viral surface glycans has raised a major question about the origin of their antigens.  Recent epitope mapping studies of the bNAb PG9 indicated a requirement of a properly spaced high mannose and a complex type glycan connected by a short peptide spacer.  We have recently discovered that a 1:1 mixt. of Man5 and sialyl biantennary glycan with well-defined distance and without the peptide spacer is well recognized by PG9 with high avidity and, thus, proposed that a hybrid glycan with oligomannose and complex-type arm could be the proper ligand of PG9.  To verify this proposition, we first designed and chemo-enzymically synthesized a series of unusual hybrid-type N-glycan structures, which may exist on HIV surface glycoproteins through the host-guided N-glycosylation pathway.  The synthetic hybrid glycans were then used to prep. glycan arrays for the binding studies of PG9 and several other highly potent bNAbs, including PG16, PGT121, PGT128-3C, 2G12, VRC13, VRC-PG05, VRC26.25, VRC26.09, PGDM1400, 35O22, and 10-1074.  Our results demonstrated that PG9 and some other bNAbs bind with strong avidity (subnanomolar Kd) to certain hybrid structures, suggesting that these unusual glycans may serve as epitopes for the design of vaccines against HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRmzrcr3QyLVg90H21EOLACvtfcHk0ljNvyIiY9TywQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVKrsrY%253D&md5=ac69e306f179dd311c0e73da92551b3b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b00896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b00896%26sid%3Dliteratum%253Aachs%26aulast%3DShivatare%26aufirst%3DV.%2BS.%26aulast%3DShivatare%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BD.%26aulast%3DLiang%26aufirst%3DC.%2BH.%26aulast%3DLiao%26aufirst%3DK.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BY.%26aulast%3DSaidachary%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DN.%2BH.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DUnprecedented%2520role%2520of%2520hybrid%2520N-glycans%2520as%2520ligands%2520for%2520HIV-1%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D5202%26epage%3D5210%26doi%3D10.1021%2Fjacs.8b00896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreider, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerhoff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussedat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkowicz, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladden, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louder, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pier, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jette, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelsoe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamanga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hraber, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korber, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaai7514</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aai7514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscitranslmed.aai7514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28298420" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaai7514&author=M.+Bonsignoriauthor=E.+F.+Kreiderauthor=D.+Feraauthor=R.+R.+Meyerhoffauthor=T.+Bradleyauthor=K.+Wieheauthor=S.+M.+Alamauthor=B.+Aussedatauthor=W.+E.+Walkowiczauthor=K.+K.+Hwangauthor=K.+O.+Saundersauthor=R.+Zhangauthor=M.+A.+Gladdenauthor=A.+Monroeauthor=A.+Kumarauthor=S.+M.+Xiaauthor=M.+Cooperauthor=M.+K.+Louderauthor=K.+McKeeauthor=R.+T.+Bailerauthor=B.+W.+Pierauthor=C.+A.+Jetteauthor=G.+Kelsoeauthor=W.+B.+Williamsauthor=L.+Morrisauthor=J.+Kappesauthor=K.+Waghauthor=G.+Kamangaauthor=M.+S.+Cohenauthor=P.+T.+Hraberauthor=D.+C.+Montefioriauthor=A.+Tramaauthor=H.+X.+Liaoauthor=T.+B.+Keplerauthor=M.+A.+Moodyauthor=F.+Gaoauthor=S.+J.+Danishefskyauthor=J.+R.+Mascolaauthor=G.+M.+Shawauthor=B.+H.+Hahnauthor=S.+C.+Harrisonauthor=B.+T.+Korberauthor=B.+F.+Haynes&title=Staged+induction+of+HIV-1+glycan-dependent+broadly+neutralizing+antibodies&doi=10.1126%2Fscitranslmed.aai7514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aai7514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aai7514%26sid%3Dliteratum%253Aachs%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DKreider%26aufirst%3DE.%2BF.%26aulast%3DFera%26aufirst%3DD.%26aulast%3DMeyerhoff%26aufirst%3DR.%2BR.%26aulast%3DBradley%26aufirst%3DT.%26aulast%3DWiehe%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DAussedat%26aufirst%3DB.%26aulast%3DWalkowicz%26aufirst%3DW.%2BE.%26aulast%3DHwang%26aufirst%3DK.%2BK.%26aulast%3DSaunders%26aufirst%3DK.%2BO.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DGladden%26aufirst%3DM.%2BA.%26aulast%3DMonroe%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DXia%26aufirst%3DS.%2BM.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DLouder%26aufirst%3DM.%2BK.%26aulast%3DMcKee%26aufirst%3DK.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DPier%26aufirst%3DB.%2BW.%26aulast%3DJette%26aufirst%3DC.%2BA.%26aulast%3DKelsoe%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DW.%2BB.%26aulast%3DMorris%26aufirst%3DL.%26aulast%3DKappes%26aufirst%3DJ.%26aulast%3DWagh%26aufirst%3DK.%26aulast%3DKamanga%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DHraber%26aufirst%3DP.%2BT.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DTrama%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DKepler%26aufirst%3DT.%2BB.%26aulast%3DMoody%26aufirst%3DM.%2BA.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DShaw%26aufirst%3DG.%2BM.%26aulast%3DHahn%26aufirst%3DB.%2BH.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26aulast%3DKorber%26aufirst%3DB.%2BT.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DStaged%2520induction%2520of%2520HIV-1%2520glycan-dependent%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaai7514%26doi%3D10.1126%2Fscitranslmed.aai7514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarzotti-Kelsoe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span> <span> </span><span class="NLM_article-title">Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>409</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.jim.2013.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.jim.2013.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=24291345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2014&pages=131-146&author=M.+Sarzotti-Kelsoeauthor=R.+T.+Bailerauthor=E.+Turkauthor=C.+L.+Linauthor=M.+Bilskaauthor=K.+M.+Greeneauthor=H.+Gaoauthor=C.+A.+Toddauthor=D.+A.+Ozakiauthor=M.+S.+Seamanauthor=J.+R.+Mascolaauthor=D.+C.+Montefiori&title=Optimization+and+validation+of+the+TZM-bl+assay+for+standardized+assessments+of+neutralizing+antibodies+against+HIV-1&doi=10.1016%2Fj.jim.2013.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</span></div><div class="casAuthors">Sarzotti-Kelsoe, Marcella; Bailer, Robert T.; Turk, Ellen; Lin, Chen-li; Bilska, Miroslawa; Greene, Kelli M.; Gao, Hongmei; Todd, Christopher A.; Ozaki, Daniel A.; Seaman, Michael S.; Mascola, John R.; Montefiori, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-146</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The TZM-bl assay measures antibody-mediated neutralization of HIV-1 as a function of redns. in HIV-1 Tat-regulated firefly luciferase (Luc) reporter gene expression after a single round of infection with Env-pseudotyped viruses.  This assay has become the main endpoint neutralization assay used for the assessment of pre-clin. and clin. trial samples by a growing no. of labs. worldwide.  Here we present the results of the formal optimization and validation of the TZM-bl assay, performed in compliance with Good Clin. Lab. Practice (GCLP) guidelines.  The assay was evaluated for specificity, accuracy, precision, limits of detection and quantitation, linearity, range and robustness.  The validated manual TZM-bl assay was also adapted, optimized and qualified to an automated 384-well format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRlthftSkNArVg90H21EOLACvtfcHk0lhwl3DjUGSPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKgug%253D%253D&md5=be95a68aa529fa6346a0749f22bd9895</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jim.2013.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jim.2013.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DSarzotti-Kelsoe%26aufirst%3DM.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DTurk%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DBilska%26aufirst%3DM.%26aulast%3DGreene%26aufirst%3DK.%2BM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DTodd%26aufirst%3DC.%2BA.%26aulast%3DOzaki%26aufirst%3DD.%2BA.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26atitle%3DOptimization%2520and%2520validation%2520of%2520the%2520TZM-bl%2520assay%2520for%2520standardized%2520assessments%2520of%2520neutralizing%2520antibodies%2520against%2520HIV-1%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D2014%26volume%3D409%26spage%3D131%26epage%3D146%26doi%3D10.1016%2Fj.jim.2013.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hangartner, L.</span></span> <span> </span><span class="NLM_article-title">Broadly neutralizing antibodies to HIV and their role in vaccine design</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-041015-055515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1146%2Fannurev-immunol-041015-055515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27168247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnslemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=635-659&author=D.+R.+Burtonauthor=L.+Hangartner&title=Broadly+neutralizing+antibodies+to+HIV+and+their+role+in+vaccine+design&doi=10.1146%2Fannurev-immunol-041015-055515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design</span></div><div class="casAuthors">Burton, Dennis R.; Hangartner, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">635-659</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">HIV employs multiple means to evade the humoral immune response, particularly the elicitation of and recognition by broadly neutralizing antibodies (bnAbs).  Such antibodies can act antivirally against a wide spectrum of viruses by targeting relatively conserved regions on the surface HIV envelope trimer spike.  Elicitation of and recognition by bnAbs are hindered by the arrangement of spikes on virions and the relatively difficult access to bnAb epitopes on spikes, including the proximity of variable regions and a high d. of glycans.  Yet, in a small proportion of HIV-infected individuals, potent bnAb responses do develop, and isolation of the corresponding monoclonal antibodies has been facilitated by identification of favorable donors with potent bnAb sera and by development of improved methods for human antibody generation.  Mol. studies of recombinant Env trimers, alone and in interaction with bnAbs, are providing new insights that are fueling the development and testing of promising immunogens aimed at the elicitation of bnAbs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDZd_PZ1EhhLVg90H21EOLACvtfcHk0lhwl3DjUGSPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnslemsr4%253D&md5=b5361d73371daf855d99645e417c66e1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-041015-055515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-041015-055515%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DHangartner%26aufirst%3DL.%26atitle%3DBroadly%2520neutralizing%2520antibodies%2520to%2520HIV%2520and%2520their%2520role%2520in%2520vaccine%2520design%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2016%26volume%3D34%26spage%3D635%26epage%3D659%26doi%3D10.1146%2Fannurev-immunol-041015-055515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelsoe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Host controls of HIV broadly neutralizing antibody development</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1111/imr.12508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1111%2Fimr.12508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28133807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2017&pages=79-88&author=G.+Kelsoeauthor=B.+F.+Haynes&title=Host+controls+of+HIV+broadly+neutralizing+antibody+development&doi=10.1111%2Fimr.12508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Host controls of HIV broadly neutralizing antibody development</span></div><div class="casAuthors">Kelsoe, Garnett; Haynes, Barton F.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Induction of broadly neutralizing antibodies (bNAbs) is a major goal of HIV vaccine development.  BNAbs are made during HIV infection by a subset of individuals but currently cannot be induced in the setting of vaccination.  Considerable progress has been made recently in understanding host immunol. controls of bNAb induction and maturation in the setting of HIV infection, and point to key roles for both central and peripheral immunol. tolerance mechanisms in limiting bnAb development.  Immune tolerance checkpoint inhibition has been transformative in promotion of anti-tumor CD8 T-cell responses in the treatment of certain malignancies.  Here, we review the evidence for host controls of bNAb responses, and discuss strategies for the transient modulation of immune responses with vaccines toward the goal of enhancing germinal center B-cell responses to favor bNAb B-cell lineages and to foster their maturation to full neutralization potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp4ql3C9zrLbVg90H21EOLACvtfcHk0lgTFLnUpxHBLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsb4%253D&md5=07f52b4426b2d70309bc4d91e364694d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fimr.12508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12508%26sid%3Dliteratum%253Aachs%26aulast%3DKelsoe%26aufirst%3DG.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DHost%2520controls%2520of%2520HIV%2520broadly%2520neutralizing%2520antibody%2520development%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D275%26spage%3D79%26epage%3D88%26doi%3D10.1111%2Fimr.12508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1111/imr.12509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1111%2Fimr.12509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28133802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2017&pages=145-160&author=M.+Bonsignoriauthor=H.+X.+Liaoauthor=F.+Gaoauthor=W.+B.+Williamsauthor=S.+M.+Alamauthor=D.+C.+Montefioriauthor=B.+F.+Haynes&title=Antibody-virus+co-evolution+in+HIV+infection%3A+paths+for+HIV+vaccine+development&doi=10.1111%2Fimr.12509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development</span></div><div class="casAuthors">Bonsignori, Mattia; Liao, Hua-Xin; Gao, Feng; Williams, Wilton B.; Alam, S. Munir; Montefiori, David C.; Haynes, Barton F.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-160</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Induction of HIV-1 broadly neutralizing antibodies (bnAbs) to date has only been obsd. in the setting of HIV-1 infection, and then only years after HIV transmission.  Thus, the concept has emerged that one path to induction of bnAbs is to define the viral and immunol. events that occur during HIV-1 infection, and then to mimic those events with a vaccine formulation.  This concept has led to efforts to map both virus and antibody events that occur from the time of HIV-1 transmission to development of bnAbs.  This work has revealed that a virus-antibody "arms race" occurs in which a HIV-1 transmitted/founder (TF) Env induces autologous neutralizing antibodies that can not only neutralize the TF virus but also can select virus escape mutants that in turn select affinity-matured neutralizing antibodies.  From these studies has come a picture of bnAb development that has led to new insights in host-pathogen interactions and, as well, led to insight into immunol. mechanisms of control of bnAb development.  Here, we review the progress to date in elucidating bnAb B cell lineages in HIV-1 infection, discuss new research leading to understanding the immunol. mechanisms of bnAb induction, and address issues relevant to the use of this information for the design of new HIV-1 sequential envelope vaccine candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-u4Iil4-_rVg90H21EOLACvtfcHk0lgTFLnUpxHBLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLY%253D&md5=73f2ad9876ecbb66d964dcc3522b4544</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fimr.12509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12509%26sid%3Dliteratum%253Aachs%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DW.%2BB.%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DAntibody-virus%2520co-evolution%2520in%2520HIV%2520infection%253A%2520paths%2520for%2520HIV%2520vaccine%2520development%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D275%26spage%3D145%26epage%3D160%26doi%3D10.1111%2Fimr.12509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadnais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saye-Francisco, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardine, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criscitiello, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwangi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smider, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>548</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1038/nature23301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature23301" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2017&pages=108-111&author=D.+Sokauthor=K.+M.+Leauthor=M.+Vadnaisauthor=K.+L.+Saye-Franciscoauthor=J.+G.+Jardineauthor=J.+L.+Torresauthor=Z.+T.+Berndsenauthor=L.+Kongauthor=R.+Stanfieldauthor=J.+Ruizauthor=A.+Ramosauthor=C.+H.+Liangauthor=P.+L.+Chenauthor=M.+F.+Criscitielloauthor=W.+Mwangiauthor=I.+A.+Wilsonauthor=A.+B.+Wardauthor=V.+V.+Smiderauthor=D.+R.+Burton&title=Rapid+elicitation+of+broadly+neutralizing+antibodies+to+HIV+by+immunization+in+cows&doi=10.1038%2Fnature23301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnature23301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23301%26sid%3Dliteratum%253Aachs%26aulast%3DSok%26aufirst%3DD.%26aulast%3DLe%26aufirst%3DK.%2BM.%26aulast%3DVadnais%26aufirst%3DM.%26aulast%3DSaye-Francisco%26aufirst%3DK.%2BL.%26aulast%3DJardine%26aufirst%3DJ.%2BG.%26aulast%3DTorres%26aufirst%3DJ.%2BL.%26aulast%3DBerndsen%26aufirst%3DZ.%2BT.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DStanfield%26aufirst%3DR.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DP.%2BL.%26aulast%3DCriscitiello%26aufirst%3DM.%2BF.%26aulast%3DMwangi%26aufirst%3DW.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DSmider%26aufirst%3DV.%2BV.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DRapid%2520elicitation%2520of%2520broadly%2520neutralizing%2520antibodies%2520to%2520HIV%2520by%2520immunization%2520in%2520cows%26jtitle%3DNature%26date%3D2017%26volume%3D548%26spage%3D108%26epage%3D111%26doi%3D10.1038%2Fnature23301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicely, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerhoff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkowicz, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussedat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vohra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Holle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anasti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desaire, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letvin, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabel, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2175</span>– <span class="NLM_lpage">2188</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2017.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.celrep.2017.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28249163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Ontb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2175-2188&author=K.+O.+Saundersauthor=N.+I.+Nicelyauthor=K.+Wieheauthor=M.+Bonsignoriauthor=R.+R.+Meyerhoffauthor=R.+Parksauthor=W.+E.+Walkowiczauthor=B.+Aussedatauthor=N.+R.+Wuauthor=F.+Caiauthor=Y.+Vohraauthor=P.+K.+Parkauthor=A.+Eatonauthor=E.+P.+Goauthor=L.+L.+Sutherlandauthor=R.+M.+Scearceauthor=D.+H.+Barouchauthor=R.+Zhangauthor=T.+Von+Holleauthor=R.+G.+Overmanauthor=K.+Anastiauthor=R.+W.+Sandersauthor=M.+A.+Moodyauthor=T.+B.+Keplerauthor=B.+Korberauthor=H.+Desaireauthor=S.+Santraauthor=N.+L.+Letvinauthor=G.+J.+Nabelauthor=D.+C.+Montefioriauthor=G.+D.+Tomarasauthor=H.+X.+Liaoauthor=S.+M.+Alamauthor=S.+J.+Danishefskyauthor=B.+F.+Haynes&title=Vaccine+elicitation+of+high+mannose-dependent+neutralizing+antibodies+against+the+V3-glycan+broadly+neutralizing+epitope+in+nonhuman+primates&doi=10.1016%2Fj.celrep.2017.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates</span></div><div class="casAuthors">Saunders, Kevin O.; Nicely, Nathan I.; Wiehe, Kevin; Bonsignori, Mattia; Meyerhoff, R. Ryan; Parks, Robert; Walkowicz, William E.; Aussedat, Baptiste; Wu, Nelson R.; Cai, Fangping; Vohra, Yusuf; Park, Peter K.; Eaton, Amanda; Go, Eden P.; Sutherland, Laura L.; Scearce, Richard M.; Barouch, Dan H.; Zhang, Ruijun; Von Holle, Tarra; Overman, R. Glenn; Anasti, Kara; Sanders, Rogier W.; Moody, M. Anthony; Kepler, Thomas B.; Korber, Bette; Desaire, Heather; Santra, Sampa; Letvin, Norman L.; Nabel, Gary J.; Montefiori, David C.; Tomaras, Georgia D.; Liao, Hua-Xin; Alam, S. Munir; Danishefsky, Samuel J.; Haynes, Barton F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2175-2188</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Induction of broadly neutralizing antibodies (bnAbs) that target HIV-1 envelope (Env) is a goal of HIV-1 vaccine development.  A bnAb target is the Env third variable loop (V3)-glycan site.  To det. whether immunization could induce antibodies to the V3-glycan bnAb binding site, we repetitively immunized macaques over a 4-yr period with an Env expressing V3-high mannose glycans.  Env immunizations elicited plasma antibodies that neutralized HIV-1 expressing only high-mannose glycans-a characteristic shared by early bnAb B cell lineage members.  A rhesus recombinant monoclonal antibody from a vaccinated macaque bound to the V3-glycan site at the same amino acids as broadly neutralizing antibodies.  A structure of the antibody bound to glycan revealed that the three variable heavy-chain complementarity-detg. regions formed a cavity into which glycan could insert and neutralized multiple HIV-1 isolates with high-mannose glycans.  Thus, HIV-1 Env vaccination induced mannose-dependent antibodies with characteristics of V3-glycan bnAb precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL6sb_yZj8prVg90H21EOLACvtfcHk0lixIpNY4Lk6HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Ontb8%253D&md5=7ce8b063eebb312d62db661f080f0837</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2017.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2017.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DK.%2BO.%26aulast%3DNicely%26aufirst%3DN.%2BI.%26aulast%3DWiehe%26aufirst%3DK.%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DMeyerhoff%26aufirst%3DR.%2BR.%26aulast%3DParks%26aufirst%3DR.%26aulast%3DWalkowicz%26aufirst%3DW.%2BE.%26aulast%3DAussedat%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DN.%2BR.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DVohra%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DP.%2BK.%26aulast%3DEaton%26aufirst%3DA.%26aulast%3DGo%26aufirst%3DE.%2BP.%26aulast%3DSutherland%26aufirst%3DL.%2BL.%26aulast%3DScearce%26aufirst%3DR.%2BM.%26aulast%3DBarouch%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DVon%2BHolle%26aufirst%3DT.%26aulast%3DOverman%26aufirst%3DR.%2BG.%26aulast%3DAnasti%26aufirst%3DK.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DMoody%26aufirst%3DM.%2BA.%26aulast%3DKepler%26aufirst%3DT.%2BB.%26aulast%3DKorber%26aufirst%3DB.%26aulast%3DDesaire%26aufirst%3DH.%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DLetvin%26aufirst%3DN.%2BL.%26aulast%3DNabel%26aufirst%3DG.%2BJ.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DTomaras%26aufirst%3DG.%2BD.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DVaccine%2520elicitation%2520of%2520high%2520mannose-dependent%2520neutralizing%2520antibodies%2520against%2520the%2520V3-glycan%2520broadly%2520neutralizing%2520epitope%2520in%2520nonhuman%2520primates%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D18%26spage%3D2175%26epage%3D2188%26doi%3D10.1016%2Fj.celrep.2017.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mallory K. Kern, <span class="NLM_string-name hlFld-ContribAuthor">Nicola L. B. Pohl</span>. </span><span class="cited-content_cbyCitation_article-title">Automated Solution-Phase Synthesis of S-Glycosides for the Production of Oligomannopyranoside Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (11)
                                     , 4156-4159. <a href="https://doi.org/10.1021/acs.orglett.0c01236" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c01236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c01236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c01236%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DAutomated%252BSolution-Phase%252BSynthesis%252Bof%252BS-Glycosides%252Bfor%252Bthe%252BProduction%252Bof%252BOligomannopyranoside%252BDerivatives%26aulast%3DKern%26aufirst%3DMallory%2BK.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07042020%26date%3D20052020%26volume%3D22%26issue%3D11%26spage%3D4156%26epage%3D4159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dung N. Nguyen, Richard L. Redman, Satoru Horiya, Jennifer K. Bailey, Bokai Xu, Robyn L. Stanfield, J. Sebastian Temme, Celia C. LaBranche, Shiyu Wang, Avital A. Rodal, David C. Montefiori, Ian A. Wilson, <span class="NLM_string-name hlFld-ContribAuthor">Isaac J. Krauss</span>. </span><span class="cited-content_cbyCitation_article-title">The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (3)
                                     , 789-798. <a href="https://doi.org/10.1021/acschembio.0c00053" title="DOI URL">https://doi.org/10.1021/acschembio.0c00053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00053%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DThe%252BImpact%252Bof%252BSustained%252BImmunization%252BRegimens%252Bon%252Bthe%252BAntibody%252BResponse%252Bto%252BOligomannose%252BGlycans%26aulast%3DNguyen%26aufirst%3DDung%2BN.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D21012020%26date%3D28022020%26date%3D09032020%26date%3D28022020%26volume%3D15%26issue%3D3%26spage%3D789%26epage%3D798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marko  Anderluh</span>, <span class="hlFld-ContribAuthor ">Francesco  Berti</span>, <span class="hlFld-ContribAuthor ">Anna  Bzducha‐Wróbel</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Chiodo</span>, <span class="hlFld-ContribAuthor ">Cinzia  Colombo</span>, <span class="hlFld-ContribAuthor ">Federica  Compostella</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Durlik</span>, <span class="hlFld-ContribAuthor ">Xhenti  Ferhati</span>, <span class="hlFld-ContribAuthor ">Rikard  Holmdahl</span>, <span class="hlFld-ContribAuthor ">Dragana  Jovanovic</span>, <span class="hlFld-ContribAuthor ">Wieslaw  Kaca</span>, <span class="hlFld-ContribAuthor ">Luigi  Lay</span>, <span class="hlFld-ContribAuthor ">Milena  Marinovic‐Cincovic</span>, <span class="hlFld-ContribAuthor ">Marco  Marradi</span>, <span class="hlFld-ContribAuthor ">Musa  Ozil</span>, <span class="hlFld-ContribAuthor ">Laura  Polito</span>, <span class="hlFld-ContribAuthor ">Josè Juan  Reina</span>, <span class="hlFld-ContribAuthor ">Celso A.  Reis</span>, <span class="hlFld-ContribAuthor ">Robert  Sackstein</span>, <span class="hlFld-ContribAuthor ">Alba  Silipo</span>, <span class="hlFld-ContribAuthor ">Urban  Švajger</span>, <span class="hlFld-ContribAuthor ">Ondřej  Vaněk</span>, <span class="hlFld-ContribAuthor ">Fumiichiro  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Barbara  Richichi</span>, <span class="hlFld-ContribAuthor ">Sandra J.  Vliet</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances on smart glycoconjugate vaccines in infections and cancer. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.1111/febs.15909" title="DOI URL">https://doi.org/10.1111/febs.15909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15909%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DRecent%252Badvances%252Bon%252Bsmart%252Bglycoconjugate%252Bvaccines%252Bin%252Binfections%252Band%252Bcancer%26aulast%3DAnderluh%26aufirst%3DMarko%26date%3D2021%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asuka  Shirakawa</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Manabe</span>, <span class="hlFld-ContribAuthor ">Koichi  Fukase</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Chemical Biology of N-Glycans. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1040. <a href="https://doi.org/10.3390/molecules26041040" title="DOI URL">https://doi.org/10.3390/molecules26041040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041040%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BChemical%252BBiology%252Bof%252BN-Glycans%26aulast%3DShirakawa%26aufirst%3DAsuka%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iñaki  Bastida</span>, <span class="hlFld-ContribAuthor ">Alberto  Fernández-Tejada</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic carbohydrate-based HIV-1 vaccines. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2020,</strong> <em>35-36 </em>, 45-56. <a href="https://doi.org/10.1016/j.ddtec.2020.09.004" title="DOI URL">https://doi.org/10.1016/j.ddtec.2020.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2020.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2020.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DSynthetic%252Bcarbohydrate-based%252BHIV-1%252Bvaccines%26aulast%3DBastida%26aufirst%3DI%25C3%25B1aki%26date%3D2020%26volume%3D35-36%26spage%3D45%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shreya  Sharma</span>, <span class="hlFld-ContribAuthor ">Shashank  Shekhar</span>, <span class="hlFld-ContribAuthor ">Bhasha  Sharma</span>, <span class="hlFld-ContribAuthor ">Purnima  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Decoding glycans: deciphering the sugary secrets to be coherent on the implication. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (56)
                                     , 34099-34113. <a href="https://doi.org/10.1039/D0RA04471G" title="DOI URL">https://doi.org/10.1039/D0RA04471G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA04471G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA04471G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDecoding%252Bglycans%25253A%252Bdeciphering%252Bthe%252Bsugary%252Bsecrets%252Bto%252Bbe%252Bcoherent%252Bon%252Bthe%252Bimplication%26aulast%3DSharma%26aufirst%3DShreya%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D56%26spage%3D34099%26epage%3D34113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanghui  Zong</span>, <span class="hlFld-ContribAuthor ">Chao  Li</span>, <span class="hlFld-ContribAuthor ">Lai-Xi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoenzymatic Synthesis of HIV-1 Glycopeptide Antigens. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 249-262. <a href="https://doi.org/10.1007/978-1-0716-0227-0_17" title="DOI URL">https://doi.org/10.1007/978-1-0716-0227-0_17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-0716-0227-0_17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-0716-0227-0_17%26sid%3Dliteratum%253Aachs%26atitle%3DChemoenzymatic%252BSynthesis%252Bof%252BHIV-1%252BGlycopeptide%252BAntigens%26aulast%3DZong%26aufirst%3DGuanghui%26date%3D2020%26date%3D2019%26spage%3D249%26epage%3D262%26pub%3DSpringer%2520US%26atitle%3DPeptide%252BSynthesis%26aulast%3DHussein%26aufirst%3DWaleed%2BM.%26date%3D2020%26volume%3D2103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pablo  Valverde</span>, <span class="hlFld-ContribAuthor ">Ana  Ardá</span>, <span class="hlFld-ContribAuthor ">Niels-Christian  Reichardt</span>, <span class="hlFld-ContribAuthor ">Jesús  Jiménez-Barbero</span>, <span class="hlFld-ContribAuthor ">Ana  Gimeno</span>. </span><span class="cited-content_cbyCitation_article-title">Glycans in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (10)
                                     , 1678-1691. <a href="https://doi.org/10.1039/C9MD00292H" title="DOI URL">https://doi.org/10.1039/C9MD00292H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00292H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00292H%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DGlycans%252Bin%252Bdrug%252Bdiscovery%26aulast%3DValverde%26aufirst%3DPablo%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D10%26spage%3D1678%26epage%3D1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Behren</span>, <span class="hlFld-ContribAuthor ">Ulrika  Westerlind</span>. </span><span class="cited-content_cbyCitation_article-title">Glycopeptides and -Mimetics to Detect, Monitor and Inhibit Bacterial and Viral Infections: Recent Advances and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (6)
                                     , 1004. <a href="https://doi.org/10.3390/molecules24061004" title="DOI URL">https://doi.org/10.3390/molecules24061004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24061004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24061004%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DGlycopeptides%252Band%252B-Mimetics%252Bto%252BDetect%25252C%252BMonitor%252Band%252BInhibit%252BBacterial%252Band%252BViral%252BInfections%25253A%252BRecent%252BAdvances%252Band%252BPerspectives%26aulast%3DBehren%26aufirst%3DSandra%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D6%26spage%3D1004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine N.  Daniels</span>, <span class="hlFld-ContribAuthor ">Kevin O.  Saunders</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody responses to the HIV-1 envelope high mannose patch. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 11-73. <a href="https://doi.org/10.1016/bs.ai.2019.08.002" title="DOI URL">https://doi.org/10.1016/bs.ai.2019.08.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.ai.2019.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.ai.2019.08.002%26sid%3Dliteratum%253Aachs%26atitle%3DAntibody%252Bresponses%252Bto%252Bthe%252BHIV-1%252Benvelope%252Bhigh%252Bmannose%252Bpatch%26aulast%3DDaniels%26aufirst%3DChristine%2BN.%26date%3D2019%26spage%3D11%26epage%3D73%26pub%3DElsevier%26date%3D2019%26volume%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemoenzymatic synthesis of HIV-1 A244 V3 glycopeptides: (a) synthesis of A244 V3 glycopeptides carrying a high-mannose or a complex-type <i>N</i>-glycan at the N334 site; (b) structures of additional synthetic A244 V3 peptides and glycopeptides carrying a high-mannose or a complex-type <i>N</i>-glycan at the N301 and N295 sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SPR sensorgrams of binding to A244 V3 high-mannose glycopeptides (<b>3</b>, <b>6</b>, and <b>8</b>) by bNAb PGT128, 10-1074, and PGT126.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Synthesis of three-component HIV immunogen containing the A244 V3 N334 high-mannose glycopeptide.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the binding of the antisera and selected bNAbs to an array of HIV-1 gp120/gp140 envelope glycoproteins: (a) antisera from the A244 glycopeptide immunogen; (b) antibody PGT128; (c) antibody 10-1074. The HIV-1 A244 gp120 carries an <i>N</i>-glycan at the N334 site, while HIV-1 JR-FL gp140, CN54 gp120, and MCON gp120 have an <i>N</i>-glycan at the N332 site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. ELISA analysis of the binding of the antisera and antibody PGT128 to synthetic A244 V3 glycopeptides: (a–c) ELISA binding of the rabbit antisera to A244 V3 glycopeptides; (d–f) ELISA binding of the pretreated (V3 peptide-depressed) rabbit sera to A244 V3 glycopeptides; (g–i) ELISA binding of PGT128 to A244 V3 glycopeptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/medium/jm-2018-01290j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. ELISA analysis of the binding of the antisera with additional HIV-1 V3 glycopeptides and free high-mannose <i>N</i>-glycans: (a) ELISA binding of the pretreated sera to A244 N334 high-mannose glycopeptide with different length of the peptide backbone; (b) ELISA binding of the pretreated sera to different V3 N332 high-mannose glycopeptides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01290/20181119/images/large/jm-2018-01290j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01290&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pejchal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khayat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depetris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katpally, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marozsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloveste, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogohara, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scanlan, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">1097</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1126/science.1213256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscience.1213256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=21998254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2mu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=1097-1103&author=R.+Pejchalauthor=K.+J.+Dooresauthor=L.+M.+Walkerauthor=R.+Khayatauthor=P.+S.+Huangauthor=S.+K.+Wangauthor=R.+L.+Stanfieldauthor=J.+P.+Julienauthor=A.+Ramosauthor=M.+Crispinauthor=R.+Depetrisauthor=U.+Katpallyauthor=A.+Marozsanauthor=A.+Cupoauthor=S.+Malovesteauthor=Y.+Liuauthor=R.+McBrideauthor=Y.+Itoauthor=R.+W.+Sandersauthor=C.+Ogoharaauthor=J.+C.+Paulsonauthor=T.+Feiziauthor=C.+N.+Scanlanauthor=C.+H.+Wongauthor=J.+P.+Mooreauthor=W.+C.+Olsonauthor=A.+B.+Wardauthor=P.+Poignardauthor=W.+R.+Schiefauthor=D.+R.+Burtonauthor=I.+A.+Wilson&title=A+potent+and+broad+neutralizing+antibody+recognizes+and+penetrates+the+HIV+glycan+shield&doi=10.1126%2Fscience.1213256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield</span></div><div class="casAuthors">Pejchal, Robert; Doores, Katie J.; Walker, Laura M.; Khayat, Reza; Huang, Po-Ssu; Wang, Sheng-Kai; Stanfield, Robyn L.; Julien, Jean-Philippe; Ramos, Alejandra; Crispin, Max; Depetris, Rafael; Katpally, Umesh; Marozsan, Andre; Cupo, Albert; Maloveste, Sebastien; Liu, Yan; McBride, Ryan; Ito, Yukishige; Sanders, Rogier W.; Ogohara, Cassandra; Paulson, James C.; Feizi, Ten; Scanlan, Christopher N.; Wong, Chi-Huey; Moore, John P.; Olson, William C.; Ward, Andrew B.; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Wilson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6059</span>),
    <span class="NLM_cas:pages">1097-1103</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield.  However, several of the recently identified PGT broadly neutralizing antibodies appear to interact directly with the HIV glycan coat.  Crystal structures of antigen-binding fragments (Fabs) PGT 127 and 128 with Man9 at 1.65 and 1.29 angstrom resoln., resp., and glycan binding data delineate a specific high mannose-binding site.  Fab PGT 128 complexed with a fully glycosylated gp120 outer domain at 3.25 angstroms reveals that the antibody penetrates the glycan shield and recognizes two conserved glycans as well as a short β-strand segment of the gp120 V3 loop, accounting for its high binding affinity and broad specificify.  Furthermore, our data suggest that the high neutralization potency of PGT 127 and 128 IgGs may be mediated by crosslinking Env trimers on the viral surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbe0WYPsyGi7Vg90H21EOLACvtfcHk0lhxTQfhNirErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2mu7jK&md5=9320a11936c8da451d3bc7c494ba6c4c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1213256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1213256%26sid%3Dliteratum%253Aachs%26aulast%3DPejchal%26aufirst%3DR.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DWalker%26aufirst%3DL.%2BM.%26aulast%3DKhayat%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DP.%2BS.%26aulast%3DWang%26aufirst%3DS.%2BK.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DCrispin%26aufirst%3DM.%26aulast%3DDepetris%26aufirst%3DR.%26aulast%3DKatpally%26aufirst%3DU.%26aulast%3DMarozsan%26aufirst%3DA.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DMaloveste%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DOgohara%26aufirst%3DC.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DScanlan%26aufirst%3DC.%2BN.%26aulast%3DWong%26aufirst%3DC.%2BH.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DOlson%26aufirst%3DW.%2BC.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DA%2520potent%2520and%2520broad%2520neutralizing%2520antibody%2520recognizes%2520and%2520penetrates%2520the%2520HIV%2520glycan%2520shield%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D1097%26epage%3D1103%26doi%3D10.1126%2Fscience.1213256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkowska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pejchal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Hui, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitcham, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phogat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simek, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koff, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span> <span> </span><span class="NLM_article-title">Broad neutralization coverage of HIV by multiple highly potent antibodies</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>477</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1038/nature10373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature10373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=21849977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFers7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2011&pages=466-470&author=L.+M.+Walkerauthor=M.+Huberauthor=K.+J.+Dooresauthor=E.+Falkowskaauthor=R.+Pejchalauthor=J.+P.+Julienauthor=S.+K.+Wangauthor=A.+Ramosauthor=P.+Y.+Chan-Huiauthor=M.+Moyleauthor=J.+L.+Mitchamauthor=P.+W.+Hammondauthor=O.+A.+Olsenauthor=P.+Phungauthor=S.+Flingauthor=C.+H.+Wongauthor=S.+Phogatauthor=T.+Wrinauthor=M.+D.+Simekauthor=W.+C.+Koffauthor=I.+A.+Wilsonauthor=D.+R.+Burtonauthor=P.+Poignard&title=Broad+neutralization+coverage+of+HIV+by+multiple+highly+potent+antibodies&doi=10.1038%2Fnature10373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Broad neutralization coverage of HIV by multiple highly potent antibodies</span></div><div class="casAuthors">Walker, Laura M.; Huber, Michael; Doores, Katie J.; Falkowska, Emilia; Pejchal, Robert; Julien, Jean-Philippe; Wang, Sheng-Kai; Ramos, Alejandra; Chan-Hui, Po-Ying; Moyle, Matthew; Mitcham, Jennifer L.; Hammond, Phillip W.; Olsen, Ole A.; Phung, Pham; Fling, Steven; Wong, Chi-Huey; Phogat, Sanjay; Wrin, Terri; Simek, Melissa D.; Koff, Wayne C.; Wilson, Ian A.; Burton, Dennis R.; Poignard, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">477</span>
        (<span class="NLM_cas:issue">7365</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses.  Here we probed the neutralizing antibody repertoires of four human immunodeficiency virus (HIV)-infected donors with remarkably broad and potent neutralizing responses and rescued 17 new monoclonal antibodies that neutralize broadly across clades.  Many of the new monoclonal antibodies are almost tenfold more potent than the recently described PG9, PG16 and VRC01 broadly neutralizing monoclonal antibodies and 100-fold more potent than the original prototype HIV broadly neutralizing monoclonal antibodies.  The monoclonal antibodies largely recapitulate the neutralization breadth found in the corresponding donor serum and many recognize novel epitopes on envelope (Env) glycoprotein gp120, illuminating new targets for vaccine design.  Anal. of neutralization by the full complement of anti-HIV broadly neutralizing monoclonal antibodies now available reveals that certain combinations of antibodies should offer markedly more favorable coverage of the enormous diversity of global circulating viruses than others and these combinations might be sought in active or passive immunization regimes.  Overall, the isolation of multiple HIV broadly neutralizing monoclonal antibodies from several donors that, in aggregate, provide broad coverage at low concns. is a highly pos. indicator for the eventual design of an effective antibody-based HIV vaccine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZDU82fw15s7Vg90H21EOLACvtfcHk0lhxTQfhNirErg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFers7nM&md5=8e1e3b8a562bce684067f701efe9e9eb</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature10373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10373%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DL.%2BM.%26aulast%3DHuber%26aufirst%3DM.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DFalkowska%26aufirst%3DE.%26aulast%3DPejchal%26aufirst%3DR.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DS.%2BK.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DChan-Hui%26aufirst%3DP.%2BY.%26aulast%3DMoyle%26aufirst%3DM.%26aulast%3DMitcham%26aufirst%3DJ.%2BL.%26aulast%3DHammond%26aufirst%3DP.%2BW.%26aulast%3DOlsen%26aufirst%3DO.%2BA.%26aulast%3DPhung%26aufirst%3DP.%26aulast%3DFling%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DC.%2BH.%26aulast%3DPhogat%26aufirst%3DS.%26aulast%3DWrin%26aufirst%3DT.%26aulast%3DSimek%26aufirst%3DM.%2BD.%26aulast%3DKoff%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DPoignard%26aufirst%3DP.%26atitle%3DBroad%2520neutralization%2520coverage%2520of%2520HIV%2520by%2520multiple%2520highly%2520potent%2520antibodies%26jtitle%3DNature%26date%3D2011%26volume%3D477%26spage%3D466%26epage%3D470%26doi%3D10.1038%2Fnature10373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moldt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakasz, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan-Hui, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swiderek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weisgrau, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piaskowski, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">18921</span>– <span class="NLM_lpage">18925</span>, <span class="refDoi"> DOI: 10.1073/pnas.1214785109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1073%2Fpnas.1214785109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=18921-18925&author=B.+Moldtauthor=E.+G.+Rakaszauthor=N.+Schultzauthor=P.+Y.+Chan-Huiauthor=K.+Swiderekauthor=K.+L.+Weisgrauauthor=S.+M.+Piaskowskiauthor=Z.+Bergmanauthor=D.+I.+Watkinsauthor=P.+Poignardauthor=D.+R.+Burton&title=Highly+potent+HIV-specific+antibody+neutralization+in+vitro+translates+into+effective+protection+against+mucosal+SHIV+challenge+in+vivo&doi=10.1073%2Fpnas.1214785109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1214785109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1214785109%26sid%3Dliteratum%253Aachs%26aulast%3DMoldt%26aufirst%3DB.%26aulast%3DRakasz%26aufirst%3DE.%2BG.%26aulast%3DSchultz%26aufirst%3DN.%26aulast%3DChan-Hui%26aufirst%3DP.%2BY.%26aulast%3DSwiderek%26aufirst%3DK.%26aulast%3DWeisgrau%26aufirst%3DK.%2BL.%26aulast%3DPiaskowski%26aufirst%3DS.%2BM.%26aulast%3DBergman%26aufirst%3DZ.%26aulast%3DWatkins%26aufirst%3DD.%2BI.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DHighly%2520potent%2520HIV-specific%2520antibody%2520neutralization%2520in%2520vitro%2520translates%2520into%2520effective%2520protection%2520against%2520mucosal%2520SHIV%2520challenge%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D18921%26epage%3D18925%26doi%3D10.1073%2Fpnas.1214785109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barouch, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moldt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkolola, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borducchi, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabral, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackmore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanisetty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinaldi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">224</span>– <span class="NLM_lpage">228</span>, <span class="refDoi"> DOI: 10.1038/nature12744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature12744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=24172905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSnsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=224-228&author=D.+H.+Barouchauthor=J.+B.+Whitneyauthor=B.+Moldtauthor=F.+Kleinauthor=T.+Y.+Oliveiraauthor=J.+Liuauthor=K.+E.+Stephensonauthor=H.+W.+Changauthor=K.+Shekharauthor=S.+Guptaauthor=J.+P.+Nkololaauthor=M.+S.+Seamanauthor=K.+M.+Smithauthor=E.+N.+Borducchiauthor=C.+Cabralauthor=J.+Y.+Smithauthor=S.+Blackmoreauthor=S.+Sanisettyauthor=J.+R.+Perryauthor=M.+Beckauthor=M.+G.+Lewisauthor=W.+Rinaldiauthor=A.+K.+Chakrabortyauthor=P.+Poignardauthor=M.+C.+Nussenzweigauthor=D.+R.+Burton&title=Therapeutic+efficacy+of+potent+neutralizing+HIV-1-specific+monoclonal+antibodies+in+SHIV-infected+rhesus+monkeys&doi=10.1038%2Fnature12744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys</span></div><div class="casAuthors">Barouch, Dan H.; Whitney, James B.; Moldt, Brian; Klein, Florian; Oliveira, Thiago Y.; Liu, Jinyan; Stephenson, Kathryn E.; Chang, Hui-Wen; Shekhar, Karthik; Gupta, Sanjana; Nkolola, Joseph P.; Seaman, Michael S.; Smith, Kaitlin M.; Borducchi, Erica N.; Cabral, Crystal; Smith, Jeffrey Y.; Blackmore, Stephen; Sanisetty, Srisowmya; Perry, James R.; Beck, Matthew; Lewis, Mark G.; Rinaldi, William; Chakraborty, Arup K.; Poignard, Pascal; Nussenzweig, Michel C.; Burton, Dennis R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">7475</span>),
    <span class="NLM_cas:pages">224-228</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with extraordinary potency and breadth have recently been described.  In humanized mice, combinations of monoclonal antibodies have been shown to suppress viremia, but the therapeutic potential of these monoclonal antibodies has not yet been evaluated in primates with an intact immune system.  Here we show that administration of a cocktail of HIV-1-specific monoclonal antibodies, as well as the single glycan-dependent monoclonal antibody PGT121, resulted in a rapid and precipitous decline of plasma viremia to undetectable levels in rhesus monkeys chronically infected with the pathogenic simian-human immunodeficiency virus SHIV-SF162P3.  A single monoclonal antibody infusion afforded up to a 3.1 log decline of plasma viral RNA in 7 days and also reduced proviral DNA in peripheral blood, gastrointestinal mucosa and lymph nodes without the development of viral resistance.  Moreover, after monoclonal antibody administration, host Gag-specific T-lymphocyte responses showed improved functionality.  Virus rebounded in most animals after a median of 56 days when serum monoclonal antibody titers had declined to undetectable levels, although, notably, a subset of animals maintained long-term virol. control in the absence of further monoclonal antibody infusions.  These data demonstrate a profound therapeutic effect of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys as well as an impact on host immune responses.  Our findings strongly encourage the investigation of monoclonal antibody therapy for HIV-1 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFJNqWV26uV7Vg90H21EOLACvtfcHk0liDJjFIDafmXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSnsbzE&md5=c05e1d0bebf3686841bb0a4897032d48</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature12744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12744%26sid%3Dliteratum%253Aachs%26aulast%3DBarouch%26aufirst%3DD.%2BH.%26aulast%3DWhitney%26aufirst%3DJ.%2BB.%26aulast%3DMoldt%26aufirst%3DB.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DT.%2BY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DStephenson%26aufirst%3DK.%2BE.%26aulast%3DChang%26aufirst%3DH.%2BW.%26aulast%3DShekhar%26aufirst%3DK.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DNkolola%26aufirst%3DJ.%2BP.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DBorducchi%26aufirst%3DE.%2BN.%26aulast%3DCabral%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DJ.%2BY.%26aulast%3DBlackmore%26aufirst%3DS.%26aulast%3DSanisetty%26aufirst%3DS.%26aulast%3DPerry%26aufirst%3DJ.%2BR.%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DM.%2BG.%26aulast%3DRinaldi%26aufirst%3DW.%26aulast%3DChakraborty%26aufirst%3DA.%2BK.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520efficacy%2520of%2520potent%2520neutralizing%2520HIV-1-specific%2520monoclonal%2520antibodies%2520in%2520SHIV-infected%2520rhesus%2520monkeys%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D224%26epage%3D228%26doi%3D10.1038%2Fnature12744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halper-Stromberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horwitz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheid, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bournazos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spatz, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diskin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billerbeck, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labitt, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaebler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcovecchio, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Incesu, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenreich, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieniasz, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravetch, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span> <span> </span><span class="NLM_article-title">HIV therapy by a combination of broadly neutralizing antibodies in humanized mice</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1038/nature11604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature11604" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=118-122&author=F.+Kleinauthor=A.+Halper-Strombergauthor=J.+A.+Horwitzauthor=H.+Gruellauthor=J.+F.+Scheidauthor=S.+Bournazosauthor=H.+Mouquetauthor=L.+A.+Spatzauthor=R.+Diskinauthor=A.+Abadirauthor=T.+Zangauthor=M.+Dornerauthor=E.+Billerbeckauthor=R.+N.+Labittauthor=C.+Gaeblerauthor=P.+M.+Marcovecchioauthor=R.+B.+Incesuauthor=T.+R.+Eisenreichauthor=P.+D.+Bieniaszauthor=M.+S.+Seamanauthor=P.+J.+Bjorkmanauthor=J.+V.+Ravetchauthor=A.+Plossauthor=M.+C.+Nussenzweig&title=HIV+therapy+by+a+combination+of+broadly+neutralizing+antibodies+in+humanized+mice&doi=10.1038%2Fnature11604"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature11604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11604%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DHalper-Stromberg%26aufirst%3DA.%26aulast%3DHorwitz%26aufirst%3DJ.%2BA.%26aulast%3DGruell%26aufirst%3DH.%26aulast%3DScheid%26aufirst%3DJ.%2BF.%26aulast%3DBournazos%26aufirst%3DS.%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DSpatz%26aufirst%3DL.%2BA.%26aulast%3DDiskin%26aufirst%3DR.%26aulast%3DAbadir%26aufirst%3DA.%26aulast%3DZang%26aufirst%3DT.%26aulast%3DDorner%26aufirst%3DM.%26aulast%3DBillerbeck%26aufirst%3DE.%26aulast%3DLabitt%26aufirst%3DR.%2BN.%26aulast%3DGaebler%26aufirst%3DC.%26aulast%3DMarcovecchio%26aufirst%3DP.%2BM.%26aulast%3DIncesu%26aufirst%3DR.%2BB.%26aulast%3DEisenreich%26aufirst%3DT.%2BR.%26aulast%3DBieniasz%26aufirst%3DP.%2BD.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26aulast%3DPloss%26aufirst%3DA.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26atitle%3DHIV%2520therapy%2520by%2520a%2520combination%2520of%2520broadly%2520neutralizing%2520antibodies%2520in%2520humanized%2520mice%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D118%26epage%3D122%26doi%3D10.1038%2Fnature11604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shingai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donau, O. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plishka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckler-White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piatak, M.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrov, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. A.</span></span> <span> </span><span class="NLM_article-title">Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1038/nature12746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature12746" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2013&pages=277-280&author=M.+Shingaiauthor=Y.+Nishimuraauthor=F.+Kleinauthor=H.+Mouquetauthor=O.+K.+Donauauthor=R.+Plishkaauthor=A.+Buckler-Whiteauthor=M.+Seamanauthor=M.+Piatakauthor=J.+D.+Lifsonauthor=D.+S.+Dimitrovauthor=M.+C.+Nussenzweigauthor=M.+A.+Martin&title=Antibody-mediated+immunotherapy+of+macaques+chronically+infected+with+SHIV+suppresses+viraemia&doi=10.1038%2Fnature12746"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature12746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12746%26sid%3Dliteratum%253Aachs%26aulast%3DShingai%26aufirst%3DM.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DDonau%26aufirst%3DO.%2BK.%26aulast%3DPlishka%26aufirst%3DR.%26aulast%3DBuckler-White%26aufirst%3DA.%26aulast%3DSeaman%26aufirst%3DM.%26aulast%3DPiatak%26aufirst%3DM.%26aulast%3DLifson%26aufirst%3DJ.%2BD.%26aulast%3DDimitrov%26aufirst%3DD.%2BS.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26atitle%3DAntibody-mediated%2520immunotherapy%2520of%2520macaques%2520chronically%2520infected%2520with%2520SHIV%2520suppresses%2520viraemia%26jtitle%3DNature%26date%3D2013%26volume%3D503%26spage%3D277%26epage%3D280%26doi%3D10.1038%2Fnature12746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gautam, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pegu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nason, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazumyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golijanin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckler-White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadjadpour, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankoff, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. A.</span></span> <span> </span><span class="NLM_article-title">A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>533</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1038/nature17677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature17677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27120156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvVGntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2016&pages=105-109&author=R.+Gautamauthor=Y.+Nishimuraauthor=A.+Peguauthor=M.+C.+Nasonauthor=F.+Kleinauthor=A.+Gazumyanauthor=J.+Golijaninauthor=A.+Buckler-Whiteauthor=R.+Sadjadpourauthor=K.+Wangauthor=Z.+Mankoffauthor=S.+D.+Schmidtauthor=J.+D.+Lifsonauthor=J.+R.+Mascolaauthor=M.+C.+Nussenzweigauthor=M.+A.+Martin&title=A+single+injection+of+anti-HIV-1+antibodies+protects+against+repeated+SHIV+challenges&doi=10.1038%2Fnature17677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges</span></div><div class="casAuthors">Gautam, Rajeev; Nishimura, Yoshiaki; Pegu, Amarendra; Nason, Martha C.; Klein, Florian; Gazumyan, Anna; Golijanin, Jovana; Buckler-White, Alicia; Sadjadpour, Reza; Wang, Keyun; Mankoff, Zachary; Schmidt, Stephen D.; Lifson, Jeffrey D.; Mascola, John R.; Nussenzweig, Michel C.; Martin, Malcolm A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">7601</span>),
    <span class="NLM_cas:pages">105-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Despite the success of potent anti-retroviral drugs in controlling human immunodeficiency virus type 1 (HIV-1) infection, little progress has been made in generating an effective HIV-1 vaccine.  Although passive transfer of anti-HIV-1 broadly neutralizing antibodies can protect mice or macaques against a single high-dose challenge with HIV or simian/human (SIV/HIV) chimeric viruses (SHIVs) resp., the long-term efficacy of a passive antibody transfer approach for HIV-1 has not been examd.  Here we show, on the basis of the relatively long-term protection conferred by hepatitis A immune globulin, the efficacy of a single injection (20 mg kg-1) of four anti-HIV-1-neutralizing monoclonal antibodies (VRC01, VRC01-LS, 3BNC117, and 10-1074 (refs 9, 10, 11, 12)) in blocking repeated weekly low-dose virus challenges of the clade B SHIVAD8.  Compared with control animals, which required two to six challenges (median = 3) for infection, a single broadly neutralizing antibody infusion prevented virus acquisition for up to 23 weekly challenges.  This effect depended on antibody potency and half-life.  The highest levels of plasma-neutralizing activity and, correspondingly, the longest protection were found in monkeys administered the more potent antibodies 3BNC117 and 10-1074 (median = 13 and 12.5 wk, resp.).  VRC01, which showed lower plasma-neutralizing activity, protected for a shorter time (median = 8 wk).  The introduction of a mutation that extends antibody half-life into the crystallizable fragment (Fc) domain of VRC01 increased median protection from 8 to 14.5 wk.  If administered to populations at high risk of HIV-1 transmission, such an immunoprophylaxis regimen could have a major impact on virus transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopfDc-leNrmrVg90H21EOLACvtfcHk0lhsk3ejs-s6fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvVGntL8%253D&md5=d2b317db5192db8323f6b835aa6f3d4d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature17677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature17677%26sid%3Dliteratum%253Aachs%26aulast%3DGautam%26aufirst%3DR.%26aulast%3DNishimura%26aufirst%3DY.%26aulast%3DPegu%26aufirst%3DA.%26aulast%3DNason%26aufirst%3DM.%2BC.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DGazumyan%26aufirst%3DA.%26aulast%3DGolijanin%26aufirst%3DJ.%26aulast%3DBuckler-White%26aufirst%3DA.%26aulast%3DSadjadpour%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DMankoff%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DS.%2BD.%26aulast%3DLifson%26aufirst%3DJ.%2BD.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DM.%2BA.%26atitle%3DA%2520single%2520injection%2520of%2520anti-HIV-1%2520antibodies%2520protects%2520against%2520repeated%2520SHIV%2520challenges%26jtitle%3DNature%26date%3D2016%26volume%3D533%26spage%3D105%26epage%3D109%26doi%3D10.1038%2Fnature17677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caskey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoofs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruell, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Settler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karagounis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreider, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murrell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nogueira, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Learn, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimeliovich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unson-O’Brien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiland, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummerle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer-Pack, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignacio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zingman, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulick, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatkenheuer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlesinger, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine, F.</span></span> <span> </span><span class="NLM_article-title">Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1038/nm.4268</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnm.4268" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28092665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=185-191&author=M.+Caskeyauthor=T.+Schoofsauthor=H.+Gruellauthor=A.+Settlerauthor=T.+Karagounisauthor=E.+F.+Kreiderauthor=B.+Murrellauthor=N.+Pfeiferauthor=L.+Nogueiraauthor=T.+Y.+Oliveiraauthor=G.+H.+Learnauthor=Y.+Z.+Cohenauthor=C.+Lehmannauthor=D.+Gillorauthor=I.+Shimeliovichauthor=C.+Unson-O%E2%80%99Brienauthor=D.+Weilandauthor=A.+Roblesauthor=T.+Kummerleauthor=C.+Wyenauthor=R.+Levinauthor=M.+Witmer-Packauthor=K.+Erenauthor=C.+Ignacioauthor=S.+Kissauthor=A.+P.+Westauthor=H.+Mouquetauthor=B.+S.+Zingmanauthor=R.+M.+Gulickauthor=T.+Kelerauthor=P.+J.+Bjorkmanauthor=M.+S.+Seamanauthor=B.+H.+Hahnauthor=G.+Fatkenheuerauthor=S.+J.+Schlesingerauthor=M.+C.+Nussenzweigauthor=F.+Kleine&title=Antibody+10-1074+suppresses+viremia+in+HIV-1-infected+individuals&doi=10.1038%2Fnm.4268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody 10-1074 suppresses viremia in HIV-1-infected individuals</span></div><div class="casAuthors">Caskey, Marina; Schoofs, Till; Gruell, Henning; Settler, Allison; Karagounis, Theodora; Kreider, Edward F.; Murrell, Ben; Pfeifer, Nico; Nogueira, Lilian; Oliveira, Thiago Y.; Learn, Gerald H.; Cohen, Yehuda Z.; Lehmann, Clara; Gillor, Daniel; Shimeliovich, Irina; Unson-O'Brien, Cecilia; Weiland, Daniela; Robles, Alexander; Kummerle, Tim; Wyen, Christoph; Levin, Rebeka; Witmer-Pack, Maggi; Eren, Kemal; Ignacio, Caroline; Kiss, Szilard; West, Anthony P., Jr.; Mouquet, Hugo; Zingman, Barry S.; Gulick, Roy M.; Keler, Tibor; Bjorkman, Pamela J.; Seaman, Michael S.; Hahn, Beatrice H.; Fatkenheuer, Gerd; Schlesinger, Sarah J.; Nussenzweig, Michel C.; Klein, Florian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-191</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monoclonal antibody 10-1074 targets the V3 glycan supersite on the HIV-1 envelope (Env) protein.  It is among the most potent anti-HIV-1 neutralizing antibodies isolated so far.  Here we report on its safety and activity in 33 individuals who received a single i.v. infusion of the antibody. 10-1074 was well tolerated and had a half-life of 24.0 d in participants without HIV-1 infection and 12.8 d in individuals with HIV-1 infection.  Thirteen individuals with viremia received the highest dose of 30 mg/kg 10-1074.  Eleven of these participants were 10-1074-sensitive and showed a rapid decline in viremia by a mean of 1.52 log10 copies/mL.  Virol. anal. revealed the emergence of multiple independent 10-1074-resistant viruses in the first weeks after infusion.  Emerging escape variants were generally resistant to the related V3-specific antibody PGT121, but remained sensitive to antibodies targeting nonoverlapping epitopes, such as the anti-CD4-binding-site antibodies 3BNC117 and VRC01.  The results demonstrate the safety and activity of 10-1074 in humans and support the idea that antibodies targeting the V3 glycan supersite might be useful for the treatment and prevention of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohubBuHPyKerVg90H21EOLACvtfcHk0lhsk3ejs-s6fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCls78%253D&md5=c3ec584ad3426c930869f92ee2748e6b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnm.4268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4268%26sid%3Dliteratum%253Aachs%26aulast%3DCaskey%26aufirst%3DM.%26aulast%3DSchoofs%26aufirst%3DT.%26aulast%3DGruell%26aufirst%3DH.%26aulast%3DSettler%26aufirst%3DA.%26aulast%3DKaragounis%26aufirst%3DT.%26aulast%3DKreider%26aufirst%3DE.%2BF.%26aulast%3DMurrell%26aufirst%3DB.%26aulast%3DPfeifer%26aufirst%3DN.%26aulast%3DNogueira%26aufirst%3DL.%26aulast%3DOliveira%26aufirst%3DT.%2BY.%26aulast%3DLearn%26aufirst%3DG.%2BH.%26aulast%3DCohen%26aufirst%3DY.%2BZ.%26aulast%3DLehmann%26aufirst%3DC.%26aulast%3DGillor%26aufirst%3DD.%26aulast%3DShimeliovich%26aufirst%3DI.%26aulast%3DUnson-O%25E2%2580%2599Brien%26aufirst%3DC.%26aulast%3DWeiland%26aufirst%3DD.%26aulast%3DRobles%26aufirst%3DA.%26aulast%3DKummerle%26aufirst%3DT.%26aulast%3DWyen%26aufirst%3DC.%26aulast%3DLevin%26aufirst%3DR.%26aulast%3DWitmer-Pack%26aufirst%3DM.%26aulast%3DEren%26aufirst%3DK.%26aulast%3DIgnacio%26aufirst%3DC.%26aulast%3DKiss%26aufirst%3DS.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DZingman%26aufirst%3DB.%2BS.%26aulast%3DGulick%26aufirst%3DR.%2BM.%26aulast%3DKeler%26aufirst%3DT.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DHahn%26aufirst%3DB.%2BH.%26aulast%3DFatkenheuer%26aufirst%3DG.%26aulast%3DSchlesinger%26aufirst%3DS.%2BJ.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DKleine%26aufirst%3DF.%26atitle%3DAntibody%252010-1074%2520suppresses%2520viremia%2520in%2520HIV-1-infected%2520individuals%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26spage%3D185%26epage%3D191%26doi%3D10.1038%2Fnm.4268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garces, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saye-Francisco, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">Structural evolution of glycan recognition by a family of potent HIV antibodies</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>159</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2014.09.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.cell.2014.09.009" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=69-79&author=F.+Garcesauthor=D.+Sokauthor=L.+Kongauthor=R.+McBrideauthor=H.+J.+Kimauthor=K.+F.+Saye-Franciscoauthor=J.+P.+Julienauthor=Y.+Huaauthor=A.+Cupoauthor=J.+P.+Mooreauthor=J.+C.+Paulsonauthor=A.+B.+Wardauthor=D.+R.+Burtonauthor=I.+A.+Wilson&title=Structural+evolution+of+glycan+recognition+by+a+family+of+potent+HIV+antibodies&doi=10.1016%2Fj.cell.2014.09.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DGarces%26aufirst%3DF.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DSaye-Francisco%26aufirst%3DK.%2BF.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DStructural%2520evolution%2520of%2520glycan%2520recognition%2520by%2520a%2520family%2520of%2520potent%2520HIV%2520antibodies%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D69%26epage%3D79%26doi%3D10.1016%2Fj.cell.2014.09.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briney, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saye-Francisco, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulp, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickramasinghe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poignard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">236ra63</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3008104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscitranslmed.3008104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=24828077" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=236ra63&author=D.+Sokauthor=K.+J.+Dooresauthor=B.+Brineyauthor=K.+M.+Leauthor=K.+L.+Saye-Franciscoauthor=A.+Ramosauthor=D.+W.+Kulpauthor=J.+P.+Julienauthor=S.+Menisauthor=L.+Wickramasingheauthor=M.+S.+Seamanauthor=W.+R.+Schiefauthor=I.+A.+Wilsonauthor=P.+Poignardauthor=D.+R.+Burton&title=Promiscuous+glycan+site+recognition+by+antibodies+to+the+high-mannose+patch+of+gp120+broadens+neutralization+of+HIV&doi=10.1126%2Fscitranslmed.3008104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3008104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3008104%26sid%3Dliteratum%253Aachs%26aulast%3DSok%26aufirst%3DD.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DBriney%26aufirst%3DB.%26aulast%3DLe%26aufirst%3DK.%2BM.%26aulast%3DSaye-Francisco%26aufirst%3DK.%2BL.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DKulp%26aufirst%3DD.%2BW.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DMenis%26aufirst%3DS.%26aulast%3DWickramasinghe%26aufirst%3DL.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DPoignard%26aufirst%3DP.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DPromiscuous%2520glycan%2520site%2520recognition%2520by%2520antibodies%2520to%2520the%2520high-mannose%2520patch%2520of%2520gp120%2520broadens%2520neutralization%2520of%2520HIV%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D236ra63%26doi%3D10.1126%2Fscitranslmed.3008104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mouquet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharf, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheid, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halper-Stromberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanapragasam, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuitemaker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span> <span> </span><span class="NLM_article-title">Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">E3268</span>– <span class="NLM_lpage">3277</span>, <span class="refDoi"> DOI: 10.1073/pnas.1217207109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1073%2Fpnas.1217207109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=23115339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvValsrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E3268-3277&author=H.+Mouquetauthor=L.+Scharfauthor=Z.+Eulerauthor=Y.+Liuauthor=C.+Edenauthor=J.+F.+Scheidauthor=A.+Halper-Strombergauthor=P.+N.+Gnanapragasamauthor=D.+I.+Spencerauthor=M.+S.+Seamanauthor=H.+Schuitemakerauthor=T.+Feiziauthor=M.+C.+Nussenzweigauthor=P.+J.+Bjorkman&title=Complex-type+N-glycan+recognition+by+potent+broadly+neutralizing+HIV+antibodies&doi=10.1073%2Fpnas.1217207109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies</span></div><div class="casAuthors">Mouquet, Hugo; Scharf, Louise; Euler, Zelda; Liu, Yan; Eden, Caroline; Scheid, Johannes F.; Halper-Stromberg, Ariel; Gnanapragasam, Priyanthi N. P.; Spencer, Daniel I. R.; Seaman, Michael S.; Schuitemaker, Hanneke; Feizi, Ten; Nussenzweig, Michel C.; Bjorkman, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">E3268-E3277, SE3268/1-SE3268/55</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Broadly neutralizing HIV antibodies (bNAbs) can recognize carbohydrate-dependent epitopes on gp120.  In contrast to previously characterized glycan-dependent bNAbs that recognize high-mannose N-glycans, PGT121 binds complex-type N-glycans in glycan microarrays.  We isolated the B-cell clone encoding PGT121, which segregates into PGT121-like and 10-1074-like groups distinguished by sequence, binding affinity, carbohydrate recognition, and neutralizing activity.  Group 10-1074 exhibits remarkable potency and breadth but no detectable binding to protein-free glycans.  Crystal structures of unliganded PGT121, 10-1074, and their likely germ-line precursor reveal that differential carbohydrate recognition maps to a cleft between complementarity detg. region (CDR)H2 and CDRH3.  This cleft was occupied by a complex-type N-glycan in a "liganded" PGT121 structure.  Swapping glycan contact residues between PGT121 and 10-1074 confirmed their importance for neutralization.  Although PGT121 binds complex-type N-glycans, PGT121 recognized high-mannose-only HIV envelopes in isolation and on virions.  As HIV envelopes exhibit varying proportions of high-mannose- and complex-type N-glycans, these results suggest promiscuous carbohydrate interactions, an advantageous adaptation ensuring neutralization of all viruses within a given strain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAQMgrEu6up7Vg90H21EOLACvtfcHk0liw_cLXv-KYcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvValsrvM&md5=ab234bbc5bad15a72dc23d23d602a6c7</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217207109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217207109%26sid%3Dliteratum%253Aachs%26aulast%3DMouquet%26aufirst%3DH.%26aulast%3DScharf%26aufirst%3DL.%26aulast%3DEuler%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DEden%26aufirst%3DC.%26aulast%3DScheid%26aufirst%3DJ.%2BF.%26aulast%3DHalper-Stromberg%26aufirst%3DA.%26aulast%3DGnanapragasam%26aufirst%3DP.%2BN.%26aulast%3DSpencer%26aufirst%3DD.%2BI.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DSchuitemaker%26aufirst%3DH.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26atitle%3DComplex-type%2520N-glycan%2520recognition%2520by%2520potent%2520broadly%2520neutralizing%2520HIV%2520antibodies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE3268%26epage%3D3277%26doi%3D10.1073%2Fpnas.1217207109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gristick, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escolano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyubimov, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartweger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span> <span> </span><span class="NLM_article-title">Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1251</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-03632-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fs41467-018-03632-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=29593217" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A280%3ADC%252BC1MnmsFSlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1251&author=C.+O.+Barnesauthor=H.+B.+Gristickauthor=N.+T.+Freundauthor=A.+Escolanoauthor=A.+Y.+Lyubimovauthor=H.+Hartwegerauthor=A.+P.+Westauthor=A.+E.+Cohenauthor=M.+C.+Nussenzweigauthor=P.+J.+Bjorkman&title=Structural+characterization+of+a+highly-potent+V3-glycan+broadly+neutralizing+antibody+bound+to+natively-glycosylated+HIV-1+envelope&doi=10.1038%2Fs41467-018-03632-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope</span></div><div class="casAuthors">Barnes Christopher O; Gristick Harry B; West Anthony P Jr; Bjorkman Pamela J; Freund Natalia T; Escolano Amelia; Hartweger Harald; Nussenzweig Michel C; Freund Natalia T; Lyubimov Artem Y; Cohen Aina E; Nussenzweig Michel C</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1251</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccine design efforts.  Developing bNAbs with increased efficacy requires understanding how antibodies interact with the native oligomannose and complex-type N-glycan shield that hides most protein epitopes on HIV-1 envelope (Env).  Here we present crystal structures, including a 3.8-ÅA X-ray free electron laser dataset, of natively glycosylated Env trimers complexed with BG18, the most potent V3/N332gp120 glycan-targeting bNAb reported to date.  Our structures show conserved contacts mediated by common D gene-encoded residues with the N332gp120 glycan and the gp120 GDIR peptide motif, but a distinct Env-binding orientation relative to PGT121/10-1074 bNAbs.  BG18's binding orientation provides additional contacts with N392gp120 and N386gp120 glycans near the V3-loop base and engages protein components of the V1-loop.  The BG18-natively-glycosylated Env structures facilitate understanding of bNAb-glycan interactions critical for using V3/N332gp120 bNAbs therapeutically and targeting their epitope for immunogen design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSUOmuADByiLoUSrryheKE6fW6udTcc2eapzUuGz6i7y7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MnmsFSlsA%253D%253D&md5=fa256c8aaf8426492c8e6765d417fbfe</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-03632-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-03632-y%26sid%3Dliteratum%253Aachs%26aulast%3DBarnes%26aufirst%3DC.%2BO.%26aulast%3DGristick%26aufirst%3DH.%2BB.%26aulast%3DFreund%26aufirst%3DN.%2BT.%26aulast%3DEscolano%26aufirst%3DA.%26aulast%3DLyubimov%26aufirst%3DA.%2BY.%26aulast%3DHartweger%26aufirst%3DH.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DCohen%26aufirst%3DA.%2BE.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26atitle%3DStructural%2520characterization%2520of%2520a%2520highly-potent%2520V3-glycan%2520broadly%2520neutralizing%2520antibody%2520bound%2520to%2520natively-glycosylated%2520HIV-1%2520envelope%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26spage%3D1251%26doi%3D10.1038%2Fs41467-018-03632-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toonstra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Systematic synthesis and binding study of HIV V3 glycopeptides reveal the fine epitopes of several broadly neutralizing antibodies</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1566</span>– <span class="NLM_lpage">1575</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00319</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1566-1575&author=J.+Orwenyoauthor=H.+Caiauthor=J.+Giddensauthor=M.+N.+Aminauthor=C.+Toonstraauthor=L.+X.+Wang&title=Systematic+synthesis+and+binding+study+of+HIV+V3+glycopeptides+reveal+the+fine+epitopes+of+several+broadly+neutralizing+antibodies&doi=10.1021%2Facschembio.7b00319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic synthesis and binding study of HIV V3 glycopeptides reveal the fine epitopes of several broadly neutralizing antibodies</span></div><div class="casAuthors">Orwenyo, Jared; Cai, Hui; Giddens, John; Amin, Mohammed N.; Toonstra, Christian; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1566-1575</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A class of new glycan-reactive broadly neutralizing antibodies represented by PGT121, 10-1074, and PGT128 has recently been discovered that targets specific N-glycans and the peptide region around the V3 domain.  However, the glycan specificity and fine epitopes of these bNAbs remain to be further defined.  We report here a systematic chemoenzymic synthesis of homogeneous V3 glycopeptides derived from the HIV-1 JR-FL strain carrying defined N-glycans at N332, N301, and N295 sites.  Antibody binding studies revealed that both the nature and site of glycosylation in the context of the V3 domain were crit. for high-affinity binding.  It was found that antibody PGT128 exhibited specificity for high-mannose N-glycan with glycosylation site promiscuity, PGT121 showed binding specificity for glycopeptide carrying a sialylated N-glycan at N301 site, and 10-1074 was specific for glycopeptide carrying a high-mannose N-glycan at N332 site.  The synthesis and binding studies permit a detailed assessment of the glycan specificity and the requirement of peptide in the context of antibody-antigen recognition.  The identified glycopeptides can be used as potential templates for HIV vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEO2wxUHa1-7Vg90H21EOLACvtfcHk0lgIkWNq4_b07g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCksLo%253D&md5=39749d23caab82b374b2b8a95342c7b5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00319%26sid%3Dliteratum%253Aachs%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DGiddens%26aufirst%3DJ.%26aulast%3DAmin%26aufirst%3DM.%2BN.%26aulast%3DToonstra%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DSystematic%2520synthesis%2520and%2520binding%2520study%2520of%2520HIV%2520V3%2520glycopeptides%2520reveal%2520the%2520fine%2520epitopes%2520of%2520several%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D1566%26epage%3D1575%26doi%3D10.1021%2Facschembio.7b00319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Synthetic three-component HIV-1 V3 glycopeptide immunogens induce glycan-dependent antibody responses</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1513</span>– <span class="NLM_lpage">1522</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.chembiol.2017.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=29107699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehsL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1513-1522&author=H.+Caiauthor=J.+Orwenyoauthor=J.+P.+Giddensauthor=Q.+Yangauthor=R.+Zhangauthor=C.+C.+LaBrancheauthor=D.+C.+Montefioriauthor=L.+X.+Wang&title=Synthetic+three-component+HIV-1+V3+glycopeptide+immunogens+induce+glycan-dependent+antibody+responses&doi=10.1016%2Fj.chembiol.2017.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses</span></div><div class="casAuthors">Cai, Hui; Orwenyo, Jared; Giddens, John P.; Yang, Qiang; Zhang, Roushu; La Branche, Celia C.; Montefiori, David C.; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1513-1522.e4</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Eliciting broadly neutralizing antibody (bNAb) responses against HIV-1 is a major goal for a prophylactic HIV-1 vaccine.  One approach is to design immunogens based on known broadly neutralizing epitopes.  Here we report the design and synthesis of an HIV-1 glycopeptide immunogen derived from the V3 domain.  We performed glycopeptide epitope mapping to det. the minimal glycopeptide sequence as the epitope of V3-glycan-specific bNAbs PGT128 and 10-1074.  We further constructed a self-adjuvant three-component immunogen that consists of a 33-mer V3 glycopeptide epitope, a universal T helper epitope P30, and a lipopeptide (Pam3CSK4) that serves as a ligand of Toll-like receptor 2.  Rabbit immunization revealed that the synthetic self-adjuvant glycopeptide could elicit substantial glycan-dependent antibodies that exhibited broader recognition of HIV-1 gp120s than the non-glycosylated V3 peptide.  These results suggest that the self-adjuvant synthetic glycopeptides can serve as an important component to elicit glycan-specific antibodies in HIV vaccine design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJGZKJM6oJ4rVg90H21EOLACvtfcHk0lhxhdXwvTEfwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehsL%252FE&md5=c5a1544360c7608d5831ddeb89d51087</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DGiddens%26aufirst%3DJ.%2BP.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLaBranche%26aufirst%3DC.%2BC.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DSynthetic%2520three-component%2520HIV-1%2520V3%2520glycopeptide%2520immunogens%2520induce%2520glycan-dependent%2520antibody%2520responses%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2017%26volume%3D24%26spage%3D1513%26epage%3D1522%26doi%3D10.1016%2Fj.chembiol.2017.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussedat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vohra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerhoff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cale, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkowicz, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radakovich, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anasti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armand, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pancera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiev, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Holle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdool-Karim, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Tejada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaai7521</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aai7521</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscitranslmed.aai7521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28298421" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=S.+M.+Alamauthor=B.+Aussedatauthor=Y.+Vohraauthor=R.+R.+Meyerhoffauthor=E.+M.+Caleauthor=W.+E.+Walkowiczauthor=N.+A.+Radakovichauthor=K.+Anastiauthor=L.+Armandauthor=R.+Parksauthor=L.+Sutherlandauthor=R.+Scearceauthor=M.+G.+Joyceauthor=M.+Panceraauthor=A.+Druzauthor=I.+S.+Georgievauthor=T.+Von+Holleauthor=A.+Eatonauthor=C.+Foxauthor=S.+G.+Reedauthor=M.+Louderauthor=R.+T.+Bailerauthor=L.+Morrisauthor=S.+S.+Abdool-Karimauthor=M.+Cohenauthor=H.+X.+Liaoauthor=D.+C.+Montefioriauthor=P.+K.+Parkauthor=A.+Fernandez-Tejadaauthor=K.+Wieheauthor=S.+Santraauthor=T.+B.+Keplerauthor=K.+O.+Saundersauthor=J.+Sodroskiauthor=P.+D.+Kwongauthor=J.+R.+Mascolaauthor=M.+Bonsignoriauthor=M.+A.+Moodyauthor=S.+Danishefskyauthor=B.+F.+Haynes&title=Mimicry+of+an+HIV+broadly+neutralizing+antibody+epitope+with+a+synthetic+glycopeptide&doi=10.1126%2Fscitranslmed.aai7521"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aai7521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aai7521%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DAussedat%26aufirst%3DB.%26aulast%3DVohra%26aufirst%3DY.%26aulast%3DMeyerhoff%26aufirst%3DR.%2BR.%26aulast%3DCale%26aufirst%3DE.%2BM.%26aulast%3DWalkowicz%26aufirst%3DW.%2BE.%26aulast%3DRadakovich%26aufirst%3DN.%2BA.%26aulast%3DAnasti%26aufirst%3DK.%26aulast%3DArmand%26aufirst%3DL.%26aulast%3DParks%26aufirst%3DR.%26aulast%3DSutherland%26aufirst%3DL.%26aulast%3DScearce%26aufirst%3DR.%26aulast%3DJoyce%26aufirst%3DM.%2BG.%26aulast%3DPancera%26aufirst%3DM.%26aulast%3DDruz%26aufirst%3DA.%26aulast%3DGeorgiev%26aufirst%3DI.%2BS.%26aulast%3DVon%2BHolle%26aufirst%3DT.%26aulast%3DEaton%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DC.%26aulast%3DReed%26aufirst%3DS.%2BG.%26aulast%3DLouder%26aufirst%3DM.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DMorris%26aufirst%3DL.%26aulast%3DAbdool-Karim%26aufirst%3DS.%2BS.%26aulast%3DCohen%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DPark%26aufirst%3DP.%2BK.%26aulast%3DFernandez-Tejada%26aufirst%3DA.%26aulast%3DWiehe%26aufirst%3DK.%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DKepler%26aufirst%3DT.%2BB.%26aulast%3DSaunders%26aufirst%3DK.%2BO.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DMoody%26aufirst%3DM.%2BA.%26aulast%3DDanishefsky%26aufirst%3DS.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DMimicry%2520of%2520an%2520HIV%2520broadly%2520neutralizing%2520antibody%2520epitope%2520with%2520a%2520synthetic%2520glycopeptide%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aai7521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Multivalent antigen presentation enhances the immunogenicity of a synthetic three-component HIV-1 V3 glycopeptide vaccine</span>. <i>ACS Cent. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1021/acscentsci.8b00060</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acscentsci.8b00060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVyms70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2018&pages=582-589&author=H.+Caiauthor=R.+Zhangauthor=J.+Orwenyoauthor=J.+Giddensauthor=Q.+Yangauthor=C.+C.+LaBrancheauthor=D.+C.+Montefioriauthor=L.+X.+Wang&title=Multivalent+antigen+presentation+enhances+the+immunogenicity+of+a+synthetic+three-component+HIV-1+V3+glycopeptide+vaccine&doi=10.1021%2Facscentsci.8b00060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Multivalent Antigen Presentation Enhances the Immunogenicity of a Synthetic Three-Component HIV-1 V3 Glycopeptide Vaccine</span></div><div class="casAuthors">Cai, Hui; Zhang, Roushu; Orwenyo, Jared; Giddens, John; Yang, Qiang; LaBranche, Celia C.; Montefiori, David C.; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Central Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">582-589</span>CODEN:
                <span class="NLM_cas:coden">ACSCII</span>;
        ISSN:<span class="NLM_cas:issn">2374-7951</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV-1 envelope glycoproteins gp120 and gp41 are presented on the virus surface as a trimer of heterodimer and are the targets of broadly neutralizing antibodies (bNAbs).  We describe here the synthesis and preliminary immunol. evaluation of a three-component trivalent HIV-1 V3 glycopeptide immunogen aiming to raise glycopeptide epitope-specific antibodies.  Click chem. confers efficient synthesis of the lipopeptide-glycopeptide conjugate that carries three copies of HIV-1 JR-FL gp120 V3 glycopeptide with a high-mannose glycan at the N332 glycosylation site.  We found that the multi-valent presentation substantially enhanced the immunogenicity of the V3 glycopeptide.  The antisera induced by the three-component multi-valent glycopeptide immunogen exhibited stronger binding to heterologous HIV-1 gp120s and the trimeric gp140s than that from the monovalent glycopeptide immunogen.  The antisera generated from this preliminary rabbit immunization did not show virus neutralization activity, probably due to the lack of somatic maturation.  The ability to elicit substantial glycopeptide epitope-specific antibodies by the three-component trivalent glycopeptide immunogen suggests that it could serve as a valuable vaccine component in combination with other vaccine candidates for further immunization studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9RP_0rT13bVg90H21EOLACvtfcHk0lhxhdXwvTEfwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVyms70%253D&md5=c35d7c340270a14337c7d0afd63b7c5f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facscentsci.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facscentsci.8b00060%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DGiddens%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLaBranche%26aufirst%3DC.%2BC.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DMultivalent%2520antigen%2520presentation%2520enhances%2520the%2520immunogenicity%2520of%2520a%2520synthetic%2520three-component%2520HIV-1%2520V3%2520glycopeptide%2520vaccine%26jtitle%3DACS%2520Cent.%2520Sci.%26date%3D2018%26volume%3D4%26spage%3D582%26epage%3D589%26doi%3D10.1021%2Facscentsci.8b00060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doores, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murin, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marozsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffenberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caulfield, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khayat, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deller, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feizi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulson, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span> <span> </span><span class="NLM_article-title">Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">803</span>, <span class="refDoi"> DOI: 10.1038/nsmb.2594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnsmb.2594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=23708606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXot1Cqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=796-803&author=L.+Kongauthor=J.+H.+Leeauthor=K.+J.+Dooresauthor=C.+D.+Murinauthor=J.+P.+Julienauthor=R.+McBrideauthor=Y.+Liuauthor=A.+Marozsanauthor=A.+Cupoauthor=P.+J.+Klasseauthor=S.+Hoffenbergauthor=M.+Caulfieldauthor=C.+R.+Kingauthor=Y.+Huaauthor=K.+M.+Leauthor=R.+Khayatauthor=M.+C.+Dellerauthor=T.+Claytonauthor=H.+Tienauthor=T.+Feiziauthor=R.+W.+Sandersauthor=J.+C.+Paulsonauthor=J.+P.+Mooreauthor=R.+L.+Stanfieldauthor=D.+R.+Burtonauthor=A.+B.+Wardauthor=I.+A.+Wilson&title=Supersite+of+immune+vulnerability+on+the+glycosylated+face+of+HIV-1+envelope+glycoprotein+gp120&doi=10.1038%2Fnsmb.2594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120</span></div><div class="casAuthors">Kong, Leopold; Lee, Jeong Hyun; Doores, Katie J.; Murin, Charles D.; Julien, Jean-Philippe; McBride, Ryan; Liu, Yan; Marozsan, Andre; Cupo, Albert; Klasse, Per-Johan; Hoffenberg, Simon; Caulfield, Michael; King, C. Richter; Hua, Yuanzi; Le, Khoa M.; Khayat, Reza; Deller, Marc C.; Clayton, Thomas; Tien, Henry; Feizi, Ten; Sanders, Rogier W.; Paulson, James C.; Moore, John P.; Stanfield, Robyn L.; Burton, Dennis R.; Ward, Andrew B.; Wilson, Ian A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">796-803</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A substantial proportion of the broadly neutralizing antibodies (bnAbs) identified in certain HIV-infected donors recognize glycan-dependent epitopes on HIV-1 gp120.  Here we elucidate how the bnAb PGT 135 binds its Asn332 glycan-dependent epitope from its 3.1-Å crystal structure with gp120, CD4 and Fab 17b.  PGT 135 interacts with glycans at Asn332, Asn392 and Asn386, using long CDR loops H1 and H3 to penetrate the glycan shield and access the gp120 protein surface.  EM reveals that PGT 135 can accommodate the conformational and chem. diversity of gp120 glycans by altering its angle of engagement.  Combined structural studies of PGT 135, PGT 128 and 2G12 show that this Asn332-dependent antigenic region is highly accessible and much more extensive than initially appreciated, which allows for multiple binding modes and varied angles of approach; thereby it represents a supersite of vulnerability for antibody neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXb1rDhP3sPrVg90H21EOLACvtfcHk0lgewnNUdMqyzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXot1Cqu7o%253D&md5=a9dba6767a1e724af9601ee88b1dc990</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.2594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.2594%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DDoores%26aufirst%3DK.%2BJ.%26aulast%3DMurin%26aufirst%3DC.%2BD.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DMcBride%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMarozsan%26aufirst%3DA.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DHoffenberg%26aufirst%3DS.%26aulast%3DCaulfield%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DC.%2BR.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DLe%26aufirst%3DK.%2BM.%26aulast%3DKhayat%26aufirst%3DR.%26aulast%3DDeller%26aufirst%3DM.%2BC.%26aulast%3DClayton%26aufirst%3DT.%26aulast%3DTien%26aufirst%3DH.%26aulast%3DFeizi%26aufirst%3DT.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DPaulson%26aufirst%3DJ.%2BC.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26atitle%3DSupersite%2520of%2520immune%2520vulnerability%2520on%2520the%2520glycosylated%2520face%2520of%2520HIV-1%2520envelope%2520glycoprotein%2520gp120%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D20%26spage%3D796%26epage%3D803%26doi%3D10.1038%2Fnsmb.2594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majeed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montabana, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrov, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodroski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span> <span> </span><span class="NLM_article-title">Structure of a V3-containing HIV-1 gp120 core</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>310</i></span>,  <span class="NLM_fpage">1025</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1126/science.1118398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscience.1118398" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2005&pages=1025-1028&author=C.+C.+Huangauthor=M.+Tangauthor=M.+Y.+Zhangauthor=S.+Majeedauthor=E.+Montabanaauthor=R.+L.+Stanfieldauthor=D.+S.+Dimitrovauthor=B.+Korberauthor=J.+Sodroskiauthor=I.+A.+Wilsonauthor=R.+Wyattauthor=P.+D.+Kwong&title=Structure+of+a+V3-containing+HIV-1+gp120+core&doi=10.1126%2Fscience.1118398"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1126%2Fscience.1118398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1118398%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DTang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DMajeed%26aufirst%3DS.%26aulast%3DMontabana%26aufirst%3DE.%26aulast%3DStanfield%26aufirst%3DR.%2BL.%26aulast%3DDimitrov%26aufirst%3DD.%2BS.%26aulast%3DKorber%26aufirst%3DB.%26aulast%3DSodroski%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWyatt%26aufirst%3DR.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520of%2520a%2520V3-containing%2520HIV-1%2520gp120%2520core%26jtitle%3DScience%26date%3D2005%26volume%3D310%26spage%3D1025%26epage%3D1028%26doi%3D10.1126%2Fscience.1118398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rerks-Ngarm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitisuttithum, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nitayaphan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaewkungwal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Premsri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namwat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benenson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurunathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeil, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stablein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birx, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chunsuttiwat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamboonruang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thongcharoen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robb, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunasol, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span> <span> </span><span class="NLM_article-title">Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>361</i></span>,  <span class="NLM_fpage">2209</span>– <span class="NLM_lpage">2220</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0908492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1056%2FNEJMoa0908492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=19843557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsb%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=2209-2220&author=S.+Rerks-Ngarmauthor=P.+Pitisuttithumauthor=S.+Nitayaphanauthor=J.+Kaewkungwalauthor=J.+Chiuauthor=R.+Parisauthor=N.+Premsriauthor=C.+Namwatauthor=M.+de+Souzaauthor=E.+Adamsauthor=M.+Benensonauthor=S.+Gurunathanauthor=J.+Tartagliaauthor=J.+G.+McNeilauthor=D.+P.+Francisauthor=D.+Stableinauthor=D.+L.+Birxauthor=S.+Chunsuttiwatauthor=C.+Khamboonruangauthor=P.+Thongcharoenauthor=M.+L.+Robbauthor=N.+L.+Michaelauthor=P.+Kunasolauthor=J.+H.+Kim&title=Vaccination+with+ALVAC+and+AIDSVAX+to+prevent+HIV-1+infection+in+Thailand&doi=10.1056%2FNEJMoa0908492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand</span></div><div class="casAuthors">Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Nitayaphan, Sorachai; Kaewkungwal, Jaranit; Chiu, Joseph; Paris, Robert; Premsri, Nakorn; Namwat, Chawetsan; De Souza, Mark; Adams, Elizabeth; Benenson, Michael; Gurunathan, Sanjay; Tartaglia, Jim; Mcneil, John G.; Francis, Donald P.; Stablein, Donald; Birx, Deborah L.; Chunsuttiwat, Supamit; Khamboonruang, Chirasak; Thongcharoen, Prasert; Robb, Merlin L.; Michael, Nelson L.; Kunasol, Prayura; Kim, Jerome H.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2209-2220</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is crit. to pandemic control.  In a community-based, randomized, multicenter, double-blind, placebo-controlled efficacy trial, the authors evaluated four priming injections of a recombinant canarypox vector vaccine (ALVAC-HIV [vCP1521]) plus two booster injections of a recombinant glycoprotein 120 subunit vaccine (AIDSVAX B/E).  The vaccine and placebo injections were administered to 16,402 healthy men and women between the ages of 18 and 30 years in Rayong and Chon Buri provinces in Thailand.  The volunteers, primarily at heterosexual risk for HIV infection, were monitored for the coprimary end points: HIV-1 infection and early HIV-1 viremia, at the end of the 6-mo vaccination series and every 6 mo thereafter for 3 years.  In the intention-to-treat anal. involving 16,402 subjects, there was a trend toward the prevention of HIV-1 infection among the vaccine recipients, with a vaccine efficacy of 26.4% (95% confidence interval [CI], -4.0 to 47.9).  In the perprotocol anal. involving 12,542 subjects, the vaccine efficacy was 26.2% (95% CI, -13.3 to 51.9).  In the modified intention-to-treat anal. involving 16,395 subjects (with the exclusion of 7 subjects who were found to have had HIV-1 infection at baseline), the vaccine efficacy was 31.2% (95% CI, 1.1 to 52.1).  Vaccination did not affect the degree of viremia or the CD4+ T-cell count in subjects in whom HIV-1 infection was subsequently diagnosed.  This ALVAC-HIV and AIDSVAX B/E vaccine regimen may reduce the risk of HIV infection in a community-based population with largely heterosexual risk.  Vaccination did not affect the viral load or CD4+ count in subjects with HIV infection.  Although the results show only a modest benefit, they offer insight for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyn4FIQSdHi7Vg90H21EOLACvtfcHk0lhMd2czKPTzjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWhsb%252FO&md5=22aa3862aeaf5c28e7d595a369fbd134</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0908492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0908492%26sid%3Dliteratum%253Aachs%26aulast%3DRerks-Ngarm%26aufirst%3DS.%26aulast%3DPitisuttithum%26aufirst%3DP.%26aulast%3DNitayaphan%26aufirst%3DS.%26aulast%3DKaewkungwal%26aufirst%3DJ.%26aulast%3DChiu%26aufirst%3DJ.%26aulast%3DParis%26aufirst%3DR.%26aulast%3DPremsri%26aufirst%3DN.%26aulast%3DNamwat%26aufirst%3DC.%26aulast%3Dde%2BSouza%26aufirst%3DM.%26aulast%3DAdams%26aufirst%3DE.%26aulast%3DBenenson%26aufirst%3DM.%26aulast%3DGurunathan%26aufirst%3DS.%26aulast%3DTartaglia%26aufirst%3DJ.%26aulast%3DMcNeil%26aufirst%3DJ.%2BG.%26aulast%3DFrancis%26aufirst%3DD.%2BP.%26aulast%3DStablein%26aufirst%3DD.%26aulast%3DBirx%26aufirst%3DD.%2BL.%26aulast%3DChunsuttiwat%26aufirst%3DS.%26aulast%3DKhamboonruang%26aufirst%3DC.%26aulast%3DThongcharoen%26aufirst%3DP.%26aulast%3DRobb%26aufirst%3DM.%2BL.%26aulast%3DMichael%26aufirst%3DN.%2BL.%26aulast%3DKunasol%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26atitle%3DVaccination%2520with%2520ALVAC%2520and%2520AIDSVAX%2520to%2520prevent%2520HIV-1%2520infection%2520in%2520Thailand%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D2209%26epage%3D2220%26doi%3D10.1056%2FNEJMoa0908492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rerks-Ngarm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Excler, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, N. L.</span></span> <span> </span><span class="NLM_article-title">HIV vaccines: lessons learned and the way forward</span>. <i>Curr. Opin. HIV AIDS</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">434</span>, <span class="refDoi"> DOI: 10.1097/COH.0b013e32833d17ac</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1097%2FCOH.0b013e32833d17ac" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=20978385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A280%3ADC%252BC3cbisFSgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=428-434&author=J.+H.+Kimauthor=S.+Rerks-Ngarmauthor=J.+L.+Exclerauthor=N.+L.+Michael&title=HIV+vaccines%3A+lessons+learned+and+the+way+forward&doi=10.1097%2FCOH.0b013e32833d17ac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">HIV vaccines: lessons learned and the way forward</span></div><div class="casAuthors">Kim Jerome H; Rerks-Ngarm Supachai; Excler Jean-Louis; Michael Nelson L</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in HIV and AIDS</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  An effective HIV vaccine is a global health priority.  We describe lessons learned from four HIV vaccine trials that failed to demonstrate efficacy and one that showed modest protection as a pathway forward.  RECENT FINDINGS:  The Merck Ad5 phase IIb T-cell vaccine failed to show efficacy and might have increased the risk of HIV acquisition in men who have sex with men.  Although VaxGen gp120 alone was not efficacious in groups at high risk for HIV-1 infection, the RV144 ALVAC prime and gp120 boost regimen showed 31% efficacy in low-incidence heterosexuals.  All trials demonstrated the limitations of available laboratory and animal models to assess relevant vaccine-induced immune responses and predict clinical trial outcome.  Analysis of innate and adaptive responses induced in RV144 will guide future trial design.  SUMMARY:  Future HIV vaccine trials should define the RV144 immune responses relevant to protection, improve durability and level of protection, and assess efficacy in diverse risk groups.  New strategies examining heterologous vector prime-boost, universal inserts, replicating vectors, and novel protein or adjuvant immunogens should be explored to induce T-cell and antibody responses.  HIV vaccine development requires innovative ideas and a sustained long-term commitment of scientists, governments, and the community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTK-9zJcAGcnELvajU9pjPfW6udTcc2eaXGcoI6PQ3W7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbisFSgtg%253D%253D&md5=ff455e858b9acf48fd14744ac5afcfec</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1097%2FCOH.0b013e32833d17ac&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOH.0b013e32833d17ac%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DRerks-Ngarm%26aufirst%3DS.%26aulast%3DExcler%26aufirst%3DJ.%2BL.%26aulast%3DMichael%26aufirst%3DN.%2BL.%26atitle%3DHIV%2520vaccines%253A%2520lessons%2520learned%2520and%2520the%2520way%2520forward%26jtitle%3DCurr.%2520Opin.%2520HIV%2520AIDS%26date%3D2010%26volume%3D5%26spage%3D428%26epage%3D434%26doi%3D10.1097%2FCOH.0b013e32833d17ac" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwenyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenaga, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giddens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toonstra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">5453</span>– <span class="NLM_lpage">5456</span>, <span class="refDoi"> DOI: 10.1039/C7CC02059G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1039%2FC7CC02059G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28466900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslWrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2017&pages=5453-5456&author=H.+Caiauthor=J.+Orwenyoauthor=J.+Guenagaauthor=J.+Giddensauthor=C.+Toonstraauthor=R.+T.+Wyattauthor=L.+X.+Wang&title=Synthetic+multivalent+V3+glycopeptides+display+enhanced+recognition+by+glycan-dependent+HIV-1+broadly+neutralizing+antibodies&doi=10.1039%2FC7CC02059G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies</span></div><div class="casAuthors">Cai, Hui; Orwenyo, Jared; Guenaga, Javier; Giddens, John; Toonstra, Christian; Wyatt, Richard T.; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">5453-5456</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We describe here the synthesis of novel multivalent HIV V3 domain glycopeptides and their binding to broadly neutralizing antibodies PGT128 and 10-1074.  Our binding data reveal a distinct mode of antigen recognition by the two antibodies and further suggest that multivalent glycopeptides could mimic the neutralizing epitopes more efficiently than the monomeric glycopeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquUL0g4ELWL7Vg90H21EOLACvtfcHk0lhMd2czKPTzjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslWrt78%253D&md5=a03830b43cb5b099e89fa134f244984d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2FC7CC02059G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CC02059G%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DOrwenyo%26aufirst%3DJ.%26aulast%3DGuenaga%26aufirst%3DJ.%26aulast%3DGiddens%26aufirst%3DJ.%26aulast%3DToonstra%26aufirst%3DC.%26aulast%3DWyatt%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DSynthetic%2520multivalent%2520V3%2520glycopeptides%2520display%2520enhanced%2520recognition%2520by%2520glycan-dependent%2520HIV-1%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2017%26volume%3D53%26spage%3D5453%26epage%3D5456%26doi%3D10.1039%2FC7CC02059G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umekawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Glycosynthases enable a highly efficient chemoenzymatic synthesis of N-glycoproteins carrying intact natural N-glycans</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">2214</span>– <span class="NLM_lpage">2223</span>, <span class="refDoi"> DOI: 10.1021/ja8074677</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja8074677" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ogtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=2214-2223&author=W.+Huangauthor=C.+Liauthor=B.+Liauthor=M.+Umekawaauthor=K.+Yamamotoauthor=X.+Zhangauthor=L.+X.+Wang&title=Glycosynthases+enable+a+highly+efficient+chemoenzymatic+synthesis+of+N-glycoproteins+carrying+intact+natural+N-glycans&doi=10.1021%2Fja8074677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glycosynthases Enable a Highly Efficient Chemoenzymatic Synthesis of N-Glycoproteins Carrying Intact Natural N-Glycans</span></div><div class="casAuthors">Huang, Wei; Li, Cishan; Li, Bing; Umekawa, Midori; Yamamoto, Kenji; Zhang, Xinyu; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2214-2223</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Homogeneous N-glycoproteins carrying defined natural N-glycans are essential for detailed structural and functional studies.  The transglycosylation activity of the endo-β-N-acetylglucosaminidases from Arthrobacter protophormiae (Endo-A) and Mucor hiemalis (Endo-M) holds great potential for glycoprotein synthesis, but the wild-type enzymes are not practical for making glycoproteins carrying native N-glycans because of their predominant activity for product hydrolysis.  In this article, we report studies of two endoglycosidase-based glycosynthases, EndoM-N175A and EndoA-N171A, and their usefulness in constructing homogeneous N-glycoproteins carrying natural N-glycans.  The oligosaccharide oxazoline corresponding to the biantennary complex-type N-glycan was synthesized and tested with the two glycosynthases.  The EndoM-N175A mutant was able to efficiently transfer the complex-type glycan oxazoline to a GlcNAc peptide and GlcNAc-contg. RNase to form the corresponding homogeneous glycopeptide/glycoprotein.  The EndoA-N171A mutant did not recognize the complex-type N-glycan oxazoline but could efficiently use the high-mannose-type glycan oxazoline for transglycosylation.  These mutants possess the transglycosylation activity but lack the hydrolytic activity toward the product.  Kinetic studies revealed that the dramatically enhanced synthetic efficiency of the EndoA-N171A mutant was due to the significantly reduced hydrolytic activity toward both the Man9GlcNAc oxazoline and the product as well as to its enhanced activity for transglycosylation.  Thus, the two mutants described here represent the first endoglycosidase-based glycosynthases enabling a highly efficient synthesis of homogeneous natural N-glycoproteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoasUdb3lI0ibVg90H21EOLACvtfcHk0lgG5fojT95YiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ogtb8%253D&md5=9da9a7def29006536e5b0b68093ef0dc</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fja8074677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja8074677%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DUmekawa%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DGlycosynthases%2520enable%2520a%2520highly%2520efficient%2520chemoenzymatic%2520synthesis%2520of%2520N-glycoproteins%2520carrying%2520intact%2520natural%2520N-glycans%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D2214%26epage%3D2223%26doi%3D10.1021%2Fja8074677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Umekawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. X.</span></span> <span> </span><span class="NLM_article-title">Efficient glycosynthase mutant derived from Mucor hiemalis endo-beta-N-acetylglucosaminidase capable of transferring oligosaccharide from both sugar oxazoline and natural N-glycan</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">511</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.059832</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1074%2Fjbc.M109.059832" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=19880511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sqtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=511-521&author=M.+Umekawaauthor=C.+Liauthor=T.+Higashiyamaauthor=W.+Huangauthor=H.+Ashidaauthor=K.+Yamamotoauthor=L.+X.+Wang&title=Efficient+glycosynthase+mutant+derived+from+Mucor+hiemalis+endo-beta-N-acetylglucosaminidase+capable+of+transferring+oligosaccharide+from+both+sugar+oxazoline+and+natural+N-glycan&doi=10.1074%2Fjbc.M109.059832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient glycosynthase mutant derived from Mucor hiemalis endo-β-N-acetylglucosaminidase capable of transferring oligosaccharide from both sugar oxazoline and natural N-glycan</span></div><div class="casAuthors">Umekawa, Midori; Li, Cishan; Higashiyama, Takayuki; Huang, Wei; Ashida, Hisashi; Yamamoto, Kenji; Wang, Lai-Xi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">511-521</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Endo-M, an endo-β-N-acetylglucosaminidase from Mucor hiemalis, is a family 85 glycoside hydrolase.  This enzyme is unique in that it can transfer en bloc the oligosaccharide of various types of N-glycans onto different acceptors, and thereby it enzymically generates diverse glycoconjugates.  In this study, we performed mutational and kinetic studies focusing on a key catalytic asparagine 175 of Endo-M.  We have shown that most of the Asn-175 mutants had significantly diminished hydrolysis activity but acted as glycosynthases capable of using synthetic sugar oxazoline for transglycosylation.  Our results confirm the crit. role of this asparagine residue in promoting the formation of an oxazolinium ion intermediate in the first step of the substrate-assisted catalysis.  Interestingly, the N175Q mutant was found to possess dramatically enhanced glycosynthase-like activity with sugar oxazoline in comparison with N175A and a transglycosidase-like activity with "natural" N-glycan as well.  These results also implicated the significance of amide side chain in the asparagine 175 of Endo-M for promoting oxazoline transglycosylation in the second step of the catalysis.  The highly efficient syntheses of glycopeptides/glycoproteins by N175Q combined with synthetic sugar oxazolines or natural N-glycan substrates were exemplified.  In addn., we also identified several previously unknown residues that seem to play a role in the catalysis of Endo-M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBD4ZIpq3WcrVg90H21EOLACvtfcHk0lhsLO8cjOswLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sqtr%252FL&md5=0b9c4027515318c2041a2df4501cfba0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.059832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.059832%26sid%3Dliteratum%253Aachs%26aulast%3DUmekawa%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHigashiyama%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DAshida%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%2BX.%26atitle%3DEfficient%2520glycosynthase%2520mutant%2520derived%2520from%2520Mucor%2520hiemalis%2520endo-beta-N-acetylglucosaminidase%2520capable%2520of%2520transferring%2520oligosaccharide%2520from%2520both%2520sugar%2520oxazoline%2520and%2520natural%2520N-glycan%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D511%26epage%3D521%26doi%3D10.1074%2Fjbc.M109.059832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gristick, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Boehmer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, A. P.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schamber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazumyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golijanin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatkenheuer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nussenzweig, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjorkman, P. J.</span></span> <span> </span><span class="NLM_article-title">Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site</span>. <i>Nat. Struct. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">906</span>– <span class="NLM_lpage">915</span>, <span class="refDoi"> DOI: 10.1038/nsmb.3291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnsmb.3291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27617431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2rtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=906-915&author=H.+B.+Gristickauthor=L.+von+Boehmerauthor=A.+P.+Westauthor=M.+Schamberauthor=A.+Gazumyanauthor=J.+Golijaninauthor=M.+S.+Seamanauthor=G.+Fatkenheuerauthor=F.+Kleinauthor=M.+C.+Nussenzweigauthor=P.+J.+Bjorkman&title=Natively+glycosylated+HIV-1+Env+structure+reveals+new+mode+for+antibody+recognition+of+the+CD4-binding+site&doi=10.1038%2Fnsmb.3291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site</span></div><div class="casAuthors">Gristick, Harry B.; von Boehmer, Lotta; West Jr, Anthony P.; Schamber, Michael; Gazumyan, Anna; Golijanin, Jovana; Seaman, Michael S.; Fatkenheuer, Gerd; Klein, Florian; Nussenzweig, Michel C.; Bjorkman, Pamela J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">906-915</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">HIV-1 vaccine design is informed by structural studies elucidating mechanisms by which broadly neutralizing antibodies (bNAbs) recognize and/or accommodate N-glycans on the trimeric envelope glycoprotein (Env).  Variability in high-mannose and complex-type Env glycoforms leads to heterogeneity that usually precludes visualization of the native glycan shield.  We present 3.5-Å- and 3.9-Å-resoln. crystal structures of the HIV-1 Env trimer with fully processed and native glycosylation, revealing a glycan shield of high-mannose and complex-type N-glycans, which we used to define complete epitopes of two bNAbs.  Env trimer was complexed with 10-1074 (against the V3-loop) and IOMA, a new CD4-binding site (CD4bs) antibody.  Although IOMA derives from VH1-2*02, the germline gene of CD4bs-targeting VRC01-class bNAbs, its light chain lacks the short CDRL3 that defines VRC01-class bNAbs.  Thus IOMA resembles 8ANC131-class/VH1-46-derived CD4bs bNAbs, which have normal-length CDRL3s.  The existence of bNAbs that combine features of VRC01-class and 8ANC131-class antibodies has implications for immunization strategies targeting VRC01-like bNAbs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrACMDFZbOSGbVg90H21EOLACvtfcHk0lhsLO8cjOswLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2rtb3I&md5=03038d4919d4cb0b6952c336d5253b8e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.3291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.3291%26sid%3Dliteratum%253Aachs%26aulast%3DGristick%26aufirst%3DH.%2BB.%26aulast%3Dvon%2BBoehmer%26aufirst%3DL.%26aulast%3DWest%26aufirst%3DA.%2BP.%26aulast%3DSchamber%26aufirst%3DM.%26aulast%3DGazumyan%26aufirst%3DA.%26aulast%3DGolijanin%26aufirst%3DJ.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DFatkenheuer%26aufirst%3DG.%26aulast%3DKlein%26aufirst%3DF.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DBjorkman%26aufirst%3DP.%2BJ.%26atitle%3DNatively%2520glycosylated%2520HIV-1%2520Env%2520structure%2520reveals%2520new%2520mode%2520for%2520antibody%2520recognition%2520of%2520the%2520CD4-binding%2520site%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D906%26epage%3D915%26doi%3D10.1038%2Fnsmb.3291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y. M.</span></span> <span> </span><span class="NLM_article-title">Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6106</span>– <span class="NLM_lpage">6110</span>, <span class="refDoi"> DOI: 10.1002/anie.201300390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1002%2Fanie.201300390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=23616304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsVeit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=6106-6110&author=H.+Caiauthor=M.+S.+Chenauthor=Z.+Y.+Sunauthor=Y.+F.+Zhaoauthor=H.+Kunzauthor=Y.+M.+Li&title=Self-adjuvanting+synthetic+antitumor+vaccines+from+MUC1+glycopeptides+conjugated+to+T-cell+epitopes+from+tetanus+toxoid&doi=10.1002%2Fanie.201300390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid</span></div><div class="casAuthors">Cai, Hui; Chen, Mei-Sha; Sun, Zhan-Yi; Zhao, Yu-Fen; Kunz, Horst; Li, Yan-Mei</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6106-6110</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The MUC1 tandem repeat glycopeptide sequence HGVTSAPDTRPAPGSTAPPA was coupled to three known universal T-helper cell epitope peptides P4 (TT1273-1284: GQIGN DPNRDIL), P2 (TT830-843: QYIKANSKFIGITE), and P30 (TT947-967: FNNFTVSFWLRVPKVSASHLE) derived from the tetanus toxoid.  Efficient two-component antitumor vaccines were obtained by conjugation of MUC1 tandem repeat glycopeptides with the tetanus toxoid P30 peptide.  The P30 T-cell epitope obviously is of superior efficiency compared to the P2 and P4 epitopes.  The sera induced by BSA-conjugated vaccines showed stronger binding to MCF-7 cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkEbHQij537LVg90H21EOLACvtfcHk0lj4VlfpUv3JNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsVeit7g%253D&md5=c8c0d5c7d46a331cda57385d5dd101e9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fanie.201300390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201300390%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DM.%2BS.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DZhao%26aufirst%3DY.%2BF.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%2BM.%26atitle%3DSelf-adjuvanting%2520synthetic%2520antitumor%2520vaccines%2520from%2520MUC1%2520glycopeptides%2520conjugated%2520to%2520T-cell%2520epitopes%2520from%2520tetanus%2520toxoid%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2013%26volume%3D52%26spage%3D6106%26epage%3D6110%26doi%3D10.1002%2Fanie.201300390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palitzsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schorlemer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stergiou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerlind, U.</span></span> <span> </span><span class="NLM_article-title">Microarray analysis of antibodies induced with synthetic antitumor vaccines: Specificity against diverse mucin core structures</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3875</span>– <span class="NLM_lpage">3884</span>, <span class="refDoi"> DOI: 10.1002/chem.201603921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1002%2Fchem.201603921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27957769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVaqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=3875-3884&author=C.+Pettauthor=H.+Caiauthor=J.+Liuauthor=B.+Palitzschauthor=M.+Schorlemerauthor=S.+Hartmannauthor=N.+Stergiouauthor=M.+Luauthor=H.+Kunzauthor=E.+Schmittauthor=U.+Westerlind&title=Microarray+analysis+of+antibodies+induced+with+synthetic+antitumor+vaccines%3A+Specificity+against+diverse+mucin+core+structures&doi=10.1002%2Fchem.201603921"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Microarray analysis of antibodies induced with synthetic antitumor vaccines: Specificity against diverse mucin core structures</span></div><div class="casAuthors">Pett, Christian; Cai, Hui; Liu, Jia; Palitzsch, Bjoern; Schorlemer, Manuel; Hartmann, Sebastian; Stergiou, Natascha; Lu, Mengji; Kunz, Horst; Schmitt, Edgar; Westerlind, Ulrika</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3875-3884</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Glycoprotein research is pivotal for vaccine development and biomarker discovery.  Many successful methodologies for reliably increasing the antigenicity toward tumor-assocd. glycopeptide structures have been reported.  Deeper insights into the quality and specificity of the raised polyclonal, humoral reactions are often not addressed, despite the fact that an immunol. memory, which produces antibodies with cross-reactivity to epitopes exposed on healthy cells, may cause autoimmune diseases.  In the current work, three MUC1 antitumor vaccine candidates conjugated with different immune stimulants are evaluated immunol.  For assessment of the influence of the immune stimulant on antibody recognition, a comprehensive library of mucin 1 glycopeptides (>100 entries) is synthesized and employed in antibody microarray profiling; these range from small tumor-assocd. glycans (TN, STN, and T-antigen structures) to heavily extended O-glycan core structures (type-1 and type-2 elongated core 1-3 tri-, tetra-, and hexasaccharides) glycosylated in variable d. at the five different sites of the MUC1 tandem repeat.  This is one of the most extensive glycopeptide libraries ever made through total synthesis.  On tumor cells, the core 2 β-1,6-N-acetylglucosaminyltransferase-1 (C2GlcNAcT-1) is down-regulated, resulting in lower amts. of the branched core 2 structures, which favor formation of linear core 1 or core 3 structures, and in particular, truncated tumor-assocd. antigen structures.  The core 2 structures are commonly found on healthy cells and the elucidation of antibody cross-reactivity to such epitopes may predict the tumor-selectivity and safety of synthetic vaccines.  With the extended mucin core structures in hand, antibody cross-reactivity toward the branched core 2 glycopeptide epitopes is explored.  It is obsd. that the induced antibodies recognize MUC1 peptides with very high glycosylation site specificity.  The nature of the antibody response is characteristically different for antibodies directed to glycosylation sites in either the immune-dominant PDTR or the GSTA domain.  All antibody sera show high reactivity to the tumor-assocd. saccharide structures on MUC1.  Extensive glycosylation with branched core 2 structures, typically found on healthy cells, abolishes antibody recognition of the antisera and suggests that all vaccine conjugates preferentially induce a tumor-specific humoral immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQUSP4J2-84rVg90H21EOLACvtfcHk0lj4VlfpUv3JNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVaqs7c%253D&md5=6af0f627abe8d7c19adef5f7c7cea23a</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fchem.201603921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201603921%26sid%3Dliteratum%253Aachs%26aulast%3DPett%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPalitzsch%26aufirst%3DB.%26aulast%3DSchorlemer%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DS.%26aulast%3DStergiou%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DKunz%26aufirst%3DH.%26aulast%3DSchmitt%26aufirst%3DE.%26aulast%3DWesterlind%26aufirst%3DU.%26atitle%3DMicroarray%2520analysis%2520of%2520antibodies%2520induced%2520with%2520synthetic%2520antitumor%2520vaccines%253A%2520Specificity%2520against%2520diverse%2520mucin%2520core%2520structures%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2017%26volume%3D23%26spage%3D3875%26epage%3D3884%26doi%3D10.1002%2Fchem.201603921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ingale, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfert, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaekwad, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buskas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G. J.</span></span> <span> </span><span class="NLM_article-title">Robust immune responses elicited by a fully synthetic three-component vaccine</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">663</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2007.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnchembio.2007.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=17767155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=663-667&author=S.+Ingaleauthor=M.+A.+Wolfertauthor=J.+Gaekwadauthor=T.+Buskasauthor=G.+J.+Boons&title=Robust+immune+responses+elicited+by+a+fully+synthetic+three-component+vaccine&doi=10.1038%2Fnchembio.2007.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Robust immune responses elicited by a fully synthetic three-component vaccine</span></div><div class="casAuthors">Ingale, Sampat; Wolfert, Margreet A.; Gaekwad, Jidnyasa; Buskas, Therese; Boons, Geert-Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">663-667</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The overexpression of saccharides such as globo-H, LewisY, and Tn antigen is a common feature of oncogenic transformed cells.  Endeavors to exploit this aberrant glycosylation for cancer vaccine development have been complicated by difficulties in eliciting high titers of IgG antibodies against classical conjugates of tumor-assocd. carbohydrates to carrier proteins.  The authors designed, chem. synthesized, and immunol. evaluated a no. of fully synthetic vaccine candidates to establish strategies to overcome the poor immunogenicity of tumor-assocd. carbohydrates and glycopeptides.  The have found that a 3-component vaccine composed of a TLR2 agonist, a promiscuous peptide T-helper epitope, and a tumor-assocd. glycopeptide can elicit in mice exceptionally high titers of IgG antibodies that can recognize cancer cells expressing the tumor-assocd. carbohydrate.  The superior properties of the vaccine candidate are attributed to the local prodn. of cytokines, upregulation of co-stimulatory proteins, enhanced uptake by macrophages and dendritic cells, and avoidance of epitope suppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdz62dPelB7Vg90H21EOLACvtfcHk0lj4VlfpUv3JNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCrtrnO&md5=43cb22b797d84c8b60bedca1a5aee7ea</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2007.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2007.25%26sid%3Dliteratum%253Aachs%26aulast%3DIngale%26aufirst%3DS.%26aulast%3DWolfert%26aufirst%3DM.%2BA.%26aulast%3DGaekwad%26aufirst%3DJ.%26aulast%3DBuskas%26aufirst%3DT.%26aulast%3DBoons%26aufirst%3DG.%2BJ.%26atitle%3DRobust%2520immune%2520responses%2520elicited%2520by%2520a%2520fully%2520synthetic%2520three-component%2520vaccine%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2007%26volume%3D3%26spage%3D663%26epage%3D667%26doi%3D10.1038%2Fnchembio.2007.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gils, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derking, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ketas, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozorowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cupo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debnath, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moldt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Breemen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isik, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Ramirez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Back, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koff, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakasz, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schief, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overbaugh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span> <span> </span><span class="NLM_article-title">HIV-1 neutralizing antibodies induced by native-like envelope trimers</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">aac4223</span>, <span class="refDoi"> DOI: 10.1126/science.aac4223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscience.aac4223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=26089353" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2015&pages=aac4223&author=R.+W.+Sandersauthor=M.+J.+van+Gilsauthor=R.+Derkingauthor=D.+Sokauthor=T.+J.+Ketasauthor=J.+A.+Burgerauthor=G.+Ozorowskiauthor=A.+Cupoauthor=C.+Simonichauthor=L.+Gooauthor=H.+Arendtauthor=H.+J.+Kimauthor=J.+H.+Leeauthor=P.+Pugachauthor=M.+Williamsauthor=G.+Debnathauthor=B.+Moldtauthor=M.+J.+van+Breemenauthor=G.+Isikauthor=M.+Medina-Ramirezauthor=J.+W.+Backauthor=W.+C.+Koffauthor=J.+P.+Julienauthor=E.+G.+Rakaszauthor=M.+S.+Seamanauthor=M.+Guttmanauthor=K.+K.+Leeauthor=P.+J.+Klasseauthor=C.+LaBrancheauthor=W.+R.+Schiefauthor=I.+A.+Wilsonauthor=J.+Overbaughauthor=D.+R.+Burtonauthor=A.+B.+Wardauthor=D.+C.+Montefioriauthor=H.+Deanauthor=J.+P.+Moore&title=HIV-1+neutralizing+antibodies+induced+by+native-like+envelope+trimers&doi=10.1126%2Fscience.aac4223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1126%2Fscience.aac4223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aac4223%26sid%3Dliteratum%253Aachs%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3Dvan%2BGils%26aufirst%3DM.%2BJ.%26aulast%3DDerking%26aufirst%3DR.%26aulast%3DSok%26aufirst%3DD.%26aulast%3DKetas%26aufirst%3DT.%2BJ.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DOzorowski%26aufirst%3DG.%26aulast%3DCupo%26aufirst%3DA.%26aulast%3DSimonich%26aufirst%3DC.%26aulast%3DGoo%26aufirst%3DL.%26aulast%3DArendt%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPugach%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DDebnath%26aufirst%3DG.%26aulast%3DMoldt%26aufirst%3DB.%26aulast%3Dvan%2BBreemen%26aufirst%3DM.%2BJ.%26aulast%3DIsik%26aufirst%3DG.%26aulast%3DMedina-Ramirez%26aufirst%3DM.%26aulast%3DBack%26aufirst%3DJ.%2BW.%26aulast%3DKoff%26aufirst%3DW.%2BC.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3DRakasz%26aufirst%3DE.%2BG.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%2BK.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLaBranche%26aufirst%3DC.%26aulast%3DSchief%26aufirst%3DW.%2BR.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DOverbaugh%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DDean%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26atitle%3DHIV-1%2520neutralizing%2520antibodies%2520induced%2520by%2520native-like%2520envelope%2520trimers%26jtitle%3DScience%26date%3D2015%26volume%3D349%26spage%3Daac4223%26doi%3D10.1126%2Fscience.aac4223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Taeye, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozorowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Pena, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guttman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Julien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van den
Kerkhof, T. L. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritchard, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugach, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasmeen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crampton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bontjer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeStefano, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koff, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuitemaker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggink, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkhout, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBranche, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crotty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crispin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klasse, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span> <span> </span><span class="NLM_article-title">Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">1702</span>– <span class="NLM_lpage">1715</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2015.11.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.cell.2015.11.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2015&pages=1702-1715&author=S.+W.+de+Taeyeauthor=G.+Ozorowskiauthor=A.+T.+de+la+Penaauthor=M.+Guttmanauthor=J.+P.+Julienauthor=T.+L.+G.+M.+van+den%0AKerkhofauthor=J.+A.+Burgerauthor=L.+K.+Pritchardauthor=P.+Pugachauthor=A.+Yasmeenauthor=J.+Cramptonauthor=J.+Huauthor=I.+Bontjerauthor=J.+L.+Torresauthor=H.+Arendtauthor=J.+DeStefanoauthor=W.+C.+Koffauthor=H.+Schuitemakerauthor=D.+Egginkauthor=B.+Berkhoutauthor=H.+Deanauthor=C.+LaBrancheauthor=S.+Crottyauthor=M.+Crispinauthor=D.+C.+Montefioriauthor=P.+J.+Klasseauthor=K.+K.+Leeauthor=J.+P.+Mooreauthor=I.+A.+Wilsonauthor=A.+B.+Wardauthor=R.+W.+Sanders&title=Immunogenicity+of+stabilized+HIV-1+envelope+trimers+with+reduced+exposure+of+non-neutralizing+epitopes&doi=10.1016%2Fj.cell.2015.11.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2015.11.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2015.11.056%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BTaeye%26aufirst%3DS.%2BW.%26aulast%3DOzorowski%26aufirst%3DG.%26aulast%3Dde%2Bla%2BPena%26aufirst%3DA.%2BT.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DJulien%26aufirst%3DJ.%2BP.%26aulast%3Dvan%2Bden%2BKerkhof%26aufirst%3DT.%2BL.%2BG.%2BM.%26aulast%3DBurger%26aufirst%3DJ.%2BA.%26aulast%3DPritchard%26aufirst%3DL.%2BK.%26aulast%3DPugach%26aufirst%3DP.%26aulast%3DYasmeen%26aufirst%3DA.%26aulast%3DCrampton%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DBontjer%26aufirst%3DI.%26aulast%3DTorres%26aufirst%3DJ.%2BL.%26aulast%3DArendt%26aufirst%3DH.%26aulast%3DDeStefano%26aufirst%3DJ.%26aulast%3DKoff%26aufirst%3DW.%2BC.%26aulast%3DSchuitemaker%26aufirst%3DH.%26aulast%3DEggink%26aufirst%3DD.%26aulast%3DBerkhout%26aufirst%3DB.%26aulast%3DDean%26aufirst%3DH.%26aulast%3DLaBranche%26aufirst%3DC.%26aulast%3DCrotty%26aufirst%3DS.%26aulast%3DCrispin%26aufirst%3DM.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DKlasse%26aufirst%3DP.%2BJ.%26aulast%3DLee%26aufirst%3DK.%2BK.%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26atitle%3DImmunogenicity%2520of%2520stabilized%2520HIV-1%2520envelope%2520trimers%2520with%2520reduced%2520exposure%2520of%2520non-neutralizing%2520epitopes%26jtitle%3DCell%26date%3D2015%26volume%3D163%26spage%3D1702%26epage%3D1715%26doi%3D10.1016%2Fj.cell.2015.11.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span> <span> </span><span class="NLM_article-title">Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">338</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.1038/nchem.2463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnchem.2463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27001729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFGrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=338-346&author=S.+S.+Shivatareauthor=S.+H.+Changauthor=T.+I.+Tsaiauthor=S.+Y.+Tsengauthor=V.+S.+Shivatareauthor=Y.+S.+Linauthor=Y.+Y.+Chengauthor=C.+T.+Renauthor=C.+C.+Leeauthor=S.+Pawarauthor=C.+S.+Tsaiauthor=H.+W.+Shihauthor=Y.+F.+Zengauthor=C.+H.+Liangauthor=P.+D.+Kwongauthor=D.+R.+Burtonauthor=C.+Y.+Wuauthor=C.+H.+Wong&title=Modular+synthesis+of+N-glycans+and+arrays+for+the+hetero-ligand+binding+analysis+of+HIV+antibodies&doi=10.1038%2Fnchem.2463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies</span></div><div class="casAuthors">Shivatare, Sachin S.; Chang, Shih-Huang; Tsai, Tsung-I.; Tseng, Susan Yu; Shivatare, Vidya S.; Lin, Yih-Shyan; Cheng, Yang-Yu; Ren, Chien-Tai; Lee, Chang-Chun David; Pawar, Sujeet; Tsai, Charng-Sheng; Shih, Hao-Wei; Zeng, Yi-Fang; Liang, Chi-Hui; Kwong, Peter D.; Burton, Dennis R.; Wu, Chung-Yi; Wong, Chi-Huey</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">338-346</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A new class of broadly neutralizing antibodies (bNAbs) from HIV donors has been reported to target the glycans on gp120-a glycoprotein found on the surface of the virus envelope-thus renewing hope of developing carbohydrate-based HIV vaccines.  However, the version of gp120 used in previous studies was not from human T cells and so the glycosylation pattern could be somewhat different to that found in the native system.  Moreover, some antibodies recognized two different glycans simultaneously and this cannot be detected with the commonly used glycan microarrays on glass slides.  Here, we have developed a glycan microarray on an aluminum-oxide-coated glass slide contg. a diverse set of glycans, including homo- and mixed N-glycans (high-mannose, hybrid and complex types) that were prepd. by modular chemo-enzymic methods to detect the presence of hetero-glycan binding behaviors.  This new approach allows rapid screening and identification of optimal glycans recognized by neutralizing antibodies, and could speed up the development of HIV-1 vaccines targeting cell surface glycans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ8px3BeQ4bLVg90H21EOLACvtfcHk0lgM8RA75kzCog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFGrtbo%253D&md5=b7603c4a18633b2ce8ded2e67e9e0812</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchem.2463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.2463%26sid%3Dliteratum%253Aachs%26aulast%3DShivatare%26aufirst%3DS.%2BS.%26aulast%3DChang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DT.%2BI.%26aulast%3DTseng%26aufirst%3DS.%2BY.%26aulast%3DShivatare%26aufirst%3DV.%2BS.%26aulast%3DLin%26aufirst%3DY.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BY.%26aulast%3DRen%26aufirst%3DC.%2BT.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DPawar%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DC.%2BS.%26aulast%3DShih%26aufirst%3DH.%2BW.%26aulast%3DZeng%26aufirst%3DY.%2BF.%26aulast%3DLiang%26aufirst%3DC.%2BH.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DModular%2520synthesis%2520of%2520N-glycans%2520and%2520arrays%2520for%2520the%2520hetero-ligand%2520binding%2520analysis%2520of%2520HIV%2520antibodies%26jtitle%3DNat.%2520Chem.%26date%3D2016%26volume%3D8%26spage%3D338%26epage%3D346%26doi%3D10.1038%2Fnchem.2463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shivatare, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saidachary, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. H.</span></span> <span> </span><span class="NLM_article-title">Unprecedented role of hybrid N-glycans as ligands for HIV-1 broadly neutralizing antibodies</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">5202</span>– <span class="NLM_lpage">5210</span>, <span class="refDoi"> DOI: 10.1021/jacs.8b00896</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.8b00896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVKrsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2018&pages=5202-5210&author=V.+S.+Shivatareauthor=S.+S.+Shivatareauthor=C.+D.+Leeauthor=C.+H.+Liangauthor=K.+S.+Liaoauthor=Y.+Y.+Chengauthor=G.+Saidacharyauthor=C.+Y.+Wuauthor=N.+H.+Linauthor=P.+D.+Kwongauthor=D.+R.+Burtonauthor=C.+H.+Wong&title=Unprecedented+role+of+hybrid+N-glycans+as+ligands+for+HIV-1+broadly+neutralizing+antibodies&doi=10.1021%2Fjacs.8b00896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Unprecedented Role of Hybrid N-Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies</span></div><div class="casAuthors">Shivatare, Vidya S.; Shivatare, Sachin S.; Lee, Chang-Chun David; Liang, Chi-Hui; Liao, Kuo-Shiang; Cheng, Yang-Yu; Saidachary, Gannerla; Wu, Chung-Yi; Lin, Nan-Horng; Kwong, Peter D.; Burton, Dennis R.; Wong, Chi-Huey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5202-5210</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of an HIV vaccine has been hampered by the extraordinary mutability and genetic diversity of the virus, particularly the substantial sequence diversity of gp120 and gp 41 envelope glycoproteins existing in more than 2000 HIV variants.  The highly diverse glycans on HIV spikes are commonly considered as immunol. silent self-antigens; however, the discovery of highly potent broadly neutralizing antibodies (bNAbs) from HIV patients targeting the viral surface glycans has raised a major question about the origin of their antigens.  Recent epitope mapping studies of the bNAb PG9 indicated a requirement of a properly spaced high mannose and a complex type glycan connected by a short peptide spacer.  We have recently discovered that a 1:1 mixt. of Man5 and sialyl biantennary glycan with well-defined distance and without the peptide spacer is well recognized by PG9 with high avidity and, thus, proposed that a hybrid glycan with oligomannose and complex-type arm could be the proper ligand of PG9.  To verify this proposition, we first designed and chemo-enzymically synthesized a series of unusual hybrid-type N-glycan structures, which may exist on HIV surface glycoproteins through the host-guided N-glycosylation pathway.  The synthetic hybrid glycans were then used to prep. glycan arrays for the binding studies of PG9 and several other highly potent bNAbs, including PG16, PGT121, PGT128-3C, 2G12, VRC13, VRC-PG05, VRC26.25, VRC26.09, PGDM1400, 35O22, and 10-1074.  Our results demonstrated that PG9 and some other bNAbs bind with strong avidity (subnanomolar Kd) to certain hybrid structures, suggesting that these unusual glycans may serve as epitopes for the design of vaccines against HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRmzrcr3QyLVg90H21EOLACvtfcHk0lgM8RA75kzCog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVKrsrY%253D&md5=ac69e306f179dd311c0e73da92551b3b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjacs.8b00896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.8b00896%26sid%3Dliteratum%253Aachs%26aulast%3DShivatare%26aufirst%3DV.%2BS.%26aulast%3DShivatare%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DC.%2BD.%26aulast%3DLiang%26aufirst%3DC.%2BH.%26aulast%3DLiao%26aufirst%3DK.%2BS.%26aulast%3DCheng%26aufirst%3DY.%2BY.%26aulast%3DSaidachary%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DC.%2BY.%26aulast%3DLin%26aufirst%3DN.%2BH.%26aulast%3DKwong%26aufirst%3DP.%2BD.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DWong%26aufirst%3DC.%2BH.%26atitle%3DUnprecedented%2520role%2520of%2520hybrid%2520N-glycans%2520as%2520ligands%2520for%2520HIV-1%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2018%26volume%3D140%26spage%3D5202%26epage%3D5210%26doi%3D10.1021%2Fjacs.8b00896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreider, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fera, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerhoff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussedat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkowicz, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladden, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monroe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louder, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pier, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jette, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelsoe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamanga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hraber, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahn, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korber, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">eaai7514</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.aai7514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1126%2Fscitranslmed.aai7514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28298420" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=eaai7514&author=M.+Bonsignoriauthor=E.+F.+Kreiderauthor=D.+Feraauthor=R.+R.+Meyerhoffauthor=T.+Bradleyauthor=K.+Wieheauthor=S.+M.+Alamauthor=B.+Aussedatauthor=W.+E.+Walkowiczauthor=K.+K.+Hwangauthor=K.+O.+Saundersauthor=R.+Zhangauthor=M.+A.+Gladdenauthor=A.+Monroeauthor=A.+Kumarauthor=S.+M.+Xiaauthor=M.+Cooperauthor=M.+K.+Louderauthor=K.+McKeeauthor=R.+T.+Bailerauthor=B.+W.+Pierauthor=C.+A.+Jetteauthor=G.+Kelsoeauthor=W.+B.+Williamsauthor=L.+Morrisauthor=J.+Kappesauthor=K.+Waghauthor=G.+Kamangaauthor=M.+S.+Cohenauthor=P.+T.+Hraberauthor=D.+C.+Montefioriauthor=A.+Tramaauthor=H.+X.+Liaoauthor=T.+B.+Keplerauthor=M.+A.+Moodyauthor=F.+Gaoauthor=S.+J.+Danishefskyauthor=J.+R.+Mascolaauthor=G.+M.+Shawauthor=B.+H.+Hahnauthor=S.+C.+Harrisonauthor=B.+T.+Korberauthor=B.+F.+Haynes&title=Staged+induction+of+HIV-1+glycan-dependent+broadly+neutralizing+antibodies&doi=10.1126%2Fscitranslmed.aai7514"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aai7514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aai7514%26sid%3Dliteratum%253Aachs%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DKreider%26aufirst%3DE.%2BF.%26aulast%3DFera%26aufirst%3DD.%26aulast%3DMeyerhoff%26aufirst%3DR.%2BR.%26aulast%3DBradley%26aufirst%3DT.%26aulast%3DWiehe%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DAussedat%26aufirst%3DB.%26aulast%3DWalkowicz%26aufirst%3DW.%2BE.%26aulast%3DHwang%26aufirst%3DK.%2BK.%26aulast%3DSaunders%26aufirst%3DK.%2BO.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DGladden%26aufirst%3DM.%2BA.%26aulast%3DMonroe%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DXia%26aufirst%3DS.%2BM.%26aulast%3DCooper%26aufirst%3DM.%26aulast%3DLouder%26aufirst%3DM.%2BK.%26aulast%3DMcKee%26aufirst%3DK.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DPier%26aufirst%3DB.%2BW.%26aulast%3DJette%26aufirst%3DC.%2BA.%26aulast%3DKelsoe%26aufirst%3DG.%26aulast%3DWilliams%26aufirst%3DW.%2BB.%26aulast%3DMorris%26aufirst%3DL.%26aulast%3DKappes%26aufirst%3DJ.%26aulast%3DWagh%26aufirst%3DK.%26aulast%3DKamanga%26aufirst%3DG.%26aulast%3DCohen%26aufirst%3DM.%2BS.%26aulast%3DHraber%26aufirst%3DP.%2BT.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DTrama%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DKepler%26aufirst%3DT.%2BB.%26aulast%3DMoody%26aufirst%3DM.%2BA.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DShaw%26aufirst%3DG.%2BM.%26aulast%3DHahn%26aufirst%3DB.%2BH.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26aulast%3DKorber%26aufirst%3DB.%2BT.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DStaged%2520induction%2520of%2520HIV-1%2520glycan-dependent%2520broadly%2520neutralizing%2520antibodies%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26spage%3Deaai7514%26doi%3D10.1126%2Fscitranslmed.aai7514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sarzotti-Kelsoe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailer, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascola, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span> <span> </span><span class="NLM_article-title">Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>409</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1016/j.jim.2013.11.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.jim.2013.11.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=24291345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=409&publication_year=2014&pages=131-146&author=M.+Sarzotti-Kelsoeauthor=R.+T.+Bailerauthor=E.+Turkauthor=C.+L.+Linauthor=M.+Bilskaauthor=K.+M.+Greeneauthor=H.+Gaoauthor=C.+A.+Toddauthor=D.+A.+Ozakiauthor=M.+S.+Seamanauthor=J.+R.+Mascolaauthor=D.+C.+Montefiori&title=Optimization+and+validation+of+the+TZM-bl+assay+for+standardized+assessments+of+neutralizing+antibodies+against+HIV-1&doi=10.1016%2Fj.jim.2013.11.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1</span></div><div class="casAuthors">Sarzotti-Kelsoe, Marcella; Bailer, Robert T.; Turk, Ellen; Lin, Chen-li; Bilska, Miroslawa; Greene, Kelli M.; Gao, Hongmei; Todd, Christopher A.; Ozaki, Daniel A.; Seaman, Michael S.; Mascola, John R.; Montefiori, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">409</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-146</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The TZM-bl assay measures antibody-mediated neutralization of HIV-1 as a function of redns. in HIV-1 Tat-regulated firefly luciferase (Luc) reporter gene expression after a single round of infection with Env-pseudotyped viruses.  This assay has become the main endpoint neutralization assay used for the assessment of pre-clin. and clin. trial samples by a growing no. of labs. worldwide.  Here we present the results of the formal optimization and validation of the TZM-bl assay, performed in compliance with Good Clin. Lab. Practice (GCLP) guidelines.  The assay was evaluated for specificity, accuracy, precision, limits of detection and quantitation, linearity, range and robustness.  The validated manual TZM-bl assay was also adapted, optimized and qualified to an automated 384-well format.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRlthftSkNArVg90H21EOLACvtfcHk0ljLsfb6gsCZoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisVKgug%253D%253D&md5=be95a68aa529fa6346a0749f22bd9895</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.jim.2013.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jim.2013.11.022%26sid%3Dliteratum%253Aachs%26aulast%3DSarzotti-Kelsoe%26aufirst%3DM.%26aulast%3DBailer%26aufirst%3DR.%2BT.%26aulast%3DTurk%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DC.%2BL.%26aulast%3DBilska%26aufirst%3DM.%26aulast%3DGreene%26aufirst%3DK.%2BM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DTodd%26aufirst%3DC.%2BA.%26aulast%3DOzaki%26aufirst%3DD.%2BA.%26aulast%3DSeaman%26aufirst%3DM.%2BS.%26aulast%3DMascola%26aufirst%3DJ.%2BR.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26atitle%3DOptimization%2520and%2520validation%2520of%2520the%2520TZM-bl%2520assay%2520for%2520standardized%2520assessments%2520of%2520neutralizing%2520antibodies%2520against%2520HIV-1%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D2014%26volume%3D409%26spage%3D131%26epage%3D146%26doi%3D10.1016%2Fj.jim.2013.11.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hangartner, L.</span></span> <span> </span><span class="NLM_article-title">Broadly neutralizing antibodies to HIV and their role in vaccine design</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">659</span>, <span class="refDoi"> DOI: 10.1146/annurev-immunol-041015-055515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1146%2Fannurev-immunol-041015-055515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=27168247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC28Xnslemsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=635-659&author=D.+R.+Burtonauthor=L.+Hangartner&title=Broadly+neutralizing+antibodies+to+HIV+and+their+role+in+vaccine+design&doi=10.1146%2Fannurev-immunol-041015-055515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design</span></div><div class="casAuthors">Burton, Dennis R.; Hangartner, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">635-659</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">HIV employs multiple means to evade the humoral immune response, particularly the elicitation of and recognition by broadly neutralizing antibodies (bnAbs).  Such antibodies can act antivirally against a wide spectrum of viruses by targeting relatively conserved regions on the surface HIV envelope trimer spike.  Elicitation of and recognition by bnAbs are hindered by the arrangement of spikes on virions and the relatively difficult access to bnAb epitopes on spikes, including the proximity of variable regions and a high d. of glycans.  Yet, in a small proportion of HIV-infected individuals, potent bnAb responses do develop, and isolation of the corresponding monoclonal antibodies has been facilitated by identification of favorable donors with potent bnAb sera and by development of improved methods for human antibody generation.  Mol. studies of recombinant Env trimers, alone and in interaction with bnAbs, are providing new insights that are fueling the development and testing of promising immunogens aimed at the elicitation of bnAbs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDZd_PZ1EhhLVg90H21EOLACvtfcHk0ljLsfb6gsCZoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xnslemsr4%253D&md5=b5361d73371daf855d99645e417c66e1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1146%2Fannurev-immunol-041015-055515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-immunol-041015-055515%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DD.%2BR.%26aulast%3DHangartner%26aufirst%3DL.%26atitle%3DBroadly%2520neutralizing%2520antibodies%2520to%2520HIV%2520and%2520their%2520role%2520in%2520vaccine%2520design%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2016%26volume%3D34%26spage%3D635%26epage%3D659%26doi%3D10.1146%2Fannurev-immunol-041015-055515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelsoe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Host controls of HIV broadly neutralizing antibody development</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1111/imr.12508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1111%2Fimr.12508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28133807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2017&pages=79-88&author=G.+Kelsoeauthor=B.+F.+Haynes&title=Host+controls+of+HIV+broadly+neutralizing+antibody+development&doi=10.1111%2Fimr.12508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Host controls of HIV broadly neutralizing antibody development</span></div><div class="casAuthors">Kelsoe, Garnett; Haynes, Barton F.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">79-88</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Induction of broadly neutralizing antibodies (bNAbs) is a major goal of HIV vaccine development.  BNAbs are made during HIV infection by a subset of individuals but currently cannot be induced in the setting of vaccination.  Considerable progress has been made recently in understanding host immunol. controls of bNAb induction and maturation in the setting of HIV infection, and point to key roles for both central and peripheral immunol. tolerance mechanisms in limiting bnAb development.  Immune tolerance checkpoint inhibition has been transformative in promotion of anti-tumor CD8 T-cell responses in the treatment of certain malignancies.  Here, we review the evidence for host controls of bNAb responses, and discuss strategies for the transient modulation of immune responses with vaccines toward the goal of enhancing germinal center B-cell responses to favor bNAb B-cell lineages and to foster their maturation to full neutralization potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp4ql3C9zrLbVg90H21EOLACvtfcHk0lhJOc58MlwTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsb4%253D&md5=07f52b4426b2d70309bc4d91e364694d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fimr.12508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12508%26sid%3Dliteratum%253Aachs%26aulast%3DKelsoe%26aufirst%3DG.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DHost%2520controls%2520of%2520HIV%2520broadly%2520neutralizing%2520antibody%2520development%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D275%26spage%3D79%26epage%3D88%26doi%3D10.1111%2Fimr.12508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.1111/imr.12509</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1111%2Fimr.12509" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28133802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2017&pages=145-160&author=M.+Bonsignoriauthor=H.+X.+Liaoauthor=F.+Gaoauthor=W.+B.+Williamsauthor=S.+M.+Alamauthor=D.+C.+Montefioriauthor=B.+F.+Haynes&title=Antibody-virus+co-evolution+in+HIV+infection%3A+paths+for+HIV+vaccine+development&doi=10.1111%2Fimr.12509"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development</span></div><div class="casAuthors">Bonsignori, Mattia; Liao, Hua-Xin; Gao, Feng; Williams, Wilton B.; Alam, S. Munir; Montefiori, David C.; Haynes, Barton F.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-160</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Summary : Induction of HIV-1 broadly neutralizing antibodies (bnAbs) to date has only been obsd. in the setting of HIV-1 infection, and then only years after HIV transmission.  Thus, the concept has emerged that one path to induction of bnAbs is to define the viral and immunol. events that occur during HIV-1 infection, and then to mimic those events with a vaccine formulation.  This concept has led to efforts to map both virus and antibody events that occur from the time of HIV-1 transmission to development of bnAbs.  This work has revealed that a virus-antibody "arms race" occurs in which a HIV-1 transmitted/founder (TF) Env induces autologous neutralizing antibodies that can not only neutralize the TF virus but also can select virus escape mutants that in turn select affinity-matured neutralizing antibodies.  From these studies has come a picture of bnAb development that has led to new insights in host-pathogen interactions and, as well, led to insight into immunol. mechanisms of control of bnAb development.  Here, we review the progress to date in elucidating bnAb B cell lineages in HIV-1 infection, discuss new research leading to understanding the immunol. mechanisms of bnAb induction, and address issues relevant to the use of this information for the design of new HIV-1 sequential envelope vaccine candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR-u4Iil4-_rVg90H21EOLACvtfcHk0lhJOc58MlwTMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1egsLY%253D&md5=73f2ad9876ecbb66d964dcc3522b4544</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1111%2Fimr.12509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fimr.12509%26sid%3Dliteratum%253Aachs%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DWilliams%26aufirst%3DW.%2BB.%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DAntibody-virus%2520co-evolution%2520in%2520HIV%2520infection%253A%2520paths%2520for%2520HIV%2520vaccine%2520development%26jtitle%3DImmunol.%2520Rev.%26date%3D2017%26volume%3D275%26spage%3D145%26epage%3D160%26doi%3D10.1111%2Fimr.12509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sok, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vadnais, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saye-Francisco, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jardine, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berndsen, Z. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanfield, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Criscitiello, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mwangi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smider, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, D. R.</span></span> <span> </span><span class="NLM_article-title">Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>548</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1038/nature23301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1038%2Fnature23301" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2017&pages=108-111&author=D.+Sokauthor=K.+M.+Leauthor=M.+Vadnaisauthor=K.+L.+Saye-Franciscoauthor=J.+G.+Jardineauthor=J.+L.+Torresauthor=Z.+T.+Berndsenauthor=L.+Kongauthor=R.+Stanfieldauthor=J.+Ruizauthor=A.+Ramosauthor=C.+H.+Liangauthor=P.+L.+Chenauthor=M.+F.+Criscitielloauthor=W.+Mwangiauthor=I.+A.+Wilsonauthor=A.+B.+Wardauthor=V.+V.+Smiderauthor=D.+R.+Burton&title=Rapid+elicitation+of+broadly+neutralizing+antibodies+to+HIV+by+immunization+in+cows&doi=10.1038%2Fnature23301"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1038%2Fnature23301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature23301%26sid%3Dliteratum%253Aachs%26aulast%3DSok%26aufirst%3DD.%26aulast%3DLe%26aufirst%3DK.%2BM.%26aulast%3DVadnais%26aufirst%3DM.%26aulast%3DSaye-Francisco%26aufirst%3DK.%2BL.%26aulast%3DJardine%26aufirst%3DJ.%2BG.%26aulast%3DTorres%26aufirst%3DJ.%2BL.%26aulast%3DBerndsen%26aufirst%3DZ.%2BT.%26aulast%3DKong%26aufirst%3DL.%26aulast%3DStanfield%26aufirst%3DR.%26aulast%3DRuiz%26aufirst%3DJ.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DP.%2BL.%26aulast%3DCriscitiello%26aufirst%3DM.%2BF.%26aulast%3DMwangi%26aufirst%3DW.%26aulast%3DWilson%26aufirst%3DI.%2BA.%26aulast%3DWard%26aufirst%3DA.%2BB.%26aulast%3DSmider%26aufirst%3DV.%2BV.%26aulast%3DBurton%26aufirst%3DD.%2BR.%26atitle%3DRapid%2520elicitation%2520of%2520broadly%2520neutralizing%2520antibodies%2520to%2520HIV%2520by%2520immunization%2520in%2520cows%26jtitle%3DNature%26date%3D2017%26volume%3D548%26spage%3D108%26epage%3D111%26doi%3D10.1038%2Fnature23301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicely, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonsignori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerhoff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parks, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walkowicz, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aussedat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vohra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Go, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barouch, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Holle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overman, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anasti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanders, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepler, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desaire, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letvin, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabel, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montefiori, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaras, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danishefsky, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes, B. F.</span></span> <span> </span><span class="NLM_article-title">Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2175</span>– <span class="NLM_lpage">2188</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2017.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=10.1016%2Fj.celrep.2017.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=28249163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjs1Ontb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=2175-2188&author=K.+O.+Saundersauthor=N.+I.+Nicelyauthor=K.+Wieheauthor=M.+Bonsignoriauthor=R.+R.+Meyerhoffauthor=R.+Parksauthor=W.+E.+Walkowiczauthor=B.+Aussedatauthor=N.+R.+Wuauthor=F.+Caiauthor=Y.+Vohraauthor=P.+K.+Parkauthor=A.+Eatonauthor=E.+P.+Goauthor=L.+L.+Sutherlandauthor=R.+M.+Scearceauthor=D.+H.+Barouchauthor=R.+Zhangauthor=T.+Von+Holleauthor=R.+G.+Overmanauthor=K.+Anastiauthor=R.+W.+Sandersauthor=M.+A.+Moodyauthor=T.+B.+Keplerauthor=B.+Korberauthor=H.+Desaireauthor=S.+Santraauthor=N.+L.+Letvinauthor=G.+J.+Nabelauthor=D.+C.+Montefioriauthor=G.+D.+Tomarasauthor=H.+X.+Liaoauthor=S.+M.+Alamauthor=S.+J.+Danishefskyauthor=B.+F.+Haynes&title=Vaccine+elicitation+of+high+mannose-dependent+neutralizing+antibodies+against+the+V3-glycan+broadly+neutralizing+epitope+in+nonhuman+primates&doi=10.1016%2Fj.celrep.2017.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates</span></div><div class="casAuthors">Saunders, Kevin O.; Nicely, Nathan I.; Wiehe, Kevin; Bonsignori, Mattia; Meyerhoff, R. Ryan; Parks, Robert; Walkowicz, William E.; Aussedat, Baptiste; Wu, Nelson R.; Cai, Fangping; Vohra, Yusuf; Park, Peter K.; Eaton, Amanda; Go, Eden P.; Sutherland, Laura L.; Scearce, Richard M.; Barouch, Dan H.; Zhang, Ruijun; Von Holle, Tarra; Overman, R. Glenn; Anasti, Kara; Sanders, Rogier W.; Moody, M. Anthony; Kepler, Thomas B.; Korber, Bette; Desaire, Heather; Santra, Sampa; Letvin, Norman L.; Nabel, Gary J.; Montefiori, David C.; Tomaras, Georgia D.; Liao, Hua-Xin; Alam, S. Munir; Danishefsky, Samuel J.; Haynes, Barton F.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2175-2188</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Induction of broadly neutralizing antibodies (bnAbs) that target HIV-1 envelope (Env) is a goal of HIV-1 vaccine development.  A bnAb target is the Env third variable loop (V3)-glycan site.  To det. whether immunization could induce antibodies to the V3-glycan bnAb binding site, we repetitively immunized macaques over a 4-yr period with an Env expressing V3-high mannose glycans.  Env immunizations elicited plasma antibodies that neutralized HIV-1 expressing only high-mannose glycans-a characteristic shared by early bnAb B cell lineage members.  A rhesus recombinant monoclonal antibody from a vaccinated macaque bound to the V3-glycan site at the same amino acids as broadly neutralizing antibodies.  A structure of the antibody bound to glycan revealed that the three variable heavy-chain complementarity-detg. regions formed a cavity into which glycan could insert and neutralized multiple HIV-1 isolates with high-mannose glycans.  Thus, HIV-1 Env vaccination induced mannose-dependent antibodies with characteristics of V3-glycan bnAb precursors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL6sb_yZj8prVg90H21EOLACvtfcHk0li3Klk1CdjJDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjs1Ontb8%253D&md5=7ce8b063eebb312d62db661f080f0837</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2017.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2017.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DSaunders%26aufirst%3DK.%2BO.%26aulast%3DNicely%26aufirst%3DN.%2BI.%26aulast%3DWiehe%26aufirst%3DK.%26aulast%3DBonsignori%26aufirst%3DM.%26aulast%3DMeyerhoff%26aufirst%3DR.%2BR.%26aulast%3DParks%26aufirst%3DR.%26aulast%3DWalkowicz%26aufirst%3DW.%2BE.%26aulast%3DAussedat%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DN.%2BR.%26aulast%3DCai%26aufirst%3DF.%26aulast%3DVohra%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DP.%2BK.%26aulast%3DEaton%26aufirst%3DA.%26aulast%3DGo%26aufirst%3DE.%2BP.%26aulast%3DSutherland%26aufirst%3DL.%2BL.%26aulast%3DScearce%26aufirst%3DR.%2BM.%26aulast%3DBarouch%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DVon%2BHolle%26aufirst%3DT.%26aulast%3DOverman%26aufirst%3DR.%2BG.%26aulast%3DAnasti%26aufirst%3DK.%26aulast%3DSanders%26aufirst%3DR.%2BW.%26aulast%3DMoody%26aufirst%3DM.%2BA.%26aulast%3DKepler%26aufirst%3DT.%2BB.%26aulast%3DKorber%26aufirst%3DB.%26aulast%3DDesaire%26aufirst%3DH.%26aulast%3DSantra%26aufirst%3DS.%26aulast%3DLetvin%26aufirst%3DN.%2BL.%26aulast%3DNabel%26aufirst%3DG.%2BJ.%26aulast%3DMontefiori%26aufirst%3DD.%2BC.%26aulast%3DTomaras%26aufirst%3DG.%2BD.%26aulast%3DLiao%26aufirst%3DH.%2BX.%26aulast%3DAlam%26aufirst%3DS.%2BM.%26aulast%3DDanishefsky%26aufirst%3DS.%2BJ.%26aulast%3DHaynes%26aufirst%3DB.%2BF.%26atitle%3DVaccine%2520elicitation%2520of%2520high%2520mannose-dependent%2520neutralizing%2520antibodies%2520against%2520the%2520V3-glycan%2520broadly%2520neutralizing%2520epitope%2520in%2520nonhuman%2520primates%26jtitle%3DCell%2520Rep.%26date%3D2017%26volume%3D18%26spage%3D2175%26epage%3D2188%26doi%3D10.1016%2Fj.celrep.2017.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01290">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51163"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01290">10.1021/acs.jmedchem.8b01290</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SPR sensor grams of the binding of PGT128, PGT126, 10-1074, and PGT121 to synthetic A244 V3 glycopeptides (Figure S1); SPR analysis of the binding of bNAbs to mutated A244 high-mannose glycopeptide (<b>11</b>) and JR-FL N332 high-mannose glycopeptide (<b>12</b>) (Figure S2); ELISA analysis of the binding of the antisera induced by JR-FL N332 V3 glycopeptide to the JR-FL V3 glycopeptide and A244 V3 glycopeptides (Figure S3); comparison of end point titers of the antisera induced by the JR-FL and A244 V3 glycopeptide immunogens to HIV-1 gp120/gp140s (Table S1); HPLC and mass spectrometry profiles of synthetic glycopeptides (<b>1</b>, <b>3</b>, <b>5</b>–<b>11</b>, and <b>14</b>–<b>17</b>) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_001.pdf">jm8b01290_si_001.pdf (2.04 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01290/suppl_file/jm8b01290_si_002.csv">jm8b01290_si_002.csv (19.45 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01290&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-22%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01290%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01290" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997dd67e933d1e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
